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PREFACE: SMALL NUCLEAR NON-CODING RNA FUNCTION IN EVERY ASPECT OF 
GENOME EXPRESSION, MAINTENANCE AND ARCHITECTURE 
The central dogma of biology, until not long ago, held that genetic information 
stored on DNA molecules was translated into the final protein products through 
RNAs as intermediate molecules. Proteins were considered to be the principal 
effectors of metabolism as well as responsible for the construction and diversity of 
organisms. During the past decade, an additional level of complexity in the 
regulation of genome expression was added, implicating new classes of RNA 
molecules called noncoding RNA (ncRNA). These ncRNAs are also often referred to 
as functional RNAs in that, although they do not contain the capacity to encode 
proteins, they a function as RNA molecules.  
The most abundant ncRNAs have been extensively studied, and were found 
to be involved in relatively generic functions in cells. As we can see in Figure 1, 
ncRNAs form tight complexes with proteins that have catalytic activities, act as 
chaperones, protect them from degradation or meditate interactions with other 
complexes. These RNA-protein complexes are named ribonucleoproteins particles 
(RNPs). Our research group has a long-standing interest in understanding the 
structural and functional diversity of the complex and fascinating world of human 
small nuclear RNPs (snRNPs). In fact, ribosomal (rRNA) and transfer RNAs (tRNA) 
participate in messenger RNA (mRNA) translation, and the signal recognition 
particle RNA (SRP RNA) functions in the translocation of the membrane and 
extracellular proteins into the endoplasmic reticulum. ncRNA also function in RNA 
processing: like spliceosomal RNAs (snRNAs), RNase P RNA, U7 snRNA, RNase 
MRP small nucleolar RNA (snoRNA), box C/D and box H/ACA RNA snoRNAs and 
small Cajal body-specific scaRNAs, and guide RNAs for mRNA editing. Eukaryotic 
chromosome end synthesis is templated by the telomerase RNA and 7SK RNA is 
implicated in transcription elongation regulation. microRNAs (miRNAs) are important 
regulators of gene expression, since they have been implicated in regulation of 
translation and heterochromatin formation and maintenance (Figure 1). 
Today, with the ability to analyze the RNA products of the genome in even 
greater depth, it has become clear that most of the eukaryotic genome is transcribed 
(Clark et al., 2011). This pervasive transcription produces a bulk of noncoding RNAs 
unknown until now and the remaining question is whether these transcripts are 
functional or they represent transcriptional noise. An increasing number of reports 
suggest regulatory roles for ncRNAs in systems ranging from bacteria to mammals, 
with reports of their involvement in nearly every cellular process (Figure 2). Novel 
classes of noncoding RNAs, such as piRNAs or long noncoding RNAs have recently 
emerged. These studies are changing our vision of the genomes, and suggest that 
the universe of noncoding RNAs extends far beyond the boundaries of what we had 
previously imagined (for reviews see (Amaral et al., 2008; Orom and Shiekhattar, 
2011; Rederstorff and Huttenhofer, 2010; Ulveling et al., 2011)).  
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Figure 1. RNPs in Gene Expression and Its Regulation. RNPs play extensive 
roles in gene expression and its regulation. Here, the major activities of RNPs are 
depicted during eukaryotic gene expression. Following transcription by RNA 
Polymerases II (RNA Pol II), pre-mRNAs are bound by diverse proteins, such as 
hnRNP and SR (serine-arginine-rich) proteins. Pre-mRNAs, containing exons (red) 
and introns (pink), are subjected to processing by a range of RNPs that include 
uridine-rich (U-rich) small nuclear RNPs (U snRNPs) that make up the spliceosome. 
Certain RNAs such as pre-transfer RNAs and mRNA transcripts encoding histones 
also undergo processing by specific RNPs (RNase P and U7 snRNP, respectively). 
Small nucleolar RNPs (snoRNPs) and small Cajal body RNPs (scaRNPs) mediate 
maturation of RNA components of RNPs such as ribosomal RNAs (transcribed by 
RNA Polymerase I, RNA Pol I) and snRNAs, respectively. Small RNAs can form 
microRNPs that regulate translation. In certain organisms, RNA-induced 
transcriptional silencing (RITS) complexes, which contain small-interfering RNAs, 
mediate heterochromatin formation and maintenance. Telomerase, a box H/ACA 
scaRNP, replenishes the terminal telomeric repeats of chromosomes to maintain 
genomic stability. In the cytoplasm, the ribosome is the key RNP that directs the 
translation of mRNA into protein. It also functions with the signal recognition particle 
(SRP) RNP to direct protein translocation into the endoplasmic reticulum (ER). 
tRNAs also form complexes in the cytoplasm with aminoacyl-tRNA (aa-tRNA) 
synthetases, which charge tRNAs with the corresponding amino acid, and with 
translation elongation factor eEF1A. Adapted from (Wahl et al., 2009). 
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Figure 2. A. Examples of small regulatory ncRNAs. B. A historic view of 
noncoding RNA. Key dates in the discovery of noncoding RNA are indicated, 
from the first ribosomal RNA (rRNA) to the first description of the regulatory 
function of micro RNAs. Correlated with the discovery of pervasive transcription, 
an increasing number of functions involving non coding RNA have been 
described, including novel functions for well characterized RNAs, such as 
tRNAs, snoRNAs, snRNAs or even mRNAs. Adapted from (Ulveling et al., 
2011). 
Examples of the various levels of regulation of eukaryotic 
gene expression by small ncRNAs. 
RNA maturation and processing 
Spliceosomal snRNAs, U7 snRNA, RNA of RNaseP, box C/D and 
box H/ACA RNAs (sRNAs, snoRNAs, scaRNAs), guide RNAs 
Transcription 
7SK, B2, Alu 
Translation 
rRNA, tRNA 
Gene expression regulation 
miRNAs, siRNAs, piRNAs 
Genome maintenance 
Telomerase RNA 
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Several classes of ncRNAs have been proposed, according to their function, 
structure, subcellular localization and biogenesis (Figure 3). Given the vast diversity 
of the RNA world, the present manuscript will focus on our current knowledge of 
small nuclear ncRNAs ranging from 60 to 300 nucleotides (nt) in length. In fact, our 
purpose was to contribute to the ongoing expansion of the functions involving small 
nuclear RNAs. Our work has focused on two particular classes of ncRNAs: the 
nucleoplasmic spliceosomal snRNAs and the nucleolar and Cajal body-specific box 
C/D 2’-O-methylation guide RNAs.  
I will first give an overview on the function of non-coding spliceosomal 
snRNAs. Their biogenesis as well as the multiple links between transcription and 
splicing will be discussed.  The second chapter will focus on the expansion of the 
functions involving small non-coding RNAs in mRNA production. Finally, the third 
part of this manuscript will concentrate on the expanding class of box C/D RNA 
modification guide RNAs.  
 
Figure 3. Different families of noncoding RNAs. Class I represents functional 
RNAs wich possess little protein coding potential, because they carry no long open 
reading frames. Class II represents RNAs translated into proteins. Note that the 
maturation steps of ncRNAs are not indicated. Recently, RNAs with both protein 
coding capacity and activity as functional ncRNAs have been reported. Inversely, 
RNA primarily classified as non-protein-coding RNA has been showed to hold 
coding capacities (Ulveling et al., 2011). Therefore, categorization of some RNA 
molecules into class I or II may be challenging. sRNA: small RNA ; lRNA: long RNA 
; siRNA: small interfering RNA ; miRNA: microRNA ; snRNA: small nuclear RNA ; 
snoRNA: small nucleolar RNA ; scaRNA: small Cajal body-specific RNA ; pre-
mRNA: precursor messenger RNA  
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CHAPTER  I:  
SMALL NUCLEAR SPLICEOSOMAL RNAs: ARCHITECTURE, 
BIOGENESIS AND FUNCTION 
A. PRECURSOR mRNA SPLICING 
Precursor mRNA introns have been found in all examined eukaryotes, and it is 
thought that they were present in the last common eukaryote ancestor. Introns of 
precursor mRNAs are removed in a process called splicing.  
Strikingly, the signal sequences in pre-mRNAs which define the exon regions are 
short: they comprise the 5’ splice site (ss), the 3’ ss and the branch site (BS). The 
BS is typically located 18-40 nucleotides upstream from the 3'ss and in higher 
eukaryotes is followed by a polypyrimidine tract (PPT). The consensus sequences 
found in the budding yeast Saccharomyces cerevisiae exhibit a higher level of 
conservation than those in metazoans, probably because this organism exhibits less 
alternative splicing events. Additional, cis-acting pre-mRNA elements include exonic 
and intronic splicing enhancers (ESEs and ISEs) or silencers (ESSs and ISSs). 
They are typically short and diverse in sequence and modulate both constitutive and 
alternative splicing by binding regulatory proteins that either stimulate or repress the 
assembly of spliceosomal complexes at an adjacent splice site (see regulation of 
splicing p 19) (for reviews see (Wang and Burge, 2008) (Chen and Manley, 2009)). 
Therefore, the splicing machinery is able to recognize functional 5’ and 3’ splice 
sites and, after removal of the intronic sequences, ligate them together.  
In the first step of splicing, the 2’ hydroxyl of an adenosine in the BS attacks the 
5’ splice site (exon-intron junction). As a consequence, the 5’ exon is cleaved off, 
and the 5’ end of the intron is ligated to the BS via the 2’ hydroxyl group. In the 
second trans-esterification reaction, the 3’ hydroxyl of the 5’ exon attacks the 3’ 
splice site, which results in the ligation of the two exons and release of the intron 
lariat. (Figure 4) Under the appropriate conditions, the chemical steps of splicing 
are reversible (Cheng and Tseng, 2008) 
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Figure 4. Catalytic reactions and conserved sequence elements of splicing. A. 
Schematic representation of the two-step mechanism of pre-mRNA splicing. Boxes 
and solid lines represent the exons (E1, E2) and the intron, respectively. The branch 
site adenosine is indicated by the letter A and the phosphate groups (p) at the 5′ and 
3′ splice sites, which are conserved in the splicing products, are also shown. B. 
Conserved sequences found at the 5′ and 3′ splice sites and branch site of U2-type 
pre-mRNA introns in metazoans and budding yeast (S. cerevisiae). Y = pyrimidine 
and R = purine. The polypyrimidine tract is indicated by (Yn). From (Will and 
Luhrmann, 2011) 
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The machinery catalyzing the splicing reaction is called the spliceosome, an 
immense RNP estimated to be several megadaltons. Here again, non-coding RNAs 
play a fundamental role: this large complex contains five uridine-rich snRNAs: the 
U1, U2, U4, U5 and U6 spliceosomal snRNAs. The U snRNAs range in length from 
107 to 210 nucleotides, and are associated with several proteins to form small 
nuclear ribonucleoprotein particles (snRNPs) (Figure 5).  The spliceosome also 
contains an impressive amount of non-snRNP splicing factors. Proteomic analyse 
indicate that over 170 proteins associate with the human spliceosome at some point 
during the splicing process (for reviews see (Wahl et al., 2009) (Will and Luhrmann, 
2011)). In vitro 100 proteins constitute the core spliceosome minimally required for 
activity in yeast (Fabrizio et al., 2009). 
The basic mechanisms of spliceosome assembly are well known (Figure 6). 
The process begins with base-pairing of the 5’ arm of U1 snRNA with the 5’ splice 
site (Figure 5 and 6) and the binding of SF1/mBBP to the branch point. This step is 
ATP independent and this stage of assembly is called the E’ complex. The E’ 
complex can be converted into the E complex by the recruitment of U2AF to the 
polypyrimide tract. All further steps of spliceosome assembly are ATP or GTP 
dependent. In a subsequent step, SF1 is replaced by the U2 snRNP at the branch 
site forming a short U2-BS duplex in which the branch adenosine is bulged out, 
specifying its 2′ OH as the nucleophile for the first catalytic step of splicing. At this 
step the complex is named A complex or pre-spliceosome. The preassembled 
U4/U6-U5 tri-snRNP is then recruited, generating the pre-catalytic B complex. At 
this step, major RNA-RNA and RNA-protein rearrangements occur. Within the 
U4/U6.U5 tri-snRNP, the U6 and U4 snRNAs are extensively base-paired with each 
other. After association of the tri-snRNP with the A complex, the U4/U6 interaction is 
disrupted, releasing the U4 snRNA. The 5′ end of U6 snRNA base pairs with the 
5′ss, displacing the U1 snRNA, and extensive U6/U2 snRNA base pairing occurs. 
This process gives rise to the activated spliceosome: the Bact complex. Subsequent 
catalytic activation by the DEAH-box RNA helicase Prp2, generates the B* 
complex, which catalyzes the first of the two steps of splicing. This yields the C 
complex, which in turn catalyzes the second trans-esterification step. The 
spliceosome then dissociates and, after additional remodeling, the released snRNPs 
take part in additional rounds of splicing. 
Summary of the assembly stages of the spliceosome: 
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Figure 5. Protein composition and snRNA secondary structures of the major 
human spliceosomal snRNPs. A. All seven Sm proteins (B/B’, D3, D2, D1, E, F, 
and G) or LSm proteins (Lsm2-8) are indicated by “Sm” or “LSm” at the top of the 
boxes showing the proteins associated with each snRNP. The U4/U6.U5 tri-snRNP 
contains two sets of Sm proteins and one set of LSm proteins. Note that several 
snRNAs undergo structural rearrangements during splicing B. Schematic structure 
of the human spliceosomal snRNP. The Sm proteins form a heptameric ring and 
bind to the Sm site of U1 snRNA. The U1-specific U1-70K and U1-A proteins 
specifically recognize the terminal stem-loop (SL) structures of first and second 
hairpins of the U1 sn RNA. Binding of U1-C protein is supported mainly by protein-
protein interactions. The U1snRNA exhibits 9 nt of full complementarity to the 
5’splice site on the pre-mRNA. Adapted from (Will and Luhrmann, 2011).  
A 
B 
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Figure 6. Pre-mRNA splicing by the U2-type spliceosome. Canonical cross-
intron assembly and disassembly pathway of the U2-dependent spliceosome. For 
simplicity, the ordered interactions of the snRNPs (indicated by circles), but not 
those of non-snRNP proteins, are shown. The various spliceosomal complexes are 
named according to the metazoan nomenclature. Exon and intron sequences are 
indicated by boxes and lines, respectively. The stages at which the evolutionarily 
conserved DExH/D-box RNA ATPases/helicases Prp5, Sub2/UAP56, Prp28, Brr2, 
Prp2, Prp16, Prp22 and Prp43, or the GTPase Snu114, act to facilitate 
conformational changes are indicated. (From (Will and Luhrmann, 2011) ) 
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Because of the enormous difficulty of studying entire spliceosomes, studies 
have been made from spliceosomes stalled at one particular stage of their 
assembly, giving a snap-shot of each of its sub-complexes. They have revealed that 
besides the extensive RNA-RNA and RNA-protein rearrangements occurring during 
splicing, the protein composition of spliceosome is highly dynamic as well. In fact 
there is a remarkable exchange of proteins from one stage of splicing to the next.  
Combination of biochemical, structural and kinetic studies is currently 
enhancing our knowledge into the compositional and morphological changes during 
spliceosome activation and catalysis. Current models suggest that: 1) the dynamics 
and complexity of the spliceosome is important for: accurate splice site recognition, 
sustaining a catalytically active structure and for the regulation and flexibility 
necessary for alternative splicing. (Will and Luhrmann, 2011) 2) every step of 
spliceosome assembly is kinetically efficient and reversible: and no single assembly 
step irreversibly commits a particular pair of splice sites to splicing. Rather, 
commitment to splicing increases as spliceosome assembles (Hoskins et al., 2011). 
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B. SnRNA BIOGENESIS  
Because ncRNAs typically function as ribonucleoprotein complexes and not 
as naked RNAs, understanding of the biogenesis of ncRNPs is crucial for 
comprehending their regulation and function. 
Biogenesis of spliceosomal snRNPs is critical for gene expression in 
eukaryotes. SMN, the complex that assembles Sm cores on snRNAs, plays a key 
role in snRNP biogenesis. SMN deficiency, the main cause of spinal muscular 
atrophy (SMA), alters the repertoire of snRNAs and causes widespread and cell-
type specific defects in pre-mRNA splicing (for reviews see (Battle et al., 2006; 
Chari et al., 2009; Patel and Bellini, 2008)). 
Integrated transcription and 3’-end processing 
Among the snRNAs, U1, U2, U4, and U5 of the major spliceosome and U11, 
U12, and U4atac of the minor spliceosome are transcribed by RNA Pol II. In 
contrast, U6 and U6atac snRNAs are generated by RNA Pol III. The snRNA genes 
are usually repeated and several pseudogenes can be found in the genome. Two 
functionally important sequence elements are contained within the core promoter 
region of Pol II and Pol III snRNA genes. The first located approximately at position 
−55 relative to the transcription start site is called the proximal sequence element 
(PSE). The second promoter element termed distal sequence element (DSE) is 
located around position −220. In addition to these two common sequence elements, 
Pol III snRNA genes contain a TATA box about 25 base pairs upstream from the 
transcription initiation site, which is in fact responsible for the recruitment of Pol III-
specific transcription factors (for reviews see (Egloff et al., 2008; White, 2011)). 
snRNA transcription by Pol II is initiated upon binding of Oct1 and STAF1 to 
different sites in the DSE, followed by the recognition of the PSE by PTF, an snRNA 
gene-specific transcription factor. The general transcription factors TFIIA, TFIIB, 
TFIIE, TFIIF, TBP, TAF100 and possibly also TFIIH then join the promoter and allow 
eventually recruitment of RNA Pol II. Efficient transcription initiation also requires the 
large multi-protein Integrator complex. This complex binds to the C-terminal domain 
(CTD) of Pol II phosphorylated at serine 2 and serine 7 positions. The requirement 
of this double mark for efficient transcription on a class of genes supports the 
existence of a CTD code (Baillat et al., 2005; Egloff et al., 2007; Egloff et al., 2010). 
Integrator subunits Int11 and Int9 display sequence homology with CPSF-7 
and CPSF-100 cleavage and polyadenylation factors of pre-mRNAs, respectively. 
Transcription termination occurs via an endonucleolytic cleavage at the 3’-box 
mediated by the Integrator. Therefore, the Integrator complex appears to travel 
along with the Polymerase to the 3’-box during transcription, integrating snRNA 
genes transcription initiation and termination. 
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Figure 7. Biogenesis of small RNPs in mammals. Adapted from (Kiss, 2004)  
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The synthesis of the Pol III-transcribed U6 snRNA has been described as a 
model for Pol III transcription. As other Pol III genes, it requires Oct-1, STAF1 and 
SNAPc, but also the recruitment of the Pol III-specific general transcription factor 
TFIIIB to the TATA box. The U6 snRNA acquires a posttranscriptional methyl group 
on the γ-phosphate of the first nucleotide in a reaction involving a methyltransferase 
termed methylphosphate-capping enzyme (MePCE). The 5’-mono-methyl cap 
protects the U6 snRNA against exonucleolytic degradation. Transcription 
termination occurs at the poly-U termination signal, recognized by the La protein. La 
binding protects the 3’ end from degradation and promotes Lsm snRNP assembly 
on the 3’ end of the U6 snRNA. Lsm assembly promotes the targeting of the PolII-
snRNAs to the nucleolus, where they undergo site-specific modifications. For review 
see (Kiss, 2004). 
Active transcription of snRNA genes often occurs in association with Cajal 
bodies. This association is mediated by the nascent snRNA transcripts (Frey and 
Matera, 2001).  
Nuclear export 
In contrast to the U6 snRNA that has an exclusively nuclear biogenesis, U1, 
U2, U4 and U5 snRNAs biogenesis requires a complicated nucleocytoplasmic 
trafficking process that is directed by transport factors. 
Like other Pol II-transcribed RNAs, nascent Pol II primary transcripts of 
snRNAs (pre-snRNAs) acquire cotranscriptionally a 7-monomethyl guanosine 
(7mGpppG) cap. The RNA cap structure recruits the cap binding complex (CBC) 
proteins, CBC20 and CBC80. The CBC bound to the RNA recruits an adaptor 
protein, PHAX, which then recruits the nuclear export receptor exportin 1 (CRM1). 
PHAX, also required for snoRNA targeting to the Cajal bodies (Boulon et al., 2004; 
Watkins et al., 2004), recognizes specific features of small RNAs, notably length, 
m7G-cap and three-dimensional structure without sequence specificity. Therefore, 
distinguishing between snRNAs and snoRNAs to target them to specific biogenesis 
pathways may involve contacts with other proteins (Masuyama et al., 2004; Mourao 
et al., 2010; Ohno et al., 2002). PHAX is phosphorylated in the nucleus by the CK2 
kinase and dephosphorylated in the cytoplasm by the phosphatase 2A, ensuring the 
directionality of the export (Kitao et al., 2008). Additional 3’ end processing is 
performed by an unknown endonuclease, and the proper pre-snRNAs, containing 
the 7mG-cap and 3’ trailer sequences are exported to the cytoplasm, where the 
export proteins dissociate (Figure 7 and 8). 
The U snRNA precursors concentrate in Cajal bodies prior to export, and the 
interaction with PHAX, but not CRM1, is required for the efficient exit of U snRNAs 
from Cajal bodies (Suzuki et al., 2010). 
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Figure 8. Schematic structure of precursor spliceosomal snRNAs and minimal 
sequences necessary for SMN binding in the cytoplasm. The mature form of 
each snRNA is depicted by black line and the precursor sequences are shown by 
dashed red lines. Nucleotide size numbers for the mature and pre-snRNAs are 
indicated on the x-axis. Green boxes represent Sm sites. The non-canonical Sm site 
of U1 is shaded in light green. The snRNP code is shown as yellow bars beneath 
each snRNA. The precursors were detected by High-Throughput sequencing of 
Gemin5-bound RNA fragments (Yong et al., 2010). 
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Sm core assembly 
In the cytoplasm, the SMN complex, comprised of the SMN, Gemin 2-8 and 
unrip proteins, assembles Sm cores in an ATP-dependent manner on each pre-
snRNA. This process requires several assembly intermediate steps and post-
transcriptional modifications of the factors involved, ensuring that the formation of 
the highly stable Sm core is effectuated only on proper snRNAs.  
To initiate the process, pICln forms a complex with D1/D2 and F/E/G Sm 
proteins (6S complex), inducing the formation of a closed pentamer ring that cannot 
bind to the snRNAs. Independently, pICln binds B/D3 Sm proteins. At this stage, the 
methylosome/PRMT5 or PRMT7 make symmetrical dimethylation on SmB, SmD1 
and SmD3 arginine residues, enhancing their association with SMN. The Sm 
proteins are transferred from the pICln complexes to the SMN complex. The SMN 
subunit Gemin2 binds to the D1/D2/F/E/G pentamer and holds it together, 
preventing their assembly on RNAs. Gemin 2 is also capable of binding the 
pentamer independently of pICln (Zhang et al., 2011). Immediately after their export 
to the cytoplasm, the SMN peripheral subunit Gemin5, via its WD repeat domain, 
recognizes specific sequence and structural features of the pre-snRNAs: the snRNP 
code (Lau et al., 2009; Yong et al., 2004; Yong et al., 2010; Yong et al., 2002). This 
snRNP code comprises the Sm site [A(U)5-6G] and an adjacent 3’ terminal stem-loop 
structure in the snRNAs. U1 snRNA (wich has a divergent Sm site) is an exception, 
since the snRNP code comprises stem-loop 1 in the precursor U1 snRNAs (Yong et 
al., 2002) (Figure 8). After the recognition of snRNAs by Gemin 5, the SMN 
complex catalyzes Sm-ring loading to the Sm site of snRNAs.  
Nuclear import 
The assembly of the Sm core is necessary for additional maturation steps 
required for further nuclear import. The m7G cap is hypermethylated to the mature 
2,2,7-trimethylguanosine (TMG) cap by the long cytoplasmic isoform of the 
methyltransferase Tgs1 (Girard et al., 2008; Mouaikel et al., 2002). The snRNAs 
undergo further 3’ end processing by the exosome in yeast, or an unknown 
exonuclease in higher eukaryotes (Houseley et al., 2006).  
Interestingly, the TMG is a characteristic hallmark of all Pol II-specific 
snRNAs, some snoRNAs and the telomerase RNA. Tgs1 binds to the m7G cap and 
further nucleotides of these small RNAs, and also interacts with Sm proteins or 
snoRNP proteins. It has been shown that the distinction between these two classes 
of RNAs by Tgs1 is made two isoforms: a long cytoplasmic isoform functioning in 
snRNAs cap hypermethylation and a short nuclear isoform functioning in snoRNA 
hypermethylation (Girard et al., 2008). 
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The associated Sm proteins together with the TMG cap structure constitute 
bipartite nuclear localization signals that bind adaptor proteins capable of recruiting 
importin β. The TMG cap is recognized by the adaptor protein snurportin-1 (SNP1) 
and the SMN complex bound to the Sm proteins is thought to be the second 
adaptor. Recently, coimmunoprecipitation studies showed that the WDR79 protein, 
also denoted TCAB1 or WRAP53, mediates SMN-importin β interaction in the 
cytoplasm, and the authors proposed that the targeting of SMN to the nuclear Cajal 
bodies is dependent on this factor. Nevertheless, no cytoplasmic snRNP retention is 
observed after WDR79 or SMN components depletion (Mahmoudi et al., 2010), 
suggesting that SMN-importin β interaction may not be essential for nuclear import 
of snRNPs.  
Completion of snRNP maturation in the nuclear Cajal bodies 
After nuclear import the nascent snRNPs accumulate in the nucleoplasmic 
Cajal bodies (CB) where their maturation is completed. In this nuclear compartment 
the snRNAs undergo site-specific nucleotide modifications (Jady et al., 2003), final 
assembly with specific proteins (Nesic et al., 2004), and RNA structural 
rearrangements (Stanek et al., 2003). The role of Cajal bodies in the final steps of 
snRNPs assembly is clearly established, since ongoing U snRNP biogenesis is 
essential for their maintenance (Lemm et al., 2006). Recently coilin, a core 
component of Cajal bodies, has been shown to be necessary for snRNP assembly 
in Zebrafish (Strzelecka et al., 2010). 
The SMN complex, with the exception of unrip and Gemin 5 subunits (Battle 
et al., 2007; Carissimi et al., 2005), is also present in the nuclear Cajal bodies. 
Several U snRNP proteins are imported to the nucleus independently of their 
cognate snRNAs, indicating that the final assembly into mature snRNPs occurs in 
the nucleus. The SMN complex interacts with several snRNP-specific proteins, 
suggesting that it could function in the final assembly of mature spliceosomal 
particles. Recently, the crystal structures of the U1 and the U4 snRNPs at high 
resolution have been resolved (Leung et al., 2011; Pomeranz Krummel et al., 2009; 
Weber et al., 2010). Their comparison revealed structural differences between the 
U1 and the U4 snRNAs emerging from the central hole of Sm proteins. These 
structural differences, together with the snRNAs sequences, are thought to 
contribute to the selectivity of the binding of particle-specific proteins.  
Our work demonstrated that the U1 snRNA can form a particle that does not 
contain Sm proteins, but this particle still depended on the Sm site for its biogenesis. 
These data suggests that a portion of the U1 snRNA dissociates from snRNP 
proteins and associates in an independent RNP (Jobert et al., 2009). This process is 
most probably chaperoned by the SMN complex in the nucleus, since the Sm cores 
on snRNAs are highly stable structures (see discussion). 
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An additional role has been proposed for Cajal bodies in the assembly of 
spliceosomal subunits. In fact, CB are the meeting place for U4, U5 and U6 snRNAs 
where the formation of the U4/U6 di-snRNP and U4/U6.U5 tri-snRNP occurs. The 
assembly of the U4/U6 di-snRNP, stimulated by LSm proteins bound to U6 snRNA, 
requires the action of the factor SART3/p110 (Stanek et al., 2003). 
 
C. REGULATION OF SPLICING 
 
In summary, the spliceosome is a macromolecular machine that faces major 
challenges in the cell. First, it has to specifically recognize the authentic splice sites 
within a multitude of potential splice sites found in a pre-mRNA. Then it has to bring 
them together to promote the two trans-esterification reactions, even if the 5’ and 3’ 
splice sites are located thousands of nucleotides appart. Besides this remarkable 
accuracy, it still has to keep enough flexibility to the choice of splice sites during 
alternative splicing. This is why the spliceosome exhibits a particularly dynamic 
catalytic cycle: its constituents are recruited stepwise to the pre-mRNA substrate, 
are remodeled multiple times in order to properly locate reactive sites on the pre-
mRNA and to generate functional active sites, and are finally disassembled in an 
ordered manner. 
As we can see, the spliceosome being a highly flexible RNP machine, it can 
be regulated at almost any step of its assembly and in many ways (See Table 1). In 
vivo, all steps of mRNA processing (therefore spliceosome assembly) are intimately 
coupled (for recent reviews see (Moore and Proudfoot, 2009; Pandit et al., 2008; 
Perales and Bentley, 2009)).  
Because our work revealed connections between the U1 snRNA, known to 
act on splicing, and the transcription initiation factor TAF15, the multiple connections 
between transcription and splicing will be discussed in detail. As an example of 
molecular machinery capable of connecting splicing and transcription, the FET 
family of proteins will be presented. In the second chapter, an overview of the 
emerging role of small non-coding RNAs on the regulation of splicing will be 
considered.  
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Table 1. 
HOW CAN SPLICING BE REGULATED? 
An « RNA splicing code » regulating splice site 
recognition and selection  
(pre-mRNA sequence elements recruiting enhancers or 
inhibitors, secondary structures folding on the pre-
mRNA affecting splice sites selection, modifications of 
the pre-mRNA) 
(Chen and Manley, 
2009; Long and 
Caceres, 2009; Tu et 
al., 2000; Wang and 
Burge, 2008; Zhong et 
al., 2009) 
 
Protein factors regulating U1-U2 pairing to the splice 
sites, or U4/U6.U5 tri-snRNP recruitment  
Regulation of splicing by transcription and chromatin 
structure: 
1. Recruitment model  
2. Kinetic model 
              3.   Epigenetic mechanisms  
(nucleosome positioning marking intron-exon 
junctions, exon-enrichment in histone variants, 
nucleosome density varies according to splice site 
strength, induction of RNA Pol II pausing, chromatin-
remodeling complexes or chromatin-binding proteins 
interacting with spliceosome components) 
 
(Allemand et al., 2008; 
Bentley, 2005; Das et 
al., 2006; Kornblihtt et 
al., 2004; Munoz et 
al., 2010; Pandit et al., 
2008) 
 
(Luco et al., 2011) 
Tissue specific splicing factors (Chen and Manley, 
2009; Luco et al., 
2011; Luco and 
Misteli, 2011) 
Constitutive splicing factors exhibiting tissue specificity 
activities 
Post-translational modifications of splicing factors 
Relocalization of splicing factors following specific 
signals 
(Luco and Misteli, 
2011) (Paronetto et 
al., 2011) 
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Multiple links between transcription and splicing 
Cotranscriptional splicing appears as a very intuitive concept. For example, 
the largest human gene, dystrophin (2400 kb), would require 16 h to be transcribed. 
It is difficult to imagine then that splicing would occur only after transcription is 
completed, and in fact, this is not the case (Tennyson et al., 1995). Many imaging 
studies have shown that splicing occurs at the site of transcription (Beyer and 
Osheim, 1988; Wuarin and Schibler, 1994; Zhang et al., 1994). Cotranscriptional 
splicing is predominant in human cells, even if intron removal can also be completed 
after the end of transcription (Schmidt et al., 2011). Nevertheless, the fact that 
splicing occurs at the site of transcription is not a proof of functional coupling 
between these two processes. Coupling implies that transcription and splicing affect 
each other, one process determining the efficiency or outcome of the other.   
The first data suggesting functional connections between transcription and 
splicing came from the observation that introns greatly enhance gene expression. In 
mice, expression of four different pairs of chimeric genes, differing only by the 
presence or absence of introns, was up to 100 fold more efficient from the intron-
containing constructs (Brinster et al., 1988). Furthermore, introns and/or their 
splicing have been found to enhance almost every step of gene expression, from 
transcription to translation (Abad et al., 2010; Juneau et al., 2006; Le Hir et al., 
2003; Lynch and Kewalramani, 2003; Nott et al., 2004; Rose et al., 2008; Skoko et 
al., 2011; Wang et al., 2007; Zhao and Hamilton, 2007; Zhu et al., 2010). The 
enhancing effect has been attributed to proteins recruited during splicing that can 
promote mRNA stability, export, and even translation.  
However, there seems to be several mechanisms by which transcription can 
increase splicing efficiency and vice versa. One possibility is that direct interactions 
between splicing components and the transcription machinery account for this 
effect: a process known as the recruitment model. In fact, many splicing factors 
directly or indirectly interact with the transcription machinery, in particular with the 
RNA Pol II carboxy terminal domain (CTD), and regulate splicing (Auboeuf et al., 
2004a; Cramer et al., 1999; Das et al., 2007; Fong and Zhou, 2001). For instance, 
only U1 snRNP, PSF and p54nrb interact with RNA Pol II CTD independently of its 
phosphorylation status, and probably in the absence of ongoing transcription (Das et 
al., 2007; Pandit et al., 2008). This suggests that coupling is not dependent on 
preassembled complexes, but rather on the increasing of commitment to splicing on 
the nascent pre-mRNA. Consistent with this model, it has been demonstrated that 
the promoter used to drive transcription can influence alternative splicing by 
differential recruitment of splicing/transcription/coactivators factors (Auboeuf et al., 
2004a; Auboeuf et al., 2004b; Auboeuf et al., 2002; Cramer et al., 1999; Nogues et 
al., 2002; Pagani et al., 2003).  
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The crosstalk between transcription and splicing seems to be a complex and 
regulated process that occurs in concert with all the signals that affect splicing 
(Table 1). In fact, another transcription-dependent mechanism affecting splicing, not 
mutually exclusive, has been proposed. The kinetic model proposes that the 
transcription elongation rate can affect subsequent splicing decisions. The strongest 
evidence supporting this model is that a slow mutant of RNA Pol II increases the 
rate of alternative exon inclusion on transfected reporter minigenes (de la Mata et 
al., 2003). More recently, this effect was demonstrated on endogenous genes: the 
RNA Pol II elongation rate can change in response to DNA damage and affect 
splicing events (Munoz et al., 2009). A change in kinetics of Pol II was also shown 
after T cells stimulation, or after membrane depolarization of neural cells, affecting 
splicing of endogenous genes (Batsche et al., 2006; Schor et al., 2009). The 
mechanisms changing the kinetics of Pol II transcription can be the CTD 
phosphorylation-dependent pausing, or chromatin modifications affecting the 
chromatin accessibility. According to this model, in vivo transcription kinetic 
analyses in yeast revealed the existence of an RNA Pol II pausing in yeast that is 
splicing dependent (Alexander et al., 2010b). Still, the study of this model was 
challenged by the fact that measuring changes in RNA Pol II elongation or 
processivity on a given gene is difficult. Most of the studies cited before assessed 
Pol II processivity in an indirect way by measuring the abundance of distal versus 
proximal pre-mRNAs with respect to the transcription start site. In this respect, novel 
methods of imaging transcription elongation are being used to study 
cotranscriptional splicing, showing that the rate of splicing can induce a delay in the 
release of the pre-mRNA from the transcription site (Brody et al., 2011; Darzacq et 
al., 2007). Recently, a novel method to monitor transcription at nucleotide resolution 
called NET-seq has been developed. This technique will probably allow going 
further on the investigation of this model by assessing directly the RNA Pol II 
processivity (Churchman and Weissman, 2011).   
However, it remains unclear to what extent RNA Pol II kinetics can be 
modulated and controlled in vivo. Several studies suggest that slower and faster 
RNA Pol II mutants can be deleterious to growth in Drosophila and yeast (Howe et 
al., 2003) (unpublished results from Christine Guthrie’s laboratory). Therefore, it 
would be more likely that RNA Pol II kinetics is regulated locally. In fact, there is 
strong accumulating evidence that chromatin structure indirectly acts on splicing 
(see Table 1 for references). On this issue I will discuss only the potential role of 
non-coding RNAs on regulating chromatin structure and influencing splicing 
decisions (see Chapter II). I will also discuss the growing evidence for 
multifunctional proteins (notably the FET family of proteins) on the regulation of 
splicing and its coordination with other steps of gene expression. 
Recently, a new hypothesis aiming to explain the enhancing effect of splicing 
on transcription has been proposed. Niu and Yang stated that interaction of DNA 
topoisomerase I with the splicing factor SF2/ASF inhibits its activity in removing 
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negative supercoiling of DNA generated by transcription. As a consequence, DNA is  
topologically opened upstream of the passage of the transcription machinery, 
favoring the access of RNA Pol II for later rounds of transcription (Niu and Yang, 
2011). However, there is still no experimental support for this hypothesis. 
Multifunctional proteins: critical to link splicing to other steps of 
gene expression? 
It was recently found that SR proteins, known for their critical role on 
spliceosome assembly regulation, can be implicated in other steps of gene 
expression (for review see (Zhong et al., 2009)). Even if it is still unknown if the 
other functions of SR proteins are dependent on their function on splicing, it is 
possible that multifunctional proteins are capable of coordinating all the steps of 
functional mRNA biosynthesis. In this respect, multifunctional proteins could be key 
factors for the integration of multiple levels of gene expression. One interesting 
family of multifunctional proteins is the FET (previously TET) family of proteins. I 
would like to introduce the main features of these proteins and their effects on 
splicing regulation. 
 FET family of proteins and their role on coupling transcription and splicing 
A new subfamily of RRM (RNA Recognition Motif) -containing proteins, 
named the FET family, is an interesting model for proteins capable of accomplishing 
many tasks during gene expression. 
FET (FUS/TLS, EWS, TAF15) proteins constitute an ubiquitously expressed 
family of nuclear proteins that share extensive sequence similarity (Figure 9). The 
CABEZA/SARFH protein in Drosophila also shares some sequence similarity with 
FET proteins (Stolow and Haynes, 1995). Translocations in TLS, EWS and TAF15 
genes lead to the expression of oncogenic fusion proteins, involved in uncontrolled 
transcriptional activation. The expression of this chimeric aberrant transcription 
factors seems to be the primary cause of several human cancers (for reviews on the 
chimeric fusion proteins and their associated phenotypes see (Kovar, 2011; Law et 
al., 2006; Tan and Manley, 2009)). Even if the chimeric fusion proteins are 
implicated in the apparition of human sarcomas, leukemias, and recently 
Amyotrophic Lateral Sclerosis, the functions of the endogenous proteins in the cell 
are still poorly understood. However, diverse associations of FET proteins with 
components of the transcriptional and splicing machineries suggest that they can 
play a role in coupling these two steps of gene expression. Nevertheless, it is 
important to note that FET proteins may be involved in a wide variety of processes 
including microRNA processing, mRNA transport, genome surveillance and DNA 
repair. It is also important to keep in mind that each member of the FET family may 
also have distinct, non-redundant functions. 
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Figure 9. Domain structure of FET and SARFH/CABEZA proteins. Schematic 
view of TLS-CHOP, EWS-FLI1, and TAF15-NR4A3 fusion proteins generated in 
human cancers. The N-terminal region is rich in glutamine, serine and tyrosine 
aminoacids and has been shown to function as a transcription activation domain 
(AD) when fused to the DNA binding domain of some transcription factors (Bertolotti 
et al., 1999; Ohno et al., 1993; Prasad et al., 1994; Sanchez-Garcia and Rabbitts, 
1994). The Arg-Gly-Gly (RGG) repeats in EWS display cis and trans repression of a 
broad range of activation domains (Alex and Lee, 2005). The central region contains 
a conserved RNA Binding Domain (RBD or RRM motif). The RBD domain of FET 
proteins can bind RNA and also single and double stranded DNA in vitro (Bertolotti 
et al., 1996). The C-terminal region contains RGG repeats, initially described as an 
RNA-binding motif in the hnRNP U protein (Kiledjian and Dreyfuss, 1992). 
Nevertheless, in the FET proteins the RGG repeats are not as closely spaced as in 
other RNA-binding proteins and the function of this domain is still unknown. FET 
proteins contain a Cys2/Cys2-type zinc finger (ZF) motif, which acts as a sequence-
specific nucleic acid-binding motif as well as a specific module for protein 
recognition (Gamsjaeger et al., 2007). Characteristic chromosomal translocations 
associated with various sarcomas and leukemias lead to chimeric fusions of the 
activation domain of the FET genes to the DNA binding domain (DBD) of potent 
transcription factor genes. Arrowheads indicate the gene breakpoints. The structure 
of TLS-CHOP, EWS-FLI1 and TAF15-NR4A3 oncogenic fusion proteins is shown in 
the right. Asterisks designate domains that display mutations associated with 
familial Amyotrophic Lateral Sclerosis. Red asterisks indicate the regions where 
most mutations identified are clustered (Kwiatkowski et al., 2009; Lagier-Tourenne 
et al., 2010; Ticozzi et al., 2011; Vance et al., 2009).       
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Several studies suggest a role for FET proteins in transcription. The 
activation domain of FET proteins activates RNA Pol II transcription of reporter 
genes (see Figure 9). Because the fusion proteins lacking the RNA-binding region 
behave as aberrant transcription factors and this domain displays transcriptional 
repression activities; it is thought that the RNA binding capacity of FET proteins 
regulate their activity on RNA Pol II transcription. All FET proteins copurify with 
TFIID in different subcomplexes of this general transcription factor (Bertolotti et al., 
1996; Bertolotti et al., 1998). Therefore, it is possible that they can influence 
transcription initiation and promoter choice within TFIID. FET proteins also bind 
RNA Pol II directly: for example TAF15 is associated to Rbp3, Rbp5, Rbp7 subunits 
of RNA Pol II (Bertolotti et al., 1996; Bertolotti et al., 1998; Zhou and Lee, 2001). 
Besides contacting the transcription machinery, FET proteins can also interact with 
transcriptional activators or repressors. EWS associates with several transcriptional 
activators such as Oct4, Brn3a and the CREB-binding protein (Araya et al., 2003; 
Lee et al., 2005; Thomas and Latchman, 2002), and regulate their activity. EWS 
also binds the transcriptional repressor/splicing factor SF1 (Zhang et al., 1998). 
TLS/FUS interacts with the DNA binding domain of various hormone receptors and 
is proposed to regulate their transcriptional effects (Powers et al., 1998).  
As mentioned before, the RNA-binding capacity of FET proteins seems to 
modulate their transcriptional activity. Consistent with this, Wang et al. reported that 
DNA damage signals could induce a set of single stranded, low-copy-number 
ncRNAs, transcribed from the 5’ regulatory region of the CCND1 gene. These 
ncRNAs could allosterically modulate the activity of TLS. The modified TLS in turn 
inhibited CREB-binding protein and p300 histone acetyltransferase activities, which 
subsequently inhibited CCND1 transcription (Wang et al., 2008).  
Taken together, these studies suggest a dual role of FET proteins on 
transcription by RNA Pol II: a transcriptional activity via their N-terminal domain, and 
a regulation of the activation domain via their RNA-binding C-terminal domain. 
Recently, TLS has been shown to inhibit specifically RNA Pol III transcription 
in vitro and in vivo (Tan and Manley, 2010). Therefore, FET proteins seem to have a 
much broader role on gene expression than thought before. 
Several studies suggest a role for FET proteins on splicing as well. All FET 
proteins have been found in functional spliceosome subcomplexes by different 
approaches (Calvio et al., 1995; Jurica and Moore, 2003; Kameoka et al., 2004; 
Rappsilber et al., 2002; Zhou et al., 2002). Both EWS and TLS/FUS proteins interact 
with several splicing factors (Knoop and Baker, 2000; Lerga et al., 2001; Shin and 
Manley, 2002; Yang et al., 1998; Yang et al., 2000). Furthermore, it has been shown 
that transient overexpression of TLS can induce alternative splicing changes in 
cotransfected reporters (Hallier et al., 1998; Yang et al., 1998).  
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More recently, transcriptome-wide studies have shown that EWS can 
regulate alternative splicing events of many genes relevant for response after DNA 
damage (Dutertre et al., 2010; Paronetto et al., 2011). By a combination of in vivo 
and in vitro experiments, the laboratory of Valcárcel shows that EWS associates 
directly to its RNA targets, preferentially in the alternatively regulated exons. ChIP 
and EMSA experiments also detected an association of EWS to the alternatively 
spliced regions of its genomic targets, in an RNA-independent manner. These 
associations decreased upon UV treatment, correlating with a partial relocalization 
of EWS into the nucleolus and alternative splicing changes. Taken together, these 
results suggest that EWS plays a role in splicing changes relevant for the DNA 
damage response. Upon UV treatment, EWS dissociates from its RNA and genomic 
targets and localizes transiently to the nucleolus, contributing to the cellular 
response to genotoxic stress.  
According with this study, a transcriptome-wide identification of RNA target 
sites of the three FET proteins revealed that they crosslink with pre-mRNA, 
preferentially to the 5’ and 3’ splice sites ((Paronetto et al., 2011) Markus Landthaler 
laboratory unpublished results). Therefore, it is possible that FET proteins can bind 
pre-mRNA after activation of transcription and regulate spliceosome assembly 
through direct interactions with splice sites. Even if the role of EWS and FUS/TLS in 
splicing regulation is beginning to be well documented, the role of TAF15 in splicing 
is unknown. However, TAF15 crosslinks preferentially with 3’ splice sites in the pre-
mRNA, and it binds specifically the U1 snRNA, so it is possible that it can function in 
direct or indirect splicing regulation (Markus Landthaler laboratory unpublished 
results and (Jobert et al., 2009)). 
The many functions of FET proteins suggest that they are capable of 
affecting and probably connecting many cellular processes.  
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CHAPTER II:  
THE EXPANDING UNIVERSE OF NONCODING RNA: 
NONCODING RNAs ARE IMPORTANT REGULATORS 
CONTROLLING mRNA PRODUCTION 
 
A. NOVEL FUNCTIONS IN mRNA PRODUCTION 
The many faces of the U1 snRNA 
In vertebrates, the U1 snRNA is the most extensively characterized and 
according to the general believe, the structurally and functionally best understood 
ncRNA (see Chapter I).  
However, particular features of the U1 snRNA indicate that it may have other 
functions in addition to splicing. To form the catalytic core of the spliceosome, the 
snRNPs come together in 1:1 stoichiometry (Wahl et al., 2009), but U1 is more 
abundant than the other snRNAs (about 5 fold more abundant than U4 snRNA), and 
the potential role of this excess is not known. In the mammalian nucleoplasm, in 
addition to be found with the other splicing snRNPs in speckles, a portion of U1 is 
more widely distributed (Carmo-Fonseca et al., 1992; Carmo-Fonseca et al., 1991a; 
Carmo-Fonseca et al., 1991b). Moreover, at an early stage of transcription 
inhibition, the U1 snRNA, but not the other spliceosomal RNAs, concentrate in 
perinucleolar caps (Carmo-Fonseca et al., 1992; Carmo-Fonseca et al., 1991a; 
Carmo-Fonseca et al., 1991b; Jobert et al., 2009). Strikingly, in an intronless gene, 
the U1 snRNP is the only U snRNP to be recruited to the transcription sites (Brody 
et al., 2011; Spiluttini et al., 2010), and it crosslinks to mRNA even in the absence of 
spliceosome formation (Wassarman and Steitz, 1993).  Even biogenesis of the U1 
snRNP seems to have specific features. In fact, the U1 snRNA possesses a non-
canonical Sm site not functionally interchangeable with the Sm site of other snRNAs 
(Battle et al., 2006).  Also, the recognition of snRNAs by SMN typically requires the 
Sm site and one stem-loop immediately downstream of it. U1 is different, since the 
minimal recognition sequences comprise the stem-loop near the 5’ end (Figure 8).  
A summary of reports suggesting spliceosome-independent functions for the 
U1 snRNA are listed in Table 2. 
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Table 2. The U1 snRNA has regulatory roles independent of its canonical role 
in splicing. (For details see text) 
Transcription 
Effect Observation Mechanism Reference 
+ General role in 
regulation of 
transcription 
initiation and 
reinitiation 
Association with the cyclin H subunit of 
TFIIH 
(Kwek et al., 2002; 
O'Gorman et al., 2005) 
+ Binding of U1 to 5’ 
splice sites 
enhances 
transcription 
recruitment of transcription initiation 
factors, 
or transcription elongation factors? 
(Damgaard et al., 2008; 
Furger et al., 2002) 
(Alexander et al., 2010a; 
Kameoka et al., 2004) 
+? Splicing-
independent 
recruitment of U1 
to transcription 
units 
Via stem-loop I of the U1 snRNA  
Association with Pol II 
(Patel et al., 2007) 
(Das et al., 2007; 
Spiluttini et al., 2010; 
Tian, 2001) 
 
+? Tight association 
with chromatin 
Association with a transcription initiation 
factor 
(Jobert et al., 2009) 
3’ end processing of pre-mRNA 
Role RNA Sequence element Reference 
- Bovine 
papillomavirus, 
Human 
papillomavirus 
Upstream 5’ splice site  
 
(Cumming et al., 2008; 
Jia and Zheng, 2009) 
- U1 site in the 
endogenous human 
U1A gene 
Upstream PIE element (Guan et al., 2007) 
- Ectopic U1 binding 
sites inserted in 
reporter genes in 
virus, human, plants 
Upstream 5’ splice site (Fortes et al., 2003; 
Guan et al., 2007; 
Wypijewski et al., 2009) 
- HIV-1 Downstream 5’ splice site (Ashe et al., 1997; 
Vagner et al., 2000) 
- General role in 
preventing 
premature cleavage 
and polyadenylation 
5’ splicing sites downstream cryptic 
polyadenylation signals 
(Kaida et al., 2010) 
+ RNA encoding 
calcitonin/calcitonin 
gene-related peptide 
Downstream intronic 5’ splice site 
enhancer 
(Lou et al., 1996; Zhu et 
al., 2003) 
+ Expected general 
role 
Upstream binding site (Wassarman and Steitz, 
1993) 
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U1 snRNA and transcription 
Recent transcriptome-wide studies (Kaida et al., 2010), reported a general 
reduction of all signals from a transcript after U1 snRNA knockdown, probably 
reflecting a general downregulation of RNA Pol II transcription. This result is 
particularly resonant with several data suggesting a role of U1 in transcription 
regulation. 
Consistent with this, the U1 snRNA was shown to associate with the Cdk7 
subunit of TFIIH, a general transcription initiation factor (Kwek et al., 2002). Cdk7 
was shown to phosphorylate the C-terminal repeats of the largest Pol II subunit 
(CTD). This phosphorylation permits the polymerase to escape from the promoter 
and engage in productive elongation (Akoulitchev et al., 1995; Hengartner et al., 
1998; Jiang et al., 1996). Analysis of the TFIIH-dependent stages of transcription in 
a reconstituted system demonstrated that U1 snRNA stimulates the rate of 
reinitiation by RNA Pol II (Kwek et al., 2002). Deletion analysis of U1 snRNA in a 
reconstituted Cdk7 pull-down assay, showed that stem-loop II is essential for 
interaction with Cdk7. Furthermore, functional assays implicated the TFIIH-U1 
snRNA interaction in the regulation of the activity of the TFIIH associated kinase, 
Cdk7 (O'Gorman et al., 2005).  
Furger and colleagues demonstrated that 5’ splice sites proximal to the 
promoter of HIV constructs enhanced their expression at the transcriptional level. 
They demonstrated by complementary mutations, FISH and run-on analysis that the 
recruitment of U1 snRNA to the splice donor accounted for the transcriptional 
enhancement (Furger et al., 2002). They also showed that this effect was 
generalizable to other transcripts.  
More recently, U1-mediated enhancement of transcription was analyzed in 
greater detail (Alexander et al., 2010a; Damgaard et al., 2008). Damgaard and 
colleagues demonstrated again a direct correlation between 5’ss/U1 snRNA pairing 
and stimulation of transcription, even in the absence of splicing. They also suggest 
that this effect is general as β-globin gene constructs harboring mutations in the 
cap-proximal 5’ss showed decreased levels of expression. By ChIP analysis, they 
revealed that increased transcription was not due to changes on the accessibility of 
chromatin but rather to an increase in the recruitment of general transcription 
factors.  
Alexander et al. analyzed the accumulation of Env-HIV mRNA from a 
construct harboring WT or mutant splice sites. In a series of elegant experiments, 
they show again that U1 recruitment to the splice donor, even in the absence of 
splicing, increased transcription. The effect of U1 on transcription was independent 
from the promoter or SR-binding sites from exonic sequences. U1 Sm site was 
necessary for rescuing transcription, indicating that the U1 snRNA has to undergo 
  p. 31 
efficient biogenesis in order to increase transcription. A mutant harboring a deletion 
of the stem-loop II couldn’t rescue transcription either. However, mutations of the 
U1-70K and U1-A binding sites snRNA were not significant for enhancement of 
transcription. Nevertheless, the only presence of an artificial intron in the proximity 
of the promoter, and therefore U1 snRNP recruitment, couldn’t account for any 
enhancement of transcription, demonstrating that the local mRNA context is 
important for the transcriptional effect. Interestingly, the elongation activator Tat was 
able to partially rescue the expression of Env in the absence of U1 recruitment. 
Given the known function of HIV Tat protein in productive elongation, it is possible 
that U1 snRNA recruitment is required for efficient mRNA elongation. The authors 
proposed a model for U1 enhancement of transcription elongation: possibly via its 
interaction with the elongation factor Tat-SF1 (Fong and Zhou, 2001). 
The major noncoding RNA associated with RNA Pol II is the U1 snRNA (Das 
et al., 2007; Spiluttini et al., 2010; Tian, 2001). In a mitotic cell-extract, were 
transcription is mainly absent, the U1 snRNA associates with RNA Pol II, suggesting 
that the association is independent of the nascent transcript and splicing (Spiluttini 
et al., 2010). Imaging studies revealed that U1 snRNA, U1-70K and ASF/SF2, but 
not the other spliceosomal snRNPs, are recruited to the transcription sites in the 
absence of splicing. The authors proposed that direct or indirect interaction of the 
U1 snRNA with RNA Pol II, is responsible for this observation. One could imagine 
that pre-association of U1 with the transcription machinery has a role in coupling of 
splicing and transcription, or it could influence other functions of U1.  
Recently, systematic analysis of the components of the human basal 
transcription machinery led to the surprising discovery that a subfraction of HeLa U1 
snRNA specifically interacts with the TATA-binding protein (TBP)-associated factor 
15 (TAF15) (see results) (Jobert et al., 2009). This work also highlights the 
possibility that the U1 snRNA can have other functions within the cell, and I will 
further discuss about this issue in the discussion. 
It is important to note that in mammals the cap-binding protein complex CBC, 
is implicated in U1 snRNP recognition of the 5’ splice site of the proximal intron. 
Therefore, U1 plays a key role in coupling the 5’ capping and splicing of precursor 
mRNAs (Lewis et al., 1996). 
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U1 snRNA and polyadenylation 
Nearly all mature eukaryotic mRNAs, with histone mRNAs being the only 
significant exception, contain a 3’-terminal poly-adenosine (poly(A)) tail that is 
important for mRNA stability, export, and translation. The poly(A) tail is 
posttranscriptionally added to pre-mRNAs in the nucleus by a two-step reaction 
called cleavage and polyadenylation. In the first step, the pre-mRNA is 
endonucleolytically cleaved into two molecules at the cleavage site. In the second 
step, a poly(A) tail is added to the 3′ end of the upstream fragment by the enzyme 
poly(A) polymerase, whereas the downstream pre-mRNA fragment is degraded. 
The reaction mechanism is relatively well understood, and the major pre-mRNA 
sequence elements as well as the components of the cleavage/polyadenylation 
machinery have been identified in both S. cerevisiae and mammalian cells (Figure 
10) (for reviews, see (Danckwardt et al., 2008; Millevoi and Vagner, 2010)).  
Numerous connections between the splicing and the polyadenylation 
machinery have been reported, and these two processes are functionally 
interdependent. For example, the replication-dependent histone genes lack introns, 
and their mRNAs are non-polyadenylated. However, insertion of an intron into a 
histone gene results in the formation of a polyadenylated histone mRNA, illustrating 
the tight coupling between splicing and polyadenylation (Pandey et al., 1990).  
In a vast majority of transcripts, regulation of poly(A) tail addition involves the 
choice between two or more poly(A) sites, resulting in mRNAs which may differ in 
their stability, localization, transport and translation efficiency (for review see 
(Neilson and Sandberg, 2010)). A second, less common way to control poly(A) tail 
addition is by an “on–off” switch mechanism whereby a single poly(A) site is either 
active or inactive. The efficiency of poly(A) signal recognition will then determine the 
level of protein expression. Indeed, transcripts that are not processed at the 3’ end 
will be degraded or not transported to the cytoplasm. 
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Figure 10. Metazoan pre-mRNA 3′ end processing/polyadenylation machinery. 
Known factors and cis-elements contributing to 3′ end processing of metazoan pre-
mRNAs. The position of the different factors takes into account the RNA-binding 
specificity of each factor and, where possible, the protein contacts within the 
machinery. The sequence elements that comprise the poly(A) signals are indicated 
by black rectangles, and the site of cleavage [and subsequent poly(A) tail addition] 
is shown by a red dotted-line. From (Millevoi and Vagner, 2010) 
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Interestingly, the U1 snRNA can regulate 3’ end processing through a 
mechanism dependent of its pairing to the pre-mRNAs, but probably independent of 
splicing.  
The first examples came from studies of papillomaviruses: they rely on a U1 
snRNP-dependent mechanism to inhibit late gene expression in early stages of their 
life cycle. In the Bovine Papillomavirus, the 3’ UTR of pre-mRNA of the late genes 
contains a 53 nucleotide negative regulatory element. This element harbors several 
5′ss-like sequences, located upstream of the major site of 3′-end formation, that 
binds the U1 snRNA. This binding results in an inhibition of polyadenylation and 
rapid degradation of the transcripts. By this mean, the virus inhibits late gene 
expression early after infection in undifferentiated epithelial cells (Furth et al., 1994; 
Gunderson et al., 1998). The mechanism by which this inhibition is relieved in the 
late stages of the virus life cycle is not known. However, the decreased level of free 
U1 snRNP during differentiation is probably involved. Subsequently, mechanistic 
studies demonstrated that the 5′ss-bound U1 snRNP, via its U1-70K subunit, directly 
binds the poly(A) polymerase (PAP) and inhibits it (Gunderson et al., 1998). This 
inhibition only occurs when the 5′ss is found in the 3′-terminal exon (Fortes et al., 
2003; Guan et al., 2007). A similar but more complex inhibitory mechanism is also 
found in human papilloma viruses types 16 and 18 (Cumming et al., 2008; 
Gunderson et al., 1998). Furthermore, this inhibitory mechanism is not restricted to 
papillomaviruses as natural examples of polyadenylation-inhibitory 5′ss sequences 
(called U1 sites) are also found in the 3′-terminal exon of certain mammalian genes 
(Guan et al., 2007). These studies led to the development of a novel gene-silencing 
method called U1in (for U1 snRNA inhibition) designed to mimic what has been 
described in papillomaviruses. U1in involves binding of either natural or modified U1 
snRNA complementary to sequences located within the 3′-terminal exon of the 
target gene that is to be silenced (either reporter or endogenous). It has been tested 
in viruses, mammals and plants suggesting conservation through evolution (Fortes 
et al., 2003; Guan et al., 2007; Sajic et al., 2007; Wypijewski et al., 2009).  
Interestingly, U1 inhibition is most effective when the U1 snRNP is not 
involved in splicing. Placement of splicing regulatory sequences near the U1-binding 
site enhances splicing but decreases inhibitory activity (Abad et al., 2008). The 
authors show that tethering MS2-SR fusion proteins to MS2 stem-loops located 
upstream the U1 binding site disrupts the inhibitory activity. They propose that SR 
proteins interact with U1-70K RS domain and therefore impede its binding to the 
poly(A) polymerase. 
In the HIV-1 virus, U1 snRNP binds downstream of a poly(A) signal in the 5’ 
long terminal repeat and suppresses its use (Ashe et al., 1997), but by a different 
mechanism. In this case, it is poly(A) site cleavage rather than polyadenylation that 
is inhibited (Vagner et al., 2000). The removal of the U1-70K interaction domain 
from PAP does not affect the inhibition of the cleavage by U1 snRNP. In 
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reconstituted cleavage assays, the interaction of U1-70K and U1A specific proteins 
with cleavage factors cannot account for the inhibitory effect (Vagner et al., 2000).  
Here again, the regulatory role of U1 depends on its binding to the transcript 
rather than the actual splicing process (Ashe et al., 1997). Ashe et al. showed that 
mutation in the downstream splice donor that cannot bind U1 snRNA activates the 
use of the upstream poly(A) site. However shifted-U1 snRNAs targeted to interact 
14 nucleotides downstream of the mutated splice donor can specifically compensate 
the mutations and restore the inhibition of the poly(A) site even if the level of splicing 
of the transcript is decreased. Meaning that formation of the spliceosome does not 
correlate with the inhibition of the poly(A) site, but U1 snRNA binding is the critical 
determinant.  
The U1 snRNP not only inhibits, but can also enhance 3’ end processing. 
One example is the intronic enhancer complex of the calcitonin/calcitonin gene-
related peptide gene, within which U1 plays a key but poorly understood role (Lou et 
al., 1996; Zhu et al., 2003). Wassarman and colleagues demonstrated that binding 
of U1 to regions of low complementarity to its 5’ end in the terminal exons enhance 
polyadenylation. This effect was expected to be general, but specific, as the 
U1/substrate interaction was significantly reduced in an extract not competent for 
polyadenylation (Wassarman and Steitz, 1993). Here again, the effect was due to 
U1 alone as other spliceosomal snRNPs, including U2, did not associate with the 
transcripts. 
Trypanosomatids harbor many exotic RNA processing events such as trans-
splicing or mitochondrial RNA editing. Trans-splicing doesn’t require U1 snRNA, 
instead, it depends on the SL RNA (Hannon et al., 1991). Even though they are well 
defined in mammals, trypanosomal snRNPs are still not well characterized. 
Recently, a shorter U1 snRNA has been identified in these organisms, but extensive 
genomic studies revealed only one internal cis-spliced intron in the poly(A) 
polymerase gene (Mair et al., 2000). Characterization of the core-protein 
composition of the trypanosomal U1 snRNP revealed Sm proteins, a U1-70K-related 
protein and the poly(A)-binding protein I. This association is intriguing and suggests 
that U1 snRNP could function in coupling splicing and polyadenylation (Palfi et al., 
2002). Therefore, it is tempting to speculate that in organisms were U1-dependent 
splicing is not prevalent, the U1 snRNA has other functions in pre-mRNA 
processing.  
Importantly, a novel general regulatory role for U1 snRNA in 3’ end 
processing has been recently documented (Kaida et al., 2010). In this study, the 
authors successfully inactivated the U1 snRNP in HeLa cells using antisense U1 
morpholinos. Subsequently they analyzed the transcriptome changes using high-
resolution genomic tiling arrays. They show that in addition to inhibit splicing, the U1 
snRNP knockdown caused premature termination of numerous pre-mRNAs. They 
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characterized the 3’ ends of these transcripts by 3’ RACE, and demonstrated that 
they were prematurely cleaved and polyadenylated (PCPA) from cryptic 
polyadenylation signals (PAS) within the introns. PCPA was specific to U1 snRNP 
knockdown as it was not detected for U2 suppression or with the use of a general 
splicing inhibitor spliceostatin A. Mutation of the cryptic polyadenylation signal in the 
NRC3 mini-gene suppressed the detected PCPA, with or without U1 morpholino.  
Without U1 inactivation, a mutation of the 5’ splice site caused the premature 
cleavage of the transcript. Taken together, these results suggest that base-pairing of 
U1 to functional 5’ss protects nascent transcripts. Interestingly, U1 inactivation 
increased the premature cleavage in the 5’ss mutant. This result shows that U1 
snRNP prevents from PCPA, probably by pairing to 5’ss, but that it can also account 
for some protection without functional 5’ss. 
These findings reveal a general, critical splicing-independent role for U1 in 
protecting the pre-mRNAs from premature cleavage and therefore degradation. 
However, the molecular mechanism by which U1 inhibits the use of cryptic 
polyadenylation signals abundantly present in the transcripts is unknown. 
 
U2 snRNA and 3’ end processing 
Other snRNA can display spliceosome-independent functions. In fact, the U2 
snRNP is important for coupling splicing and 3’ end formation of pre-mRNAs 
(Kyburz et al., 2006). Steitz and colleagues showed that CPSF and the U2 snRNP 
directly interact with each other. Furthermore, binding of U2 snRNA to the branch 
point of the last intron stimulates 3’ end cleavage in a coupled splicing and 3’ end 
cleavage in vitro assay. This stimulation was dependent on direct interactions of U2 
snRNP subunits and CPSF. Consistent with a coupling between these two 
processes, CPSF stimulates splicing at the last exon. This function of U2 snRNA 
seems to be spliceosome-independent since one specific mutation of the branch 
point reduced splicing but had no significant effect on 3’ end cleavage in vitro. 
Furthermore, specific RNase H digestion of U2 snRNA resulted in the decrease of 3’ 
end cleavage of all the substrates tested, including this mutant, confirming that U2 
snRNP is involved in enhancing 3’ end processing in in vitro assays. The authors 
proposed that the interaction of U2 snRNP and CPSF promotes 3’ end cleavage 
and splicing, by facilitating the recruitment of the splicing and polyadenylation 
machineries at the 3’ end of the pre-mRNA.  
After this study, Friend and colleagues showed that the U2 snRNA has a 
supporting role in the 3’ end processing of another class of mRNAs: the intronless 
replication-dependent histone mRNAs. In fact, a 22 nt RNA element present in 
histone mRNAs was shown to act as a binding site for U2 snRNP. Crosslinking 
  p. 37 
experiments showed that indirect interactions with histone mRNAs is mediated by 
the SF3b155 and hPrp43 subunits of the U2 snRNP. This binding stimulates U7-
dependent mRNA 3′ endonucleolytic cleavage resulting in release of the nascent 
transcript from the chromatin template (Friend et al., 2007). It is not clear how this 
stimulation works, but, based on the study described before on polyadenylation 
substrates, the mechanism may involve the interaction between U2 snRNP and 
CPSF (Kyburz et al., 2006). 
Participation of the U2 snRNP in transcription regulation is also posible. Tat-
SF1 interacts with the U2 snRNP (Fong and Zhou, 2001) and it is implicated in 
general transcription elongation and pre-mRNA splicing ((Miller et al., 2011) and 
references therein). As Tat-SF1 shares sequence homology with Cus2p, a 
component of the yeast (but not the human) U2 snRNP, McKay et al. wondered if 
these two proteins were functional homologues. They investigated if Cus2p and U2 
snRNA have a role in transcription regulation (McKay and Johnson, 2011). 
However, they did not find any genetic or physical interactions between Cus2p and 
the yeast homologs of P-TEFb (the yeast elongation factors Bur1/2, Ctk1/2/3). 
Furthermore, neither deletion/overexpression of the CUS2 gene or mutations in the 
U2 snRNA conferred a transcription-related phenotype. These results suggest that 
in yeast the U2 snRNP is not directly involved in transcription regulation. 
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Small noncoding RNAs as regulators of splicing   
Small nuclear noncoding RNAs play a key role in splicing (snRNAs), but they 
are also emerging as participants of its regulation. For reviews, see (Khanna and 
Stamm, 2010) (Luco and Misteli, 2011). The major mechanisms are summarized in 
Figure 11. 
miRNA 
 
One mode of control by ncRNAs is the regulation the expression of key 
splicing factors by short microRNAs (miRNAs) during development and 
differentiation. An example is the neuron-specific microRNA miR-124 that directly 
regulates expression of the splicing repressor PTB (Makeyev et al., 2007). A 
reduction in PTB levels triggers a neuronal-specific splicing program essential for 
the correct differentiation of progenitor cells into mature neurons.  
siRNA 
It is possible to alter chromatin structure in a direct manner using double 
stranded small RNAs. This effect can induce transcriptional gene silencing in human 
cells through heterochromatin formation at a promoter region (Morris et al., 2004). 
The mechanism involves recruitment of chromatin modifying enzymes resulting in 
specific histone 3 methylations usually associated to facultative heterochromatin 
(H3K9me2 and H3K27me3), DNA methylation and histone deacetylation (Kim et al., 
2006; Morris et al., 2004). Recently, it was demonstrated that siRNAs targeting gene 
sequences surrounding an alternative exon, affected splicing decisions (Allo et al., 
2009). The effect on splicing was not due to post-transcriptional gene silencing; 
rather the siRNAs generated a closed chromatin structure across the alternative 
exon. As a result, Pol II elongation was slower, favoring inclusion of the exon. This 
study opens the possibility that endogenous RNAi-mediated transcriptional gene 
silencing could be involved in regulation of a splicing event, although indirectly by 
modulating the chromatin conformation. This is yet a large field to explore. 
Interestingly, comparison of the splicing changes after knockdown of Dicer or 
knockdown of AGO1 (affecting only transcriptional gene silencing) revealed that a 
majority of splicing events were affected in the same way. This opens the possibility 
that many endogenous miRNA can affect splicing patterns in the cell through a 
mechanism involving chromatin modifications. 
 
snoRNA 
The SNURF-SNRPN locus located on chromosome 15 is maternally 
imprinted and generates a large transcript containing at least 148 exons. Loss of the 
paternal allele causes Prader-Willi syndrome (PWS). The 3' end of the transcript 
harbors several evolutionarily conserved C/D box small nucleolar RNAs (snoRNAs) 
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that are tissue-specifically expressed. With the exception of 47 copies of the HBII-52 
snoRNA, none of the snoRNAs exhibit complementarity to known RNAs, suggesting 
that they do not function as guide RNAs in 2’-O-methylation. Due to an 18-nt 
sequence complementarity, HBII-52 can bind to the alternatively spliced exon Vb of 
the serotonin receptor 2C pre-mRNA, where it masks a splicing silencer, which 
results in alternative exon usage. This silencer can also be destroyed by RNA 
editing, which changes the amino acid sequence but appears to be independent of 
HBII-52. Lack of HBII-52 expression in individuals with PWS causes most likely a 
lack of the high-efficacy serotonin receptor, which could contribute to the disease. It 
is therefore possible that snoRNAs could act as versatile modulators of gene 
expression by modulating alternative splicing (Kishore et al., 2010; Kishore and 
Stamm, 2006).  
  
Figure 11. Mechanisms of alternative splicing regulation by small ncRNAs. (a) 
MicroRNAs (red hairpin) regulate the protein levels of key developmental splicing 
factors (SF, blue rectangle). (b) siRNA-mediated heterochromatinization (red ovals) 
of a weak exon favors its inclusion. (c) The binding of a processed nucleoplasmic 
snoRNA (psnoRNA) (red line) by sequence complementarity to an RNA silencer in 
the exon interferes with the recruitment of a splicing factor (blue rectangle) and 
subsequent exon inclusion. (Adapted from (Luco and Misteli, 2011))  
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Other examples of multifunctional RNAs 
 
Some ncRNAs can exhibit different functions. In fact, several examples 
suggest that small cellular RNAs such as snoRNAs, tRNAs or Y RNAs can be 
processed into miRNAs by the RNAi machinery.   
For example, the small Cajal body specific RNA 45 (scaRNA45 or ACA45) 
carries both a scaRNA and a miRNA. ACA45 RNA, like other scaRNA, resides in 
Cajal bodies and guide the pseudouridylation of the U2 snRNA. A small fraction of 
ACA45 is converted by a Dicer-dependent, Drosha/DGCR8-independent, 
mechanism into a 20-22 nt RNA. This small RNA associates with Argonaute 
proteins and can function in posttranscriptional gene silencing of cotransfected 
reporter constructs (Ender et al., 2008). Nevertheless, the biogenesis of this 
scaRNA-derived miRNA remains unclear. The authors proposed that an unknown 
export factor could compete with the cotranscriptional assembly of the H/ACA 
particle, and commit the RNA for export to the cytoplasm. Once in the cytoplasm, 
ACA45 will be further processed into a miRNA by Dicer.  
The conversion of snoRNAs into miRNAs seems to be conserved. Saraiya 
and Wang (Saraiya and Wang, 2008) also reported the existence of snoRNA-
derived small RNAs in the primitive eukaryote parasite Giardia Lamblia. The 
biogenesis of two of them, miR2 and miR3, seems dependent on Giardia Dicer, and 
miR2 has the capacity to function as a miRNA when cotransfected with a reporter 
mRNA construct. 
Because snoRNA-derived miRNAs are found in two extremely distant 
eukaryotes, it is possible that similar examples would be discovered in other 
species. 
Recently, several deep-sequencing analyses revealed the existence of 
regulatory RNAs derived from tRNAs in different cell types including HIV-infected 
cells, prostatic carcinoma cell lines, HeLa cells, HEK 293 cells, and a mouse 
embryonic cell line (for reviews, see (Pederson, 2010; Sobala and Hutvagner, 
2011)). Even if it is still possible that these detected RNAs constitute degradation 
products, the data points that these tRNAs-derived micro RNAs can be specific. 
Interestingly, the data presented suggests that they can function as micro RNAs, but 
they can also exhibit different features from canonical miRNAs.  
Y RNAs are evolutionary-conserved, Pol III-specific, small cytoplasmic RNAs. 
In humans there are 4 Y RNAs with lengths of 85 to 112 nucleotides. Y RNAs are 
folded into characteristic stem-loop structures, they form Ro RNPs with the 60 kDa 
Ro60 protein and a fraction of RoRNPs contains the La protein. In addition, other 
less-well characterized proteins might be (transiently) associated. The Ro 
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ribonucleoproteins are often targeted by the immune system in several autoimmune 
diseases. For review, see (Chen and Wolin, 2004; Wolin and Reinisch, 2006).  
The function of Ro RNPs has remained poorly characterized. Nevertheless, 
Ro RNPs likely function in a pathway by which misfolded RNAs, including snRNAs, 
are recognized and targeted for degradation. Interestingly, structural studies have 
revealed that the region binding misfolded RNAs in RoRNPs is the main antigenic 
epitope of Ro60 antibodies in patients suffering from autoimmune diseases (Chen 
and Wolin, 2004). Besides a role in RNA quality control, Y RNAs seem to be 
implicated in the initiation of DNA replication. In a cell-free system, degradation of Y 
RNAs inhibits initiation of DNA replication (Christov et al., 2006; Christov et al., 
2008; Gardiner et al., 2009; Krude et al., 2009; Langley et al., 2010).  
Intriguingly, it has been proposed that Ro RNPs could dissociate upon 
cellular stress, allowing Dicer to process free Y RNAs into miRNAs. The Y-derived 
miRNAs could then function in targeting mRNAs. Although there is still no concrete 
evidence that Y RNAs can be processed this way, this will be another example of 
how a given RNA can have dual functions by associating in distinct RNPs under 
different cell conditions (Verhagen and Pruijn, 2011). 
  
  p. 42 
B. TRANSCRIPTIONAL REGULATION 
Until recently, it was generally assumed that regulation of transcription was 
accomplished by regions adjacent to a gene, mainly promoters and enhancers. 
However, it is now clear that transcription by RNA Pol II is an extremely complicated 
and regulated process. Numerous noncoding RNAs have been identified as 
important regulators of transcription. In fact, ncRNAs can target all steps of the 
transcription process from regulating chromatin structure through controlling 
transcript elongation. Several reviews discuss the role of ncRNAs in regulation of 
transcription (Barrandon et al., 2008) 
This section will focus on an abundant small nuclear noncoding RNA that 
plays a major role on transcription elongation: the 7SK RNA. 
The 7SK small nuclear snRNA 
  
The RNA Pol II transcription can be divided into several distinct steps. First, 
Pol II is recruited to the promoter of a gene, where it forms a preinitiation complex 
with the general transcription initiation factors. Even if transcription initiation is a 
fine-tuned process, eukaryotic gene expression seems to be largely regulated after 
the recruitment of Pol II. Indeed, after transcription initiation, the Pol II pauses 
downstream of the transcription start site before entering into productive 
transcription elongation. At this point, negative transcription elongation factor (N-
TEF), which consists of the negative elongation factor (NELF) and DRB-sensivity 
inducing factor (DSIF), is recruited to Pol II and generates the arrest of the 
transcription machinery. Then, if pausing is not released, transcription aborts and 
the nascent transcript is rapidly degraded. For reviews, see (Buratowski, 2009; 
Margaritis and Holstege, 2008)  
The transition into productive elongation requires the positive transcription 
elongation factor P-TEFb (for a recent review, see (Lenasi and Barboric, 2010)). 
This factor, composed of cyclin-dependent kinase 9 (cdk9) and cyclin T1, T2 or K, 
has several targets of phosphorylation. An important step into productive elongation 
is the phosphorylation of DSIF by P-TEFb, which converts DSIF into a positive 
elongation factor. It also phosphorylates NELF and Ser2 in the CTD of Pol II. This 
kinase activity is essential for productive transcription elongation but also for 
recruitment of factors involved in cotranscriptional splicing and polyadenylation of 
pre-mRNAs. 
Given the key role played by P-TEFb in RNA pol II transcription, its activity 
has to be tightly regulated in the cell. Indeed, misregulation of Cdk9 activity has 
been associated to deseases such as AIDS, cardiac hypertrophy and several types 
of cancer (Romano and Giordano, 2008). One important way of regulating P-TEFb 
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kinase activity is trhough its interaction with a small nuclear noncoding RNA, the 
7SK snRNA, and an HEXIM protein (for a recent review see (Peterlin et al., 2011)). 
Together with HEXIM proteins, 7SK snRNA sequesters a fraction of cellular P-TEFb 
into a catalytically inactive complex (Nguyen et al., 2001; Yang et al., 2001). The 
incorpopration of P-TEFb into the 7SK snRNP starts with the binding of a HEXIM1 
or HEXIM2 dimer to a distal region of the 5’-hairpin of 7SK RNA. This RNA-protein 
interaction induces a conformational change in HEXIM proteins that enables their 
interaction with P-TEFb (Michels et al., 2004). Moreover, the complete assembly of 
the 7SK/HEXIM/P-TEFb snRNP necessitates another RNA-protein interaction 
formed between the 3’-hairpin of 7SK snRNA and P-TEFb (Egloff et al., 2006).  
In the cell, P-TEFb exists in two distinct forms: the free and active form 
capable of activating transcription elongation; and the inactive form trapped into the 
7SK RNP. The two forms of P-TEFb are kept in a dynamic and reversible 
equilibrium, which can be adjusted to the transcriptional demand of the cell.  Multiple 
factors control the equilibrium between the active and inactive form of P-TEFb. For 
example, release of P-TEFB from the 7SK snRNP can be promoted by HIV-1 Tat or 
Brd4, through direct binding to P-TEFb (Bisgrove et al., 2007; Krueger et al., 2010). 
In addition HIV-1 Tat protein also binds directly to the 5’-hairpin of 7SK snRNA, 
masquing the HEXIM binding sites of the RNA, and most probably inhibiting the 
formation of the 7SK/HEXIM/P-TEFb snRNP (Muniz et al., 2010). Other signals can 
promote the remodeling of the 7SK/HEXIM/P-TEFb snRNP, such as transcriptional 
stress or UV irradiation, but the signaling pathways leading to the dissociation of the 
7SK/HEXIM/P-TEFb snRNP are not well understood. 
Upon the disassembly of the 7SK/HEXIM/P-TEFb snRNP, released 7SK RNA 
associates with a set of hnRNP proteins (A1, A2/B1, R and Q) (Barrandon et al., 
2007; Van Herreweghe et al., 2007). It is thought that binding of hnRNPs to 7SK 
prevents its re-association with HEXIM and P-TEFb. Therefore, the dynamic 
remodeling of 7SK snRNPs controls the active level of P-TEFb in the cell (Figure 
12). 
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Figure 12. A model for regulation of the nuclear level of active P-TEFb by 
dynamic and reversible remodelling of 7SK snRNPs. In exponentially growing 
HeLa cells, about 50% of P-TEFb is sequestered into the 7SK/HEXIM1/P-TEFb 
snRNP, while the other half associates with the bromodomain protein 4 (Brd4) that 
likely recruits active P-TEFb to chromatin templates. Transcription inhibition by ActD 
or DRB treatment induces dissociation of P-TEFb and HEXIM1 from the 7SK 
snRNA and at the same time, facilitates binding of RHA, hnRNP A1, A2/B1, R and 
Q proteins. Please note that two copies of HEXIM1 and P-TEFb interact with one 
7SK molecule in the 7SK/HEXIM1/P-TEFb snRNP, and that at least two different 
7SK/hnRNP particles with not yet fully clarified protein composition are formed upon 
transcription inhibition. From (Van Herreweghe et al., 2007)  
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CHAPTER III:  
BOX C/D SMALL RIBONUCLEOPROTEINS 
A. STRUCTURE AND FUNCTION OF BOX C/D RNAs  
A major class of small noncoding RNAs, involved in post-transcriptional 
nucleotide modification of target RNAs, comprises the box C/D and box H/ACA 
RNAs. These two families share a common and ancient origin: they are present in 
all Eukaryotes and Archea. Once again, studies of these two families are expanding 
the RNA world: they have revealed an unexpected degree of complexity in their 
organizations and functions. In fact, box C/D and box H/ACA RNAs display complex 
genome organization and variant biogenesis pathways. Besides, they display an 
impressive functional diversity: they have multiple cellular targets (such as rRNA, 
snRNAs, tRNAs in Archea and maybe mRNAs), they perform nucleolytic processing 
of rRNAs, and are even involved in the synthesis of telomeric DNA. Additionally, 
many orphan sno/scaRNA with unknown targets and functions have been reported. 
Furthermore, they seem to have unexpected functions as a non-canonical source of 
miRNAs (see page 39). 
The present chapter will focus on the box C/D RNPs, for a recent review on the 
box H/ACA RNPs see (Kiss et al., 2010). 
Function of Box C/D RNAs 
Box C/D RNAs contain two highly conserved sequence motifs, the C box 
(consensus RUGAUGA) (R=purine) and the D box (CUGA). The C box is located 
near the 5’ extremity of the RNA, whereas the D box is located near the 3’ end 
(Figure 13). Boxes C and D interact forming a helix–internal loop–helix structure 
known as the kink-turn (k-turn) motif. These motifs are important sites for protein 
recognition. Most box C/D RNAs contain a second, less well-conserved copy of the 
C/D motif: the C′/D′ motif.  
The majority of box C/D RNAs direct 2’-O-ribose methylation of other RNAs. To 
guide RNA methylation, a region of 10-21 nt long, adjacent to the D or D′ box, 
transiently base-pairs with the target RNA. Recent extensive sequence analysis 
combined to high-throughput crosslinking data in yeast suggests that additional 
base-pairing with the pre-rRNA usually occurs (van Nues et al., 2011).  
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Organism Target RNA 
Eukaryotes 
rRNA 
snRNA 
mRNA? 
tRNA?  
Archea 
rRNA 
snRNA 
tRNA 
 
 
Figure 13. Schematic structure and main function of box C/D RNAs. Formation 
of 2’-O-ribose methylated nucleotide is shown. The C/D boxes necessary for 
accumulation and nucleolar localization are shown in red. The canonical kink-turn 
motif formed by the box C and D sequences is shown. Regions not necessary for 
the stability of the RNA are in black. The interaction between the antisense guide 
region (shaded boxes) and the substrate RNA (in blue) is shown. The 2’-O-
methylated nucleotides located five nucleotides upstream of the D or D’ box 
sequences are indicated (m). An internal stem-loop (in green) present in many box 
C/D RNAs places the C’/D’ boxes in close proximity. The table shows different 
classes of experimentally verified and predicted methylation target RNAs of known 
box C/D RNAs. 
Potential 
hairpin 
structure 
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The architecture of box C/D RNPs 
Box C/D snoRNAs function as ribonucleoprotein particles localized in the 
nucleolus (snoRNPs) or in the Cajal body (scaRNPs). They contain several common 
core proteins, conserved from humans to Archea and they transiently associate with 
factors during biogenesis (Figure 14).  
Mature box C/D snoRNPs contain 15.5K (Snu13/L7Ae in yeast and Archea, 
respectively), Nop56, Nop58 and the methyltransferase fibrillarin. Vertebrate 15.5K 
binds directly to the k-turn structure of the box C/D motif, recognizing highly 
conserved G:A base-pairs. Surprisingly, 15.5K directly binds the C/D motif but not 
the C′/D′ motif even though the motifs share the same consensus sequence (Cahill 
et al., 2002; Szewczak et al., 2002; Szewczak et al., 2005). It is thought that the 
C’/D’ motif is not able to adopt a kink-turn conformation. This leads to an 
asymmetric distribution of core proteins. The C/D motif is bound by 15.5K, Nop58 
and one copy of fibrillarin, while Nop56 and a second copy of fibrillarin contacts the 
C′/D′ motif. Via interactions between their coiled-coil domains, Nop56 and Nop58 
form dimers that are the basis of the organization of C/D RNP particles. As fibrillarin 
is bound to the N-terminal domain of Nop56/Nop58 independently from the RNA, 
the dimerization of Nop56/Nop58 places a fibrillarin molecule at the second 
functional unit. In contrast to Archea, the distance separating eukaryotic box C/D 
and C’/D’ sequences can be long and variable. Therefore, further structural studies 
are required to establish how a second functional unit is assembled on the 
eukaryotic C’/D’ motif.    
 Archaeal snoRNPs, named sRNPs, adopt symmetrical structures. In fact, 
both C/D and C′/D′ sequences form k-turn motifs that bind one molecule of L7Ae, 
fibrillarin and Nop5. In Archea, the box C/D and C’/D’ motifs are separated by a 
highly conserved distance (Dennis and Omer, 2005). Recently, structural studies of 
in vitro assembled archeal box C/D sRNPs have explained key features of guiding 
methylation by box C/D RNAs (Bleichert et al., 2009; Xue et al., 2010; Ye et al., 
2009). One of these studies proposed a monomeric complex, whereas the two 
others reports proposed a dimeric structure containing two molecules of sRNA and 
four molecules of each of the three proteins. The structural models proposed the 
physical basis allowing to explain both substrate base-pairing and the high 
specificity of the fifth nucleotide being modified. They also revealed that a 
substantial hinge motion occurs during catalysis, and how dynamic conformational 
changes are possible during the assembly of box C/D RNPs. Unfortunately, all the 
three structures where partial; hence the structural organization of sRNPs has not 
been completely resolved. Furthermore, it is also unclear if the eukaryotic complex 
can adopt similar monomer/dimer conformations. 
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Figure 14. Box C/D snoRNPs and sRNPs core protein composition and trans-
acting factors associated during the biogenesis pathway. Adapted from 
(Motorin and Helm, 2011)  
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Recent studies in yeast have shown that the C/D and C’/D’ motifs are 
functionally and spatially coupled (Qu et al., 2011). In fact, increasing the distance 
between both motifs decreases the capacity of the C’/D’ (but not the C/D) motif to 
target methylation. If the spacer region separating both motifs is a stem-loop, the 
methylation capacity of C’/D’ motifs is conserved, even enhanced. They further 
showed by pulldown experiments that all four core proteins, including Snu13, are 
recruited into both motifs. These studies concluded that Snu13 doesn’t interact 
directly with the RNA C’/D’ motifs but it can be recruited by protein-protein 
interactions. Therefore, it seems that in yeast the distribution of the proteins in the 
particle is symmetric as in Archea. 
B. BIOGENESIS 
Production of mature sno/scaRNPs is an intricate and regulated porcess 
involving intranuclear trafficking, assisted assembly of core-proteins by multiple 
trans-acting factors, and precursor 5’ and 3’ hangs processing (Figure 14). For 
reviews, see (Kiss et al., 2006; Matera et al., 2007). It seems that the complexes are 
assembled as inactive pre-RNPs on nascent guide RNA transcripts at the 
transcription place. The pre-RNPs are transported to Cajal bodies, and further 
transit can occur to target them to the nucleoli. 
Organization of box C/D snoRNA genes 
Genes encoding the family of snoRNAs and scaRNAs are present in distant 
domains of life such as Eukaryotes and Archea. They have been identified in 
parasites (Chakrabarti et al., 2007; Mishra et al., 2009; Uliel et al., 2004) or even 
viruses (Hutzinger et al., 2009). Interestingly, snoRNA genes display a great 
diversity of organization and the strategy used to express a snoRNA influences its 
further processing. For reviews see (Brown et al., 2003; Brown et al., 2008; Dieci et 
al., 2009; Rodor et al., 2010). 
The majority of metazoan snoRNAs are encoded in introns of ribosomal 
protein or other housekeeping protein genes. Intronic snoRNAs are usually found as 
individual units, but clusters of several coding units located in the same intron can 
also be found. Drosophila is an exception in which many snoRNAs are found 
clustered in introns of non-protein coding genes. snoRNAs can also be transcribed 
from their independent promoters;  in yeast, the majority of snoRNA genes are 
expressed this way.  
As prototrophic organisms, the organization and evolution of plant genomes 
usually has specific features. This is the case for plant snoRNA genes that exhibit 
diverse organizations; implicating in some cases specific plant processing 
pathways. For example, most plant snoRNAs are expressed from polycistronic units 
that require an endonucleolytic cut to release the snoRNAs, wich is rare in 
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Eukaryotes (Figure 15). Clustered snoRNAs in plants can be found in introns or as 
individual transcription units. In addition to transcription by RNA Pol II, several 
snoRNA genes can also be transcribed by RNA Pol III, as individual units. 
Additionally, Pol III genes expressing dicistronic tRNA-snoRNA precursors are found 
in plants (Kruszka et al., 2003) that are processed by a plant specific processing 
pathway (Barbezier et al., 2009). 
The genomic localization of the small number of known parasite snoRNAs 
shows mixed patterns of those observed in plants, yeast and vertebrates. 
Plasmodium snoRNA genes can be found as individual/intronic and 
single/polycistronic transcription units. Additionally, they seem to be found in 
untranslated regions (UTR) of mRNAs (Mishra et al., 2009).   
The high diversity of snoRNA genes may arise from their capacity to be 
duplicated by retrotransposition (Weber, 2006). 
 
 
 
 
Figure 15. Processing of intronic snoRNAs. (a) Most vertebrate and a few yeast 
snoRNAs are released from linearised introns by exonucleolytic trimming. This 
processing is splicing-dependent. (b) Yeast and plant polycistronic snoRNAs and 
plant intronic snoRNAs (both single and clusters) are released by endonucleolytic 
cleavage (red arrowheads), which is followed by exonucleolytic trimming. This 
processing is splicing-independent. From (Brown et al., 2008).  
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Assembly of box C/D RNPs  
Box C/D scaRNP assembly is initiated by the binding of 15.5K to the kink-turn 
motif. Binding of 15.5K leads to structural rearrangements that trigger the ordered 
recruitment of the remaining snoRNP proteins Nop58, Nop56 and fibrillarin. 15.5K 
protein also binds to the U4 snRNA and the B/C motif of the U3 snoRNA, but in 
these cases the complex recruits Prp31 or RRP9 proteins, respectively (Granneman 
et al., 2002; Watkins et al., 2000). A GAEK motif within the RNA binding NOP-
domain present in Nop56 and Nop58 but absent in Prp31, together with box C/D 
RNA structural specificities, are important for the discrimination of different 15.5K-
containing complexes (Liu et al., 2007; Ye et al., 2009). An adjacent ALFR motif in 
archeal Nop5 has also been shown to interact with the box C/D RNA. This motif is 
also conserved in eukaryotic Nop56 and Nop58, but absent from Prp31. Therefore, 
it is likely that in Eukaryotes the ALFR motif also contacts the snoRNA and 
contributes to the discrimination and specificity of snoRNP assembly (Ghalei et al., 
2010). Archeal box H/ACA RNAs also feature a kink-turn motif that binds to L7Ae-
related Nhp2 protein. The specificity is acquired by the further binding of the core 
box C/D or box H/ACA proteins. Posttranslational SUMO modification of Nop58 and 
Nhp2 may be important for differential assembly into box H/ACA or box C/D RNPs 
(Westman et al., 2010). 
Intronic snoRNAs are released from the pre-mRNA in a splicing-dependent 
manner (Hirose et al., 2003). In fact, the 15.5K protein associates to the precursor 
snoRNA during C1 assembly stage of the spliceosome, after the first cleavage of 
the host pre-mRNA. The splicing factor IBP160 recruited to the branch point is 
thought to favor the correct folding of the kink-turn motif necessary for binding of 
15.5K (Hirose et al., 2006). Intronic box C/D RNAs located far upstream from the 
branch point assemble in a splicing-independent way. In this case, other factors 
recruited independently from splicing may contribute to the correct folding of the 
kink-turn motif (Watkins et al., 2002). In some cases, splicing of the host pre-mRNA 
is mutually exclusive with the biosynthesis of the intronic snoRNA. In this case the 
snoRNA is produced directly from the unspliced pre-mRNA by endonucleolytic 
cleavages (de Turris et al., 2004).  
A subset of snoRNAs, such as U3, U8 and U13, are expressed from an 
independent gene transcribed by RNA Pol II. Their precursors contain a short 3′ 
extension and a m7G-cap that is hypermethylated into a TMG cap by the nuclear 
short isoform of Tgs1 (Mouaikel et al., 2002).  
snoRNA precursors are present in large multiprotein complexes containing 
factors involved in trafficking/assisted assembly/or processing (Boulon et al., 2008; 
Boulon et al., 2004; Saez-Vasquez et al., 2004; Samaha et al., 2010; Watkins et al., 
2004) (see Figure 14 summarizing the known transiently associated factors). The 
exact composition of these complexes can vary according to the circumstances of 
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the processing pathway. The exact role of all of these factors is not always clear, but 
the idea is that they facilitate the splicing-coupled box C/D RNP assembly. 
The heat shock protein 90 (Hsp90) is a ubiquitous molecular chaperone that, in 
collaboration with a variety of cochaperones and cofactors, promotes the proper 
folding of important signaling factors. Hsp90 has been demonstrated to function in 
the assembly of eukaryotic RNPs containing the L7Ae-related proteins such as 
15.5K (Boulon et al., 2008; Zhao et al., 2008). Hsp90 functions in concert with the 
R2TP complex in the biogenesis of sno/scaRNPs. It has been shown that R2TP 
complex can bridge the interaction between Nop56/Nop58 (McKeegan et al., 2009). 
It is thought that the Nufip protein binds directly to 15.5K and tethers the chaperones 
to nascent RNPs.  
Recently, the plant functional homologue of Nufip has been identified, and 
mutants of atNufip underscore the importance of this protein on plant development 
(Rodor et al., 2011). 
 
Trafficking  
Transport of box C/D sno/scaRNAs to nucleoli and Cajal bodies is only partially 
characterized. Box C/D RNA precursors initially localize to Cajal bodies, the place 
where cap hypermethylation (of U3, U8 and U13), exonucleolytic trimming 
producing the mature ends and final assembly steps are thought to occur. The 
transport of box C/D RNAs to Cajal bodies is dependent on the binding of PHAX to 
uncapped pre-snoRNAs (Boulon et al., 2004). PHAX also binds to snRNAs, which 
are similar in size to snoRNAs, but targets them for export into the cytoplasm. 
Therefore, a discrimation between snoRNAs and snRNA is made, probably in the 
Cajal bodies. 
As for snRNAs, CRM1 is also a key player in the transport of C/D snoRNAs. 
CRM1 associates predominantly with TMG-capped mature snoRNAs and targets 
them to nucleoli (Boulon et al., 2004). The C-terminal domains of Nop56 and Nop58 
proteins function as a nucleolar localization signal that contributes to the nucleolar 
localization of box C/D RNPs (Pradet-Balade et al., 2011). It has been shown that 
CRM1 preferentially binds to the long isoform of Tgs1 (Tgs1 LF), promoting its 
dissociation of Nop56 and Nop58, and addressing Tgs1 LF to the cytoplasm. The 
dissociation of Tgs1 LF may discover the nucleolar localization signal of Nop56 and 
Nop58, contributing to the snoRNP localization to the nucleoli. Interesetingly, 
functional interactions between CRM1 and nucleoporins are required for snoRNP 
addressing to the nucleolus, suggesting a passage through nuclear pores (Pradet-
Balade et al., 2011). 
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Even if C/D snoRNAs associate with the PHAX and CRM1 export factors, their 
biogenesis clearly doesn’t include a cytoplasmic step (Pradet-Balade et al., 2011). 
Nevertheless, mammalian U8 snoRNA seems different, as it is detected in 
cytoplasmic extracts and the import protein Snurportin1 is involved in its biogenesis 
(Watkins et al., 2007). 
Some box C/D and H/ACA RNAs are retained in the Cajal bodies: and therefore 
they are called the small Cajal body-specific RNAs (scaRNAs). The H/ACA and 
composite H/ACA-C/D scaRNAs carry a short motif, the CAB box (ugAG), 
necessary for their localization to Cajal bodies (Richard et al., 2003). The human 
and Drosophila WDR79 proteins accumulate in Cajal bodies, and they stably 
associate with H/ACA scaRNPs, in a CAB box-dependent manner. Association with 
WDR79 is required for Cajal body localization of scaRNPs (Tycowski et al., 2009; 
Venteicher et al., 2009). Interestingly, WDR79 also interacts with both human and 
fly box C/D scaRNPs, despite the fact that human box C/D scaRNAs lack 
recognizable CAB box motifs. The Drosophila box C/D scaRNAs carry a common 
Cajal body localization sequence that seems to be an extended version of the 
vertebrate H/ACA CAB box.  
Other interactions are thought to occur in Cajal bodies. Nopp140 interacts with 
mature snoRNAs, Nop58 and fibrillarin probably in these structures. It is thought that 
this factor is involved in chaperoning assembly and transport of snoRNPs from the 
Cajal body (Yang et al., 2000b). The survival of motor neurons (SMN) complex that 
promotes assembly of various classes of RNPs has been shown to specifically 
interact with fibrillarin, suggesting that SMN also functions in C/D RNP assembly. 
Given that the nuclear fraction of SMN concentrates in Cajal bodies and that 
nascent box C/D RNPs are targeted to the Cajal bodies, it seems possible that the 
SMN complex has a role on box C/D RNPs biogenesis (Pellizzoni et al., 2001). It 
has been suggested that SMN is required for accumulation of Nopp140 in Cajal 
bodies. Therefore loss of the SMN complex, resulting in spinal muscular atrophy, 
may account for defects on snoRNP biogenesis (Renvoise et al., 2009). 
It has been recently shown that the tumor suppressor p53 controls the levels of 
Nopp140 and unrip, a cytoplasmic component of a subset of SMN complexes. This 
way, p53 can have a synergizing effect on efficient snoRNP assembly (Krastev et 
al., 2011). 
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C. BIOLOGICAL SIGNIFICANCE OF THE MODIFICATIONS 
Almost all classes of cellular RNAs carry post-transcriptionally modified 
nucleotides. So far, 109 different nucleotide modifications have been described (a 
compilation can be found in The RNA Modification Database http://rna-
mdb.cas.albany.edu/RNAmods/), which may contribute to RNA functions. The 
amount of RNA nucleotides devoted to modification has been estimated to 1-2% 
depending on the organism (Bjork, 1995). The great diversity of modifications, their 
conservation trough evolution, their particular localization on functionally important 
regions of RNAs as well as the complexity and spreading of the machineries 
devoted to nucleotide modifications suggest that they have strong biological 
significance. 
The two most abundant modifications are uridine isomerization to 
pseudouridine (ᴪ) and 2’-O-methylation, which are post-transcriptional covalent 
modifications, spread through all kingdoms of life. They are presumably the most 
ancient of RNA modifications, and can be synthesized either by stand-alone 
enzymes in all organisms or RNPs in Eukaryotes and Archea. The inclusion of RNA 
as a guide cofactor has allowed the acquisition of novel targets without reinventing 
each time a new protein substrate-recognition domain. An interesting comparison of 
the mechanisms and evolution of RNA-guided enzymes versus protein-only 
enzymes has been made (Huttenhofer and Schattner, 2006).  
The chemical properties of the modified nucleotides are different from those 
of unmodified ones. Pseudouridine residues have a C-C linkage between the base 
and the sugar instead of the N-C linkage present in other nucleotides, and feature 
an additional hydrogen bond donor when compared to uridine. The presence of a 
pseudouridine in an RNA chain provides an additional opportunity for hydrogen 
bonding and renders the RNA backbone more rigid. Pseudouridylation can be 
performed by the box H/ACA RNPs in an RNA guided-mechanism. Box H/ACA 
RNPs guide the pseudouridylation of specific sites in rRNAs and snRNAs. On the 
other hand, the repertoire of box H/ACA RNAs is still increasing in various 
organisms, which opens the possibility that other classes of cellular RNAs may be 
targeted by the box H/ACA RNAs. Several recent reviews describe the importance 
of pseudouridilation in ribosome and spliceosome function (Karijolich et al., 2010; 
Karijolich and Yu, 2010; Wu et al., 2011b). Recently, Wu and colleagues discovered 
that pseudouridylation can be inducible upon nutrient deprivation, therefore opening 
the possibility that inducible RNA modifications contribute to fine-tune cellular 
responses (Wu et al., 2011a). 
Addition of a 2’-O-ribose methyl group to a nucleotide increases 
hydrophobicity and alters the ability of the ribose to engage in hydrogen bonding. 
Hydrophobic modifications enhance base-stacking interactions, which result in 
reordering of water around the RNA molecule (Basti et al., 1996). Enhancement of 
  p. 55 
stacking adds stability to the molecular structure, therefore the presence of 2’-O-
methylations in an RNA chain increases its melting temperature (Yokoyama et al., 
1987) and contribute to the conformational dynamics and folding of RNA (Agris, 
1996).  
Deciphering the biochemical effect of modifications in cellular RNAs is a 
complicated task, since they often present multiple modifications. The interactions 
between modified nucleotides produce new conformations and alter chemical 
properties; therefore their effects must be considered collectively.  
In the cell, modifications have been demonstrated to be involved in a variety 
of complex biological functions; including stabilization of motional dynamics and 
architecture of RNA, quality control, resistance to antibiotics, translation efficiency 
and accuracy or splicing. The majority of box C/D RNPs methylate rRNAs and 
snRNAs, and several reviews discuss the importance of these modifications 
(Karijolich et al., 2010; Karijolich and Yu, 2010; Wu et al., 2011b). We can 
understand how important RNA modifications can be by introduction of new 
modifications into target RNAs. For example, expression of synthetic box C/D guide 
RNAs has been successfully used to introduce new modifications affecting splicing 
(Ge et al., 2010) or telomerase function (Huang and Yu, 2010). In the future, RNA-
guided modification could serve as a tool for regulating different RNA activities for 
research or even therapeutic purposes.  
The following paragraphs briefly discuss some of the known biological effects 
of the most extensively modified RNAs in the cell: the transfer RNAs. 
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tRNA modifications 
Transfer RNAs display the greatest variety and largest number of modified 
nucleotides. Living cells devote a great deal of resources to tRNA modification, and 
some modifications are conserved through all kingdoms. A battery of enzymes and 
RNA-guided enzymes has evolved to accomplish this function. Defective tRNA 
modification leads to rapid tRNA decay (Alexandrov et al., 2006). 
The Wooble position 
Cells contain some 40 distinct tRNA genes to decode the 61 amino acid 
codons; therefore some tRNAs recognize more than one codon. Francis Crick 
proposed a mechanism to explain how tRNAs read more than one codon, the 
Wobble Hypothesis. In fact, up to 40% of all codon recognition is accomplished 
through tRNA wobble recognition of more than one codon (Figure 16). 
               
 
 
Figure 16. Mechanism of codon recognition. Base 36 and 35 of the anticodon 
are paired to bases 1 (blue) and 2 (red) of the codon through Watson–Crick (WC) 
base pairing. The base 34 of the anticodon (cyan), the “wobble” base (often 
modified), is paired to position 3 of the codon either with Watson–Crick base pairing 
or U:G, G:U or I:C non-canonical pairing. Adapted from (Grosjean et al., 2010). 
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As shown in Figure 16, modifications at position 34 are of fundamental 
importance: they are directly implicated in the codon/anticodon recognition.  In fact, 
from the ~100 different modifications, over 36 can be found at this position, 
including the most complex ones (for recent reviews see (Agris, 2008; Agris et al., 
2007; Grosjean et al., 2010; Motorin and Helm, 2011)). 
Modifications at position 34 and 37 stabilize the codon-anticodon interaction 
and contribute to the specific recognition of more than one codon by tRNA.  They 
also contribute to ordered dynamics of the tRNA, resulting in the acceptance of the 
tRNA by the ribosome (Figure 17). Consistent with this, mutants lacking such 
modifications have been known for long to have a reduction in growth rate (Ericson 
and Bjork, 1986). 
Besides increasing ribosome acceptance, modifications at these positions 
affect translation fidelity: they negate aberrant base-pairing interactions with mRNA 
and prevent translational frameshifting. Moreover, the anticodon domain structure 
and modifications are essential for recognition by aminoacyl-tRNA synthetases of 
tRNA identity. Once again, they are important for translation accuracy (Agris, 2008; 
Agris et al., 2007; Motorin and Helm, 2011). 
Some other tRNA functions seem to be affected by anticodon stem 
modifications. For example, Trm9 methylates the uridine Wobble base of 
tRNAARG(UCU) and tRNAGLU(UUC). It has been found that these tRNA modifications 
enhance codon-specific translation of key damage response proteins, preventing 
cell death (Begley et al., 2007). It was later revealed that these and other 
modifications are controlled dynamically in response to cellular stress (Chan et al., 
2010). Just as the discovery of inducible pseudouridilation discussed earlier, the 
data suggests that dynamic control of modifications can be functionally important. 
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Figure 17. Effect of modifications at position 34 and 37 on tRNA dynamics and 
accommodation on the ribosome. The anticodon stem-loop domain (ASL) in the 
left tRNA is unmodified and disordered. The tRNA with a disordered ASL cannot 
contact the codon on the mRNA correctly and is rejected by the ribosome. Extensive 
modifications at wobble position 34 and purine 37 restrain the dynamics of the 
anticodon loop, and direct its conformation towards that of the canonical structure 
shown on the right. “Ordered” dynamics of tRNA contribute to ASL interaction with 
the codon and binding of the tRNA to the ribosome. Adapted from (Agris, 2008). 
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Archeal box C/D sRNPs guide the methylation of tRNA 
In Eukaryotes, tRNA modifications are known until now to be performed by 
RNA-modification enzymes. Archeal box C/D sRNPs has been shown to have the 
capacity of guide methylation of tRNAs (Clouet d'Orval et al., 2001; Dennis et al., 
2001; Joardar et al., 2008; Joardar et al., 2011; Omer et al., 2000; Renalier et al., 
2005; Singh et al., 2008). This is not a rare phenomenon in Archea, since many box 
C/D sRNAs exhibit complementarity to the tRNAs (an example is shown in Figure 
18). It is thought that high growth temperature is related to tRNA methylation in 
Archea, since these modifications can increase the melting temperature of the tRNA 
molecules.   
 
                                              
Figure 18. The intron-containing pre-tRNATrp in some Archea carries both box 
C/D 2’-O-methylation guide sequences and tRNATrp sequences in the same 
RNA molecule. The intronic box C/D sRNP can guide the 2’-O-methylation of C34 
and U39 in the two exon regions of the pre-tRNATrp in vivo (Joardar et al., 2008) and 
in vitro (Singh et al., 2004). The intron can function as box C/D sRNP as part of the 
pre-tRNATrp or in free excised form. The D and D′ guide sequences of the intron can 
guide 2′-O-methylations of target residues C34 and U39 (Cm34 and Um39), 
respectively. From (Clouet d'Orval et al., 2001). 
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FIRST PART OF THE RESULTS: 
DISCOVERY OF A NOVEL U1-TAF15 snRNP  
 
I. PUBLICATION 
 
The idea is emerging that one needs to think beyond the canonical well-
established functions of ncRNAs. In fact, recent findings suggest that ncRNAs may 
form distinct, probably transient, snRNPs and fulfill additional functions in the cell. 
Yet, this intriguing possibility remains largely unexplored. Our work has shown that 
human U1 snRNA forms at least two structurally and, most likely, functionally 
disctinct snRNP particles. 
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The U1 small nuclear RNA (snRNA)—in the form of the U1
spliceosomal Sm small nuclear ribonucleoprotein particle (snRNP)
that contains seven Sm and three U1-specific RNP proteins—has a
crucial function in the recognition and removal of pre-messenger
RNA introns. Here, we show that a fraction of human U1 snRNA
specifically associates with the nuclear RNA-binding protein
TBP-associated factor 15 (TAF15). We show that none of the
known protein components of the spliceosomal U1-Sm snRNP
interacts with the newly identified U1-TAF15 snRNP. In addition,
the U1-TAF15 snRNP tightly associates with chromatin in an
RNA-dependent manner and accumulates in nucleolar caps upon
transcriptional inhibition. The Sm-binding motif of U1 snRNA is
essential for the biogenesis of both U1-Sm and U1-TAF15 snRNPs,
suggesting that the U1-TAF15 particle is produced by remodelling
of the U1-Sm snRNP. A demonstration that human U1 snRNA
forms at least two structurally distinct snRNPs supports the idea
that the U1 snRNA has many nuclear functions.
Keywords: TAFII68; non-coding RNA; U1-70K
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INTRODUCTION
The U1 spliceosomal Sm small nuclear ribonucleoprotein particle
(snRNP), which is composed of the 164-nucleotide-long U1 small
nuclear RNA (snRNA), seven Sm proteins (B, D1, D2, D3, E, F and
G) and three U1-specific (U1-70K, U1-A and U1-C) snRNP
proteins, together with the U2, U4, U5 and U6 snRNPs, and many
dozens of protein factors, constitutes the spliceosome that is
responsible for the removal of pre-messenger RNA (pre-mRNA)
introns (Will & Lu¨hrmann, 2006). At the early stage of spliceosome
assembly, the U1 snRNP associates with the 50 splice site through
RNA–RNA and protein–RNA interactions, committing the nascent
pre-mRNA to the splicing pathway. The U1 snRNP/snRNA has
also been implicated in the enhancement of transcription
initiation by RNA polymerase II (Pol II; Kwek et al, 2002;
Damgaard et al, 2008), stabilization of nascent pre-mRNAs
(Hicks et al, 2006) and control of viral pre-mRNA polyadenylation
(Gunderson et al, 1998).
Biogenesis of Sm snRNPs is a complex process (Kiss, 2004).
After synthesis by Pol II, the precursor snRNAs (pre-snRNAs) are
exported to the cytoplasm, where their assembly with the seven
Sm core proteins is promoted by the survival of motor neurons
(SMNs) complex. Binding of Sm proteins is essential for both
hypermethylation of the primary monomethyl-G cap to trimethyl-G
(TMG) and removal of the 30 tail sequences of pre-snRNAs.
Finally, the nascent Sm snRNPs are imported to the nuclear Cajal
bodies where their snRNA components undergo site-specific
nucleotide modifications ( Jady et al, 2003).
During the initiation of Pol II transcription, the general Pol II
transcription factor IID (TFIID) is the first general transcription
factor that recognizes promoter sequences and initiates assembly
of the preinitiation complex. TFIID is composed of the TATA-
binding protein (TBP) and a series of TBP-associated factors
(TAFs). TAF15, formerly known as TAFII68, has been identified as
a TAF that interacts with a distinct population of TFIID (Bertolotti
et al, 1996). In addition to a transcriptional activation domain,
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TAF15 also contains an RNA recognition motif (RRM) and many
Arg-Gly-Gly repeat motifs, suggesting that it functions as an RNA-
binding protein. TAF15 and the structurally related EWS (Ewing
sarcoma) and TLS (translocated in liposarcoma) constitute the TET
family of proteins. In human sarcomas, translocation of TET genes
frequently results in chimaeric oncoproteins (Law et al, 2006). The
TET proteins have been suggested to have a function in regulating
transcription (Bertolotti et al, 1996, 1999; Jobert et al, 2009) or
in the splicing of pre-mRNA (Law et al, 2006, and references
therein), but their precise function remains elusive.
RESULTS AND DISCUSSION
TAF15 forms a new snRNP with U1 snRNA
To detect cellular RNA partners for TAF15, it was immunoprecip-
itated from a HeLa nuclear extract with two different TAF15
antibodies, and the co-precipitated RNAs were terminally labelled
and size-fractionated on a denaturing gel (Fig 1A). Both RNA
samples recovered by the TAF15 antibodies were highly enriched
by an approximately 165-nucleotide-long RNA that was hardly
detectable in control immunoprecipitations. The efficient immuno-
precipitation of TAF15 was confirmed by Western blot. When
labelled nuclear RNA was run in parallel, it became apparent
that the most abundant TAF15-associated RNA co-migrated with
U1 snRNA.
To determine unequivocally the identity of the newly
detected TAF15-associated RNA, RNase A/T1 protection analysis
was carried out by using an RNA probe complementary to the
predominant U1A sequence variant of the human U1 snRNA
(Fig 1B). RNA co-immunoprecipitated with TAF15 protected
the U1A probe, but failed to protect RNA probes specific
for the U2 and U4 snRNAs. None of the RNA probes was
efficiently protected by mock-immunoprecipitated RNAs.
An RNA-immunoprecipitation assay confirmed the in vivo
association of TAF15 with U1 (supplementary Fig 1 online).
Thus, we conclude that human U1 snRNA specifically associates
with TAF15.
Many RNA-binding proteins, including U1-70K and TAF15,
share an RRM that contains the conserved eight- and six-residue
RNP1 and RNP2 motifs. The first two amino acids (Arg 143 and
Gly 144) of the RNP1 motif of U1-70K have been shown to be
fundamental for binding to U1 snRNA (Surowy, 1989). To test
whether the RRM of TAF15 is important for in vivo binding to
U1, the first and second residues (Lys 280 and Gly 281)
in the RNP1 motif of TAF15 were replaced by proline (P) and
serine (S), respectively. The resulting TAF15 K280P and G281S
mutants, as well as the wild-type TAF15, were transiently
expressed as Flag-tagged proteins in HeLa cells. Following
anti-Flag immunoprecipitations, the recovery of U1 snRNA was
monitored by reverse transcription–quantitative PCR (RT–qPCR;
Fig 1C). As compared with the wild-type Flag–TAF15, the mutant
Flag–TAF15 K280P and Flag–TAF15 G281S proteins showed
about 54% and 64% reduced U1-binding capacities, respectively,
indicating that the RNP1 motif contributes to the U1-binding
capacity of TAF15.
To determine whether TAF15 binds to a fraction of the U1-Sm
snRNP or whether it is a component of a new, not yet identified
minor U1 snRNP, co-immunoprecipitation experiments were
performed (Fig 1D). Although immunoprecipitation of TAF15
efficiently recovered U1 snRNA, it failed to pull down detectable
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Fig 1 | TAF15 forms a new snRNP with U1 snRNA. (A) Immuno-
precipitations (IP) were performed from a HeLa nuclear extract with two
TAF15 antibodies (lanes 3 and 4), a control antibody (lane 2) or with
protein G-Sepharose alone (lane 1). RNAs co-precipitated with TAF15,
HeLa total and nuclear RNAs were terminally labelled and separated on a
sequencing gel (upper panel). TAF15 immunoprecipitation was analysed
by Western blot (lower panel). (B) RNAs precipitated by TAF15
antibodies, protein G-Sepharose alone (Ab) or a control antibody
were analysed by RNase A/T1 mapping with RNA probes specific for
U1, U2 or U4 snRNAs. The protected RNAs were fractionated on a
sequencing gel. Lane 1, control mapping with Escherichia coli tRNA.
(C) Transiently expressed Flag, Flag–TAF15, Flag–TAF15 K280P or
Flag–TAF15 G281S proteins were immunoprecipitated by Flag antibodies.
Co-immunoprecipitation of U1 snRNA was measured by RT–qPCR and
normalized with the amount of U1 co-precipitated with Flag–TAF15.
(D) Immunoprecipitations from a HeLa nuclear extract (IN) were
performed with antibodies as indicated. The co-immunoprecipitated
proteins were analysed by Western blot. Ab, antibody; M, size marker;
mAb, monoclonal antibody; RT–qPCR, reverse transcription–quantitative
PCR; snRNA, small nuclear RNA; snRNP, small nuclear ribonucleoprotein
particle; TAF, TBP-associated factor 15; tRNA, transfer RNA.
Human U1 snRNA forms a new snRNP with TAF15
L. Jobert et al
&2009 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 10 | NO 5 | 2009
scientificreport
495
amounts of the U1-70K, U1-A, U1-C and D1/D3 Sm proteins
that are integral components of the U1-Sm snRNP. By contrast,
all of the tested U1 snRNP proteins were efficiently recovered
by immunoprecipitation performed with a U1-70K antibody.
A trace amount of TAF15 detected in the pellet of the anti-
U1-70K immunoprecipitation probably derived from a weak
cross-reaction of the U1-70K antibody with TAF15. This assump-
tion was confirmed by the fact that U1-70K failed to co-precipitate
with a transiently expressed Flag-tagged TAF15 when it
was immunoprecipitated with a Flag antibody (supplementary
Fig 2 online).
TAF15 associates with the main isoform of U1 snRNA
Although human cells express minor sequence variants of the U1
snRNA (Kyriakopoulou et al, 2006), direct RNA sequencing
of 30-end labelled TAF15-associated U1 snRNA has revealed a
nucleotide sequence identical to the Gly 41–Gly 164 30-terminal
portion of the most abundant U1A sequence variant of U1 snRNA
(data not shown). Consistent with this, the TAF15-bound U1
snRNA efficiently protected the U1A-specific antisense RNA
probe (Fig 1B), showing that TAF15 predominantly associates
with the abundant U1A snRNA.
The mature U1-Sm snRNA contains an internal 20-O-ribose-
methylated adenosine (A70), two pseudouridines (C5 and C6) and
a 50-terminal TMG cap. To test whether these post-transcriptional
modifications are also present in the TAF15-associated U1 snRNA,
the U1-TAF15 snRNP and a positive control, the U1-Sm snRNP,
were immunoprecipitated from a HeLa nuclear extract with
TAF15- and Sm-specific antibodies (Fig 2A). Consistent with the
conclusion that TAF15 and Sm proteins form two distinct snRNPs
with U1, the pellets of the Sm and TAF15 immunoprecipitation
reactions were devoid of TAF15 and Sm proteins, respectively. The
U1 snRNA co-precipitated with TAF15 was further analysed by
immunoprecipitation with TMG and H-20 (specific for both TMG
and monomethyl-G) antibodies (Fig 2B). RNase A/T1 mapping
revealed that both antibodies immunoprecipitated U1 snRNA,
showing that the TAF15-bound U1 snRNA carries a TMG cap.
The 20-O-methylation status of A70 in the TAF15-associated U1
snRNA was determined by primer extension analysis in the
presence of low dNTP concentration, which is known to stop
reverse transcriptase before the methylated nucleotide ( Jady et al,
2003; Fig 2C). When TAF15- or Sm-associated U1 snRNAs were
analysed with a U1-specific primer at low dNTP concentration, a
strong stop signal was observed before A70 in both cases, showing
that the A70 residue is 20-O-methylated in both U1 samples.
Pseudouridylation of the U5 and U6 residues was determined
by the CMC primer extension method (Fig 2D). CMC reacts with
pseudouridines and arrests reverse transcriptase one nucleotide
before them ( Jady et al, 2003). Primer extension analysis of
CMC-treated TAF15- and Sm-associated U1 snRNAs resulted in
stops one nucleotide before the U5 and U6 residues, showing that
these uridines are converted into pseudouridine. In summary, we
conclude that the U1 snRNA components of the U1-TAF15 and
U1-Sm snRNPs have no distinctive structural characteristics.
Biogenesis of U1-TAF15 snRNP requires the Sm motif of U1
A demonstration that the U1-TAF15 snRNP lacks Sm proteins,
but its snRNA component is correctly processed suggests
that the TAF15-associated fraction of U1 snRNA follows an
‘Sm-independent’ processing pathway. To test this, a series of
mutant U1 snRNAs, U1sm1 to U1sm5, carrying altered Sm-binding
motifs were transiently expressed in HeLa cells (Fig 3A). RNase A/T1
mappings revealed a weak accumulation for each mutant U1 RNA.
Besides mature-sized U1 RNAs, we detected several 30-extended
unprocessed or partly processed pre-U1 snRNAs, which were also
present in non-transfected cells.
To determine the subcellular localization of the weakly
expressed mutant U1 RNAs, the U1sm3 RNA and as a control,
an Sm mutant U2 snRNA (U2sm), were expressed in HeLa cells
(Fig 3B). In contrast to U1sm3, only one 30-extended precursor
form of the U2sm RNA accumulated. Mapping of cytoplasmic and
nuclear RNAs revealed that the U2sm RNA and all variants of the
U1sm3 RNA accumulated exclusively in the cytoplasm, indicating
that they represent dead-end products of snRNA biogenesis.
Consistently, neither Sm nor TAF15 antibodies pulled down
U1sm3 RNAs (Fig 3C). A demonstration that the Sm motif is
essential not only for the biogenesis of the U1-Sm snRNP but also
for the accumulation of the U1-TAF15 snRNP, strongly supports
the idea that U1-TAF15 is produced by remodelling of the U1-Sm
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snRNP after reimportation from the cytoplasm. The cytoplasmic
assembly of Sm snRNPs is promoted by the SMN complex that can
also facilitate the disassembly of Sm snRNPs (Chari et al, 2008).
Thus, SMN might participate in the biogenesis of U1-TAF15
snRNP by promoting the disassembly of U1-Sm snRNP. The
SMN-dependent biogenesis of U1-TAF15 might take place in the
Cajal bodies, as spliceosomal snRNPs repeatedly cycle through
Cajal bodies (Stanek et al, 2008) and SMN accumulates in these
nucleoplasmic organelles (Battle et al, 2006).
The U1-TAF15 snRNP associates with chromatin
Cell extracts prepared in the presence of 0.2M NaCl, which is
routinely used to isolate nucleoplasmic snRNPs, contained only
trace amounts of TAF15 (data not shown). To examine the
possibility that TAF15 and the U1-TAF15 snRNP associate with
chromatin, HeLa nuclei were extracted with increasing concen-
trations of NaCl in the presence or absence of RNase A (Fig 4A).
Without RNase, no significant amount of TAF15 was solubilized at
0.2M or lower salt concentrations. Increasing the salt concentra-
tion of the extraction buffer up to 1M supported the solubilization
of only about 50% of nuclear TAF15. Inclusion of RNase A
significantly facilitated the solubilization of TAF15 at each step,
indicating that TAF15 tightly interacts with chromatin in an
RNA-dependent manner.
To analyse further the subcellular distribution of TAF15
and, more importantly, the U1-TAF15 snRNP, HeLa cells were
fractionated into cytoplasmic, nucleoplasmic and chromatin
fractions (Fig 4B; supplementary information online). Nuclear
fractionation was confirmed by the detection of histone H3 in the
chromatin extract. TAF15 was not detectable in the cytoplasm, but
it was present in the nucleoplasmic fraction eluted with 350mM
salt and in the chromatin extract, where proteins were further
solubilized by micrococcal nuclease digestion. To test whether
the chromatin-associated fraction of TAF15 binds to U1 snRNA,
comparable amounts of TAF15 (after normalization of TAF15
amounts) were immunoprecipitated from the nucleoplasmic and
chromatin extracts (Fig 4C). The recovery of U1 snRNA was
monitored by RNase mapping and RT–qPCR (Fig 4D). TAF15
immunoprecipitated from the chromatin extract bound about four
times more U1 snRNA than did TAF15 derived from the
nucleoplasmic extract, indicating that the U1-TAF15 snRNP is
highly enriched in the chromatin of HeLa nuclei and that only a
fraction of the nuclear soluble form of TAF15 binds to U1 snRNA.
To characterize further the nuclear-soluble and the chromatin-
associated U1-TAF15 snRNPs, the nucleoplasmic and chromatin
extracts were size-fractionated by chromatography, and fractions
were analysed by Western blotting with antibodies specific for
TAF15, U1-70K, TBP and TAF5 (Fig 4E; supplementary Fig 4A
online). In both extracts, we detected high molecular weight
complexes in fractions 14–16, which contained TAF5, TBP and
TAF15. When distribution of the U1 snRNA was determined by
RT–qPCR and compared with that of U1-70K, it became apparent
that the U1-Sm snRNP eluted mainly in fractions 24–26 of both
nucleoplasmic and chromatin extracts. In contrast to U1-70K,
TAF15 eluted mainly in fractions 30–34 in both extracts, further
showing that U1-70K and TAF15 are present in different
complexes. When fractions 30–34, obtained by fractionation of
nucleoplasmic or chromatin extracts, were pooled and TAF15
was immunoprecipitated, the U1 snRNA was present in both
immunoprecipitations, showing that both the nucleoplasmic- and
chromatin-soluble forms of TAF15 associate with U1 snRNA
(Fig 4F; supplementary Figs 3B and 4C online).
As TAF15 was originally identified as a TFIID-associated
protein (Bertolotti et al, 1996), we investigated its interaction
with two components of TFIID, TBP and TAF5, in the size-
fractionated nucleoplasmic- and chromatin-soluble extracts
(supplementary Figs 3A and 4B online). In both cases, we found
that TAF15 eluted in the low molecular weight fractions (30–34),
which contain the U1-TAF15 snRNP, did not associate with TBP
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and TAF5. By contrast, immunoprecipitation of TAF15 from the
large molecular size fractions (14–18) co-precipitated both TAF5
and TBP, but failed to pull down U1 snRNA (supplementary
Fig 4C online), indicating that TAF15 interacts with TFIID in a
U1-independent manner.
Stress-induced perinucleolar accumulation of U1-TAF15
As both TAF15 and U1 snRNAs have been implicated in Pol II
transcription, we investigated the interaction of U1 and TAF15 in
transcriptionally arrested HeLa cells (supplementary Fig 5 online).
Surprisingly, as compared with TAF15 immunoprecipitated from a
control extract, TAF15 immunoprecipitated from the extract of
a-amanitin-treated cells showed about 2.5-fold increase in U1
association, indicating that inhibition of Pol II transcription
increases the association of TAF15 with U1 snRNA.
Next, we determined the subnuclear localization of the
U1-TAF15 snRNP in a-amanitin-treated and control HeLa cells with
indirect immunofluorescence and fluorescent in situ hybridization
(Fig 5). In control cells, both TAF15 and U1 snRNAs localized
predominantly to the nucleoplasm, except that U1 showed
enrichments in the Cajal bodies and nucleoplasmic speckles
(Fig 5A). In cells treated with a-amanitin for 3 h, both TAF15
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and U1 were concentrated on the periphery of round-shaped
nucleoplasmic domains (Fig 5B). On transient expression of
a green fluorescent protein (GFP)-tagged nucleolar protein,
fibrillarin, it became apparent that U1 and TAF15 accumulated
in perinucleolar cap structures formed on the surface of nucleoli
entering transcription inhibition-induced segregation (Fig 5C and
D). After completion of nucleolar segregation (5–6 h after a-
amanitin administration), the U1-70K snRNP protein is also
known to accumulate in the nucleolar caps (Carmo-Fonseca
et al, 1992; our unpublished data). In contrast to U1 snRNA,
neither U1-70K nor Sm snRNP proteins showed perinucleolar
accumulation 3 h after a-amanitin administration, excluding the
possibility that U1 accumulated in the perinucleolar caps in the
form of U1-Sm snRNP (Fig 5E–H). Similarly, the U2-Sm snRNA
also failed to concentrate in the nucleolar caps of transcriptionally
arrested cells (Fig 5I and J), indicating that the U1-TAF15 snRNP
specifically translocates into perinucleolar caps already at an early
stage of nucleolar segregation.
The findings that both cellular accumulation and subnuclear
distribution of the U1-TAF15 snRNPs are sensitive to the
transcriptional activity of the cell might indicate that the
U1-TAF15 snRNPs have a Pol II transcription-dependent function.
By sequestering U1 snRNA into the U1-TAF15 snRNPs, TAF15
might negatively regulate either the spliceosomal function of
the U1-Sm snRNP or the transcription initiation function of the
U1–TFIIH complex (Kwek et al, 2002). Recently, non-coding
RNAs localized to the regulatory regions of transcription units
were shown to recruit and modulate the activity of the TET
proteins in response to specific signals (Wang et al, 2008). Thus,
our study might indicate that the inhibition of Pol II transcription
increases the amount of chromatin-associated U1-TAF15 snRNP
through the recruitment of more TAF15 from the nuclear-‘soluble’
pool to chromatin. These results might also suggest that the
U1-TAF15 snRNP acts following specific signals such as inhibition
of Pol II transcription.
In conclusion, we have shown that human U1 snRNA forms at
least two structurally and, most likely, functionally distinct snRNP
particles. Our findings strongly support the idea that U1 snRNA
has many nuclear functions and highlight the intriguing possibility
that non-coding RNAs with well-established functions might
participate in several cellular processes.
METHODS
Immunoprecipitation and Western blot analysis. Proteins from
500mg of nuclear extract were immunoprecipitated with 50ml of
protein G-Sepharose (Amersham Pharmacia Biotech, Uppsala,
Sweden) and approximately 5–10mg of the various antibodies as
described previously (Bertolotti et al, 1996), except that immuno-
precipitation buffers containing NaCl instead of KCl were used.
Western blot and chemiluminescence detection were performed
according to the manufacturer’s instructions (Amersham Pharmacia).
Extraction of RNA and analysis of TAF15-bound nucleic
acids. RNAs from TAF15 immunoprecipitations were isolated
by the guanidinium thiocyanate/phenol–chloroform extraction
method. RNA 30 end labelling with [50-32P]pCp and T4 RNA ligase
(New England BioLabs, Hitchin, UK) and RNase A/T1 protection
assay were performed. To generate sequence-specific antisense
RNA probes, recombinant pBluescribe plasmids carrying full-
length cDNAs of the human U1, U2 or U4 snRNAs were
U1 snRNA TAF15 Merge DAPI
U1 snRNA Fibrillarin Merge DAPI
U1 snRNA U1-70K Merge DAPI
U1 snRNA Sm Merge DAPI
U1 snRNA U2 snRNA Merge DAPI
Control
α-amanitin
Control
Control
α-amanitin
α-amanitin
Control
α-amanitin
Control
α-amanitin
A
B
C
D
E
F
G
H
I
J
Fig 5 | Transcription-dependent subnuclear localization of U1-TAF15
snRNP. HeLa cells treated either with 20mg/ml a-amanitin for 3 h
or with non-treated (control) were probed with fluorescent
oligonucleotides complementary to the human U1 and U2 snRNA,
and with antibodies specific for TAF15, U1-70K and Sm proteins.
Nucleoli were stained by transient expression of fibrillarin-GFP and
DNA was visualized by DAPI staining. DAPI, 4,6-diamidino-2-
phenylindole; GFP, green fluorescent protein; snRNA, small nuclear
RNA; snRNP, small nuclear ribonucleoprotein particle; TAF15,
TBP-associated factor 15.
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linearized and used as templates for in vitro transcription with
the T7 RNA polymerase (Promega, France) in the presence of
[a-32P]CTP (30Ci/mmol).
Immunofluorescence and in situ hybridization. Fixation, permea-
bilization, immunostaining, in situ hybridization of HeLa cells,
synthesis and chemical conjugation of amino-modified oligo-
nucleotides with Fluoro-Link Cy3 and Cy5 monofunctional dyes
were performed as described at http://singerlab.aecom.yu.edu.
Further experimental procedures are provided in the supple-
mentary information online.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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Methods 
Plasmid constructions  
TAF15 cDNA from pTL1 using BamHI and XhoI sites has been cloned into the pSG5-puro-
flagNt vector (Green et al., 1988). Point mutants were generated by PCR using the 
QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene). All constructs were verified 
by DNA sequencing. 
Cell treatments 
HeLa cells were incubated with 20 µg/ml α-amanitin (Roche) for 3 hours. 
Nuclear extract preparation 
Nuclear extracts were prepared as previously described in (Bertolotti et al., 1999).  
Immunoprecipitation, Western blot analysis and antibodies 
Proteins from 500 µg of nuclear extract were immunoprecipitated with 50 µl protein G-
Sepharose (Pharmacia) and approximately 5-10 µg of the different antibodies as described 
(Bertolotti et al., 1998), except that IP buffers containing NaCl instead of KCl were used. 
Chemiluminescence detection was performed according to manufacturer's instructions 
(Amersham). Monoclonal antibodies (mAb) directed against TAF15 (7TA2B11 and 
8TA2B10) and against TAF5 (2D2) and TBP (3G3) have been described (Bertolotti et al., 
1996; Bertolotti et al. 1998). Anti-U1-70K (Billings et al., 1982), anti-SmD recognizing 
SmD1 and D3 proteins (Billings et al., 1985), anti-Sm B/B’ D (Y12 mAb, Abcam) and anti-
GAL4 (2GV3) (White et al., 1992) monoclonal antibodies have been described previously. 
Anti-U1-A (Dumortier et al., 1999) and anti-U1-C (Dumortier et al., 1998) rabbit polyclonal 
antibodies were a kind gift from Dr. S. Muller. The anti-histone H3 (1HH3-3E1 clone) 
monoclonal antibody (Euromedex) was raised against the residues 8 to 19 of the human 
histone H3 protein. The anti-cap antibodies, TMG and H-20, were kindly provided by Dr. R. 
Lührmann. 
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RNA-immunoprecipitation (RNA-IP) assay 
RNA-IP assay was performed as described (Martianov et al., 2007). About 4x107 HeLa cells 
were crosslinked with 1% formaldehyde for 10 min. The crosslinking reaction was stopped by 
adding glycine to 330 mM final concentration. Cells were re-suspended in 500 µl RIP lysis 
buffer (50 mM HEPES, pH7.5, 1 mM EDTA, 1% triton) and sonicated 10 times for 10 sec. 
Sample was diluted and adjusted to 0.5% triton, 25 mM MgCl2, 5 mM CaCl2 and DNA was 
digested with RNase free DNase (30 units) at 37°C for 15 min. Digestion was stopped with 20 
mM EDTA. Sample was pre-cleared with protein G-Sepharose beads for 2 hours at 4°C and 
followed by addition of 10 µg of antibodies. Twenty µl of protein G-Sepharose beads were 
added after 2 hours of incubation and left for another 1 hour at 4°C. Beads were washed once 
with 1 ml binding buffer (50 mM HEPES, 0.5 % triton, 25 mM MgCl2, 5 mM CaCl2, 20 mM 
EDTA), with FA500 (50 mM HEPES, 500 mM NaCl, 1 mM EDTA, 1% triton, 0.1 % Na 
deoxycholate), with LiCl buffer (10 mM Tris, 250 mM LiCl, 1 % triton, 0.5 % Na 
deoxycholate, 1 mM EDTA) and finally, with TES (10 mM Tris, 10 mM NaCl, 1 mM 
EDTA). Immunoprecipitates were eluted with 75 µl RIP elution buffer (100 mM Tris pH 7.8, 
10 mM EDTA, 1 % SDS). NaCl was adjusted to 200 mM and the samples were treated with 
20µg of proteinase K for 1 hour at 42°C and 1 hour at 65°C. RNA was extracted with RNA 
Solv® reagent and analyzed by RT-PCR.  
Reverse transcription (RT) and real time quantitative PCR (qPCR) 
Total RNA was isolated with RNA Solv® reagent (Omega Bio-Tek), precipitated and used as 
a template for reverse transcription with random hexamer primers and M-MLV reverse 
transcriptase (Sigma) following the manufacturer’s instructions. 1/25th of each RT product 
was amplified with the QuantiTect SYBR Green PCR kit (Qiagen). Quantitative PCR were 
performed on a Light Cycler apparatus (Roche).  
RNA extraction and analysis of TAF15-bound nucleic acids 
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Preparation of HeLa cell nuclei was performed according to (Tyc and Steitz, 1989). RNAs 
from HeLa cells and from the nuclear fraction of HeLa cells were isolated by the guanidinium 
thiocyanate/phenol-chloroform extraction method (Goodall et al., 1990). RNA 3’ end 
labelling with [5’-32P]pCp and T4 RNA ligase (BioLabs) and RNase A/T1 protection assay 
were preformed as described (England et al., 1980, Goodall et al., 1990). To generate 
sequence-specific antisense RNA probes, recombinant pBluescribe plasmids carrying full 
lenght cDNAs of the human U1, U2 or U4 snRNAs were linearized with the appropriate 
restriction endonucleases and used as templates for in vitro transcription with the T7 RNA 
polymerase (Promega) in the presence of [alpha-32P]CTP (specific activity, 30 Ci/mmol). 
Before utilization, all probes were purified on a 6% sequencing gel. 
Primer extension mapping 
Primer extension mappings of ribose-methylated nucleotides and pseudouridines have been 
described (Kiss and Jády, 2004). 
Preparation of nuclei and salt extraction 
HeLa cells were harvested, washed twice with ice-cold PBS and resuspended in 15 mM Tris-
HCl buffer pH 7.5, containing 60 mM KCl, 15 mM NaCl, 10 mM MgCl2, 1 mM CaCl2, 1 mM 
DTT, 250 mM sucrose, protease inhibitor cocktail (PIC) and 0.5 mM PMSF (Buffer N). An 
equal volume of Buffer N containing 0.6% NP-40 was added to the cells and the suspension 
was gently mixed and incubated on ice for 5 min. Nuclei were pelleted by centrifugation at 
2,000 g for 5 min at 4°C and washed twice with Buffer N before final suspension in the same 
buffer. DNA was estimated by measuring UV absorption at 260 nm (A260) in a 2 M NaCl 
solution. 
HeLa nuclei were incubated in 100 µl Buffer N containing 75, 200, 350, 500 and 1000 mM 
NaCl in the absence of sucrose. After incubation for 30 min on ice, the samples were 
centrifuged at 12,800 g for 15 min at 4°C to yield the soluble and insoluble (pellet) fractions. 
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Equivalent samples from each fraction were subjected to SDS-PAGE and Western blot 
analysis. Salt extraction in the presence of RNase A was done by adding 1 µg/µl RNase A in 
Buffer N. 
Chromatin isolation 
One gram of pelleted HeLa cells were lysed in 1 ml hypotonic buffer (10 mM Tris-HCl, pH 
7.7, 1.5 mM MgCl2, 10 mM KCl) and subjected to dounce homogenization (8 strokes) using 
pestle B to release nuclei. Then, 0.33 ml of Sucrose Buffer (20 mM Tris-HCl, pH 7.7, 15 mM 
KCl, 60 mM NaCl, 0.34 M sucrose, 0.15 mM spermine, 0.5 mM spermidine) was added. 
Cytoplasm was separated from nuclei by centrifugation at 9,000 g for 10 min at 4°C. The 
nuclei pellet was resuspended in 1 ml of sucrose buffer. Nucleoplasm was separated from 
chromatin by extraction with 0.35 ml of high salt buffer (20 mM Tris-HCl, pH 7.7, 25% 
glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 900 mM NaCl) for 30 min at 4°C and 
centrifugation at 9,000 g for 10 min. The chromatin pellet was resuspended in 1 ml of sucrose 
buffer and digested with 2.5 units of micrococcal nuclease (Sigma, N3755) in the presence of 
1 mM CaCl2. Digestion was stopped by the addition of 4 mM EDTA. The digested extract 
was sonicated to shear chromatin (5 pulses, 20 seconds on, 20 seconds off on a VibraCell 
72412 sonicator, Bioblock Scientific). The obtained cytoplasmic, nucleoplasmic and 
chromatin fractions were centrifuged at 12,000 rpm and dialyzed overnight against IP buffer 
containing 150 mM NaCl. 
Gel filtration chromatography 
A HeLa chromatin extract (10 µg/µl) was loaded on a Superose 6 size exclusion 
chromatography column using the SMART FPLC system (Pharmacia) and separated at a flow 
rate of 40 µl/min in buffer A (50 mM Tris-HCl, pH 7.9, 0.1 M NaCl, 1 mM EDTA, 0.005% 
NP-40, 1 mM DTT). Forty-eight fractions of 50 µl were collected and even fractions analyzed 
by Western blot. 
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Immunofluorescence and in situ hybridization 
Fixation, permeabilization, immunostaining and in situ hybridization of HeLa cells as well as 
image acquisition and processing were performed as described (Darzacq et al., 2002). 
Synthesis and chemical conjugation of amino-modified oligonucleotides with Fluoro-Link 
Cy3 and Cy5 monofunctional dyes (Amersham) were performed according to the protocols of 
the laboratory of R.H. Singer (http://singerlab.aecom.yu.edu). The following oligonucleotide 
probes were used to detect U1 (C*CGGAGTGCAATGGAT*AAGCCTCGCCTGGG*) and 
U2 (AT*ACTGATAAGAACAGATACT*ACACTTGATCTTAGCCAT*A) snRNAs. 
Amino-allyl-modified residues are indicated by asterisks. Human TAF15, U1-70K and Sm 
proteins were detected by monoclonal anti-TAF15 (7TA2B11), anti-U1-70K and anti-Sm 
(Y12) antibodies, followed by incubation with anti-mouse antibodies conjugated to 
fluorescein (Sigma). HeLa nucleoli were visualized by transient expression of a recombinant 
fibrillarin-GFP protein (Dundr et al., 2000). Nuclear DNA was stained with 0.1 μg/ml DAPI. 
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Supplementary Figures 
 
In vivo RNA-IP assay. HeLa cells were either treated (+) or not treated (-) with 1% 
formaldehyde to form in vivo RNA-protein crosslinks. After extract preparation and TAF15 
IP, the co-immunoprecipitated RNA was purified and analysed by reverse transcription 
followed by real time quantitative PCR (RT-qPCR) with U1 snRNA-specific primers. 
Quantitative PCRs were done in duplicates. 
 
 
 
HeLa cells were transfected with an empty vector (Flag) or with a vector expressing the Flag-
TAF15 recombinant protein. Forty-eight hours after transfection, nuclear extracts (IN) were 
prepared and subjected to immunoprecipitation (IP) using an anti-Flag antibody. The Flag-
TAF15 and U1-70K proteins were detected by Western blot analysis. 
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Detection and characterization of two distinct TAF15-containg complexes in HeLa 
chromatin-soluble extract. (A) Fractions 14 to 18 or 30 to 34 obtained upon size fractionation 
of HeLa chromatin-soluble extract (see Figure 4E) were pooled and subjected to IP with 
either anti-TAF15 or control antibodies. Co-purification of TFIID subunits TAF5 and TBP 
was analyzed by Western blot. TAF15 associates with TFIID in the high molecular size 
fractions (14-18), but not in small molecular weight fractions 30-34. (C) Fractions 14 to 18 or 
fractions 30 to 34 (Figure 4E) were pooled and subjected to IPs with either anti-TAF15 or 
control antibodies. Co-precipitation of U1 snRNA was measured by RT-qPCR. TAF15 
associates with U1 snRNA only in the low molecular weight fractions 30-34.  
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Size fractionation of a HeLa nucleoplasmic extract reveals two distinct TAF15-containing 
complexes. (A) HeLa nuclear soluble extract was fractionated by gel filtration. The input (IN 
Nu) and even fractions were analysed by Western blot with the indicated antibodies. The 
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elution profile of molecular mass markers is indicated. The presence of U1 snRNA in each 
fraction was measured by RT-qPCR with or without reverse transcriptase (RT) (lower panel). 
The error bars represent the variations between triplicate measurements. (B) Fractions 14 to 
18 or 30 to 34 (from panel A) were pooled and subjected to IPs with either anti-TAF15 or 
control antibodies. Co-purification of TFIID subunits TAF5 and TBP was analyzed by 
Western blot. TAF15 associates with TFIID in fractions 14-18, but not in 30-34. (C) Fractions 
14 to 18 or 30 to 34 (from panel A) were pooled and subjected to IP with either anti-TAF15 
or control antibodies. Co-precipitation of U1 snRNA was measured by RT-qPCR. TAF15 
associates with U1 snRNA in fractions 30-34, but not in 14-18. 
 
 
 
(A) From HeLa cells, either not treated or treated with 20 µg/ml α-amanitin for 3 hours, 
nuclear extracts (IN) were prepared and subjected to IP performed with TAF15-specific and 
control antibodies. The immunoprecipitated TAF15 was analysed by Western blot. (B) The 
TAF15-associated U1 snRNA was monitored by RT-qPCR. The measured values are 
represented as fold enrichments when compared to the background values obtained with the 
control antibodies. 
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II. U1-TAF15 snRNP ADDITIONAL ANALYSIS 
An ambitious goal of our research was to understand the nuclear function of 
the novel U1-TAF15 snRNP. However, given that the major fraction of U1 snRNA 
has an essential function in pre-mRNA splicing and that most of TAF15 seems to 
have other functions including transcription initiation (see Introduction), it was 
difficult to directly address the function of the U1-TAF15 snRNP. Therefore, we tried 
to understand the molecular architecture and protein composition of the U1-TAF15 
snRNP in order to have some clues about the nuclear function of this fascinating 
snRNP. 
For details of the experimental procedures, please refer to (Jobert et al., 2009). 
Definition of U1 snRNA elements directing TAF15 binding 
Replacement of an amino acid (Arg143/Pro) in the conserved RNP2 motif of 
the RRM domain of TAF15 abolished the in vivo binding of TAF15 to the U1 snRNA, 
indicating that TAF15 directly interacts with U1. We first tried to confirm the 
interaction and define structural elements of the U1 snRNA directing TAF15 binding 
by in vitro and in vivo experiments. 
EMSA in vitro studies where performed with the aim to study the U1-TAF15 
interaction (data not shown). Unfortunately, we were unable to detect any specific 
TAF15-U1 binding. However, it remains possible that the conditions used in our 
experiments were not suitable for the interaction of TAF15 and U1. 
Therefore, a series of mutant U1 RNAs carrying nested internal deletions or 
specific sequence mutations were transiently expressed in HeLa cells. The TAF15-
binding capacity of each mutant U1 RNA was tested by co-immunoprecipitation (co-
IP) with the endogenous TAF15 protein using the 8TA monoclonal anti-TAF15 
antibody. Precipitation of the endogenous wild-type U1 snRNA was monitored to 
control the efficacy of the IP reactions. Recovery of the mutant and wild-type U1 
RNAs was measured by Northern blot analysis (deletion mutants) or RNase A/T1 
mapping (point mutants). 
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Figure 19. U1 snRNA loop sequences are not essential for TAF15 binding. A. U1 
loop mutants efficiently accumulate upon transient expression in HeLa cells. U1 RNAs carrying specific mutations in the loop sequences were constructed. RNase A/T1 mapping on total RNAs extracted from non transefected (N) and transfected (T) HeLa cells. Control: antisense probes alone.  B. U1-Lm1, U1-Lm2, U1-Lm3 and U1-Lm4 
snRNAs efficiently associate with the endogenous TAF15 protein. RNase A/T1 mapping on extract (E), control (C), and Sm (α-Sm) or TAF15 (α-TAF15) associated RNAs. Precipitation of the endogenous wild-type U1 snRNA is shown to attest of the efficacy of the IP reactions. M: molecular size marker (in nts). 
B. 
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Figure 20. U1 snRNA stem-loops 1, 2, 3 and 4, sequences surrounding the Sm site 
and the splice binding site are not essential for TAF15 binding. A. U1 RNAs carrying deletions or sequence mutations were constructed. B. Association of U1dSt1, U1St2m, U1dSt3, U1St4m U1Hm and U1Ssm RNAs (E) with TAF15 (α-TAF15) and Sm (α-Sm) proteins was assayed by IP followed by RNase mapping (for U1St2m,  U1Hm and U1Ssm upper gel) or Northern blot (for U1dSt1, U1dSt3, U1St4m and U1Ssm lower gel). NT: non transfected, M: molecular size marker (in nts), C: control. Sequences of the oligonucleotides used for Northern blots: U1 (complementary to the Sm site): 5’ CCA CTA CCA CAA ATT ATG CA 3’, U1Ssm (complementary to the Ssm mutant): 5’ TCT CCC CTG CGT CCA TTA TAT 3’ 
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Conclusion:  
 
Deletion and mutation analysis of the human U1 snRNA failed to define the 
U1 sequence and structural elements directing TAF15 binding. Substitution of the 
L1, L2, L3 and L4 loop sequences, replacement or deletion of the St1, St2, St3 and 
St4 stem-loops had no significant effect on the accumulation and TAF15-binding 
capacity of U1. In contrast, alteration of the 5’-terminal (splice-site selection) 
sequences (Ssm) or restoration of the U1-specific Sm-binding sequence to a 
canonical Sm site (Hm) largely reduced the accumulation levels of the mutant 
RNAs, but again failed to fully abolish their TAF15-binding capacity. These results 
indicated that neither the single-stranded 5’-terminal nor the U1-specific Sm 
sequences are absolutely essential for TAF15-binding, but did not exclude the 
possibility that these single-stranded regions of U1 might contribute to the in vivo 
recruitment of TAF15. Nevertheless, our data suggest that in vivo association of U1 
with TAF15 is likely supported by complex RNA-protein and probably protein-protein 
interactions.  
Other Sm mutants tested in our study either failed to accumulate or they 
showed very weak cytoplasmic accumulation (data not shown). Importantly, U1 
mutants with cytoplasmic accumulations failed to associate with the Sm core 
proteins and TAF15. This suggests that TAF15 binds to the U1 snRNA after its Sm 
protein-assisted cytoplasmic maturation and reimportation to the nucleoplasm.    
Summary of in vivo association of mutants U1 RNAs with TAF15: 
Name Sequences deleted 
Accumulation 
upon transient 
expression 
Association 
with Sm 
Association 
with TAF15 
U1dSt1 St1 low yes yes 
U1dSt2 St2 no   
U1dSt3 St3 yes yes yes 
 
Name Sequences mutated 
Accumulation 
upon transient 
expression 
Association 
with Sm 
Association 
with TAF15 
U1St123m St1, St2, St3 no   
U1St1234m St1, St2, St3, St4 no   
U1St2m St2 yes yes yes 
U1St4m St4 yes yes yes 
U1Hm around the Sm site low yes yes 
U1Ssm around the splice site low yes yes 
  p. 67 
Structural analysis of U1 snRNA associated with TAF15  
We hypothesized that the distinct protein binding capacity of U1 RNAs in the 
Sm spliceosomal or in the U1-TAF15 snRNP could be most easily explained by 
structural differences of the snRNA (see below). This hypothesis was supported by 
the early observations that vertebrate U1 RNAs can be folded into several 
alternative, energetically highly comparable structures (Branlant et al., 1981). 
Therefore, we compared the structures of U1 snRNAs incorporated into the 
splicesomal Sm snRNPs or into the TAF15 particle. To this end, the solution 
structures of U1 RNAs immunoprecipitated with anti-TAF15 or anti-Sm antibodies 
was investigated by using ribonucleases A, T1 and S1 which preferentially 
recognize nucleotides not involved in base-pairing/stacking interactions. The 
partially hydrolyzed U1 RNAs where mapped by reverse transcription with a 
terminally labeled U1-specific oligonucleotide primer and AMV reverse 
transcriptase. This strategy has been used in the laboratory of T. Kiss to define the 
in vivo structure of human telomerase RNA (Antal et al., 2002). 
 
Conclusion:  
Preliminary experiments did not reveal any difference in the partial digestion 
patterns of U1snRNAs bound to Sm or to TAF15 proteins. We concluded that the 
U1 snRNA molecules associated with TAF15 have a secondary structure similar to 
the canonical spliceosomal U1 snRNA. 
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Figure 21. Structural comparison of U1 snRNAs associated with TAF15 and Sm 
proteins. A. Secondary structure of U1 snRNA. The position of U1-speci�ic radiolabeled oligonucleotide primer used for reverse transcription is shown in red.  
B. Immunoprecipitated RNAs with antibodies against TAF15 or Sm proteins were partially digested with depicted RNases for 15 minutes at room temperature. After proteinase K treatment, isolated RNAs were analyzed by reverse transcription. Reverse-transcription stops con�irms that the loop regions of the St1, St2, St3 and the splice site donor region are single-stranded in Sm and TAF15-associated U1 snRNAs.   
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Purification of U1-TAF15 snRNP 
Identification of putative snRNP proteins specifically associated with the U1-
TAF15 snRNP is essential for understanding the function of the U1-TAF15 snRNP.  
We tried to purify the U1-TAF15 particle in order to identify its potential 
partners. Given that the major fractions of both known components of the U1-TAF15 
snRNP associate with other nuclear complexes (the U1 splicesosomal Sm snRNP 
and TFIID complexes), purification of the U1-TAF15 snRNP was a challenging task.  
We developed a cell line stably overexpressing a modified version of U1.  
The modified U1 carry a 5’-terminal extension containing two short RNA affinity 
motifs specific for the bacteriophage MS2 coat protein. The expressed MS2-U1 was 
affinity selected with a recombinant MS2 coat protein that has been fused to 
maltose-binding protein (MBP) and immobilized on amylose resin. We use maltose 
for elution of the selected RNP particles from the amylose resin.  
The fraction of expressed MS2-U1 was minimal compared to the total amount 
of endogenous U1. In addition, the MS2 affinity purification was not efficient enough 
to precipitate all MS2-U1 particles. As only a minor population of U1 snRNA 
associates with TAF15, it was difficult to obtain a sufficient amount of MS2-U1-
TAF15 snRNPs. For these reasons we did not proceeded with a further TAF15 
purification in order to enrich specifically the U1-TAF15 snRNP. We decided to turn 
to another strategy: instead of purifing specifically the U1-TAF15 snRNP we tried to 
search for TAF15-interacting proteins. We expected to perform further experiments 
to confirm their potential interaction with the U1-TAF15 snRNP. 
To this end, we carried TAF15 immunoprecipitation with the 8TA antibody, 
and eluted the particles by RNase A treatment (see materials and methods for 
details on the procedure). The following mass spectrometry analysis detected 
almost all of the known subuints of the spliceosomal U1 snRNP. This surprising 
result will be analyzed in the discussion.  
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Figure 22. Purification of U1-TAF15 snRNP. A. Nuclear exctract was prepared  from 120 million of Hela cells and fractionated in a 10-30% glycerol gradient. Fractions containing U1-TAF15 snRNP were collected and incubated with 10 µL of 8TA antibody or control beads for 3 hours. Associated proteins were eluted by Rnase A treatment, separated in an SDS-PAGE gradient gel (8-15%) and analyzed by MALDI-TOF mass spectrometry. 5% of precipitated RNAs were subjected to pCp labeling, separated in a sequencing gel and exposed for 2 hours. B. Proteins identified by mass spectrometry. 
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Kinetics of U1-TAF15 localization to the perinucleolar caps   
We observed that upon inhibition of RNA Pol II transcription by α-amanitin 
treatment of HeLa cells, the U1-TAF15 snRNP localizes into perinucleolar caps, 
while the U1-Sm snRNP concentrates in the nucleoplasmic speckles (Jobert et al., 
2009). When we characterized the localization of the U1-TAF15 snRNP under 
transcriptional stress in more details, we noticed that before concentrating in the 
perinucleolar caps, three hours after administration of α-amanitin, a fraction of the 
U1 snRNA concentrates in several dots within the nucleolus. These U1-containing 
nucleolar dots also concentrate TAF15, but they seem to lack Sm proteins.    
Conclusion:  
Our results suggest that the U1-TAF15 snRNP transiently localizes inside the 
nucleolus before accumulating in the perinucleolar caps. The spliceosomal U1-Sm 
snRNP seems to stay in speckles at these early stages of transcription inhibition. 
  
U1 TAF15 MERGEDAPI
DAPI
U1 TAF15 MERGEDAPI
U1 Sm MERGE
DAPI U1 Sm MERGE
3 hours α-amanitin 
6 hours α-amanitin 
Figure 23. Kinetics of U1-TAF15 snRNP localization to perinucleolar caps. HeLa cells were treated with 20 µg/ml of α-amanitin for 3 or 6 hours. They were probed with 
�luorescent oligonucleotides complementary to the human U1 snRNA and with antibodies speci�ic for TAF15 (8TA) or Sm proteins (Y12).  DNA was visualized by DAPI staining.  Poorly-stained DAPI regions are considered as nucleoli. 
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U1 TAF15 MERGE
U1
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Fig 23B. The U1-TAF15 snRNP localizes in nucleolar dots at an early stage of 
transcription inhibition. HeLa cells were treated with 20µg/ml of α-amanitin for 3 hours. They were probed with 
�luorescent oligonucleotides complementary to the U1 snRNA and with antibodies speci�ic for TAF15, PSF or Sm proteins. The nucleolus was stained by transient expression of fibrillarin-GFP. 
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SECOND PART OF THE RESULTS: 
STUDY OF TWO NOVEL BOX C/D RNPs 
Identification of WDR79-associated RNAs by deep-sequencing 
 
Recently, the WDR79 (WRAP53 or TCAB1) protein has been demonstrated 
to associate with both box H/ACA and box C/D scaRNPs which specifically 
accumulate in Cajal bodies. Binding of WDR79 is essential for targeting all box C/D 
and H/ACA scaRNPs into the Cajal bodies (Richard et al., 2003; Tycowski et al., 
2009; Venteicher et al., 2009). Identification of a common protein component of 
scaRNPs opened the possibility to experimentally characterize the family of human 
scaRNPs. To identify novel WDR79-associated RNAs, a FLAG-tagged version of 
human WDR79 (Flag-WDR79) was transiently expressed in human HeLa cells and 
purified by immunoprecipitation with an anti-FLAG antibody. RNAs co-precipitated 
with FL-WDR79 were converted into cDNAs and after PCR amplification, their 3’-
terminal nucleotide sequences were determined by high-throughput Illumina 
sequencing (Fasteris, Switzerland). Bioinformatic analysis of the obtained sequence 
library identified more than 450 novel box C/D and H/ACA scaRNA candidates. 
My preliminary work focused on the characterization of the newly detected 
WDR79-associated box C/D RNAs. Thus far, Northern blot analysis of human HeLa 
cellular RNAs confirmed the expression of at least 10 novel box C/D RNAs. 
Amongst these positively identified RNAs, I focused on two particularly exciting 
RNAs, called CD8 and CD5, which are predicted to direct 2’-O-methylation of the 
human U2 spliceosomal snRNA and elongator tRNA-MET-CAT, respectively.  
 
 
  
Figure 24. Identification and analysis of WDR79-associated RNAs by deep 
sequencing. RNAs coprecipitated with transiently expressed FLAG-tagged WDR79 (WRAP53) were 3’-terminally labelled and analyzed on a 6% sequencing gel. After cDNA synthesis and PCR amplification, the 3’-terminal sequences were determined by deep-sequencing. Computer-aided analysis of the obtained sequence library identified more than 450 novel putative H/ACA and C/D RNAs. 
FLAG-WDR79 
Analysis of WDR79-associated RNAs detected by deep 
sequencing Already known RNAs >40 novel putative box C/D RNAs >450 novel putative box H/ACA RNAs Box C/D and box H/ACA snoRNAs New rRNA methylation guide RNAs (snoRNAs) 
Still under analysis 
Box C/D and box H/ACA scaRNAs  
New snRNA methylation guide RNAs (scaRNAs) 
Spliceosomal snRNAs New “orphan” putative snoRNAs and scaRNAs Other small RNAs 
Ketele A., Jady B.E. and Kiss T., unpublished 
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Characterization of CD8 RNA: 
 Sequence analysis and predicted function of human CD8 RNA 
 Amongst the numerous newly detected putative WDR79-associated box C/D 
RNAs, we first selected the CD8 RNA for a detailed characterization for reasons 
explained below. Illumina sequencing identified the 75-nt-long 3’-terminal sequence 
of CD8 (Figure 25A). We noticed that 5 nts upstream from its 3’ end, the CD8 RNA 
carried a perfect C box motif (CUGA). Blast search revealed a perfect genomic copy 
of CD8 in the second intron of the human TRRAP (transformation/transcription 
domain-associated) protein gene. Closer inspection of the intronic sequences of 
host TRRAP gene identified a putative C box motif located 167 nts upstream from 
the alleged D box of CD8. Moreover, we noticed that sequences immediately 
preceding and following the C and D motifs were able to form a perfect double helix 
and thereby can facilitate formation of a Kink-turn motif that is a characteristic and 
essential structural hallmark of box C/D snoRNAs (see Introduction). Box C/D 
snoRNAs also carry internal, usually imperfect copies of the C and D boxes, called 
the C’ and D’ boxes. The C’ and D’ box sequences of CD8 RNAs seem to be poorly 
conserved, therefore, although we selected several potential C’ and D’ candidates, 
we were unable to unambiguously identify them. 
A systematic blast search of vertebrate genomes identified putative 
homologues of the human CD8 RNA in monkey, mouse, elephant, dog, opossum, 
Xenopus and chicken genomes (Figure 25A). This demonstrates that CD8 is an 
evolutionarily conserved box C/D RNA. Similarly to human CD8, the predicted 
mammalian, frog and bird CD8 RNA genes were located within introns of the 
TRRAP genes always in the sense orientation, indicating that the vertebrate CD8 
RNAs are synthesized within and processed from the introns of the TRRAP pre-
mRNA.  
 Alignment of the predicted sequences of vertebrate CD8 RNAs revealed that 
sequences upstream of the D box show a perfect evolutionarily conservation, 
indicating that they are functionally important and likely function as antisense 
elements positioning the complementary target RNA for 2’-O-methylation. A 
computer-aided analysis of the antisense sequence of CD8 revealed a perfect 11-
nt-long complementarity to the U2 spliceosomal snRNA (Figure 25B). Importantly, 
the fifth nucleotide upstream from the D box of CD8 base-pairs with the U47 residue 
of U2, that is known to be 2’-O-methylated (Donmez et al., 2004).  
 These results strongly suggest that the WDR79-associated, intron-encoded 
CD8 RNA functions in the 2’-O-methylation of the U2 snRNA at position U47. 
Modification of the U2 snRNA is important for branch site selection and interaction 
of U2 snRNP with U1 snRNP and/or other factors within the E spliceosomal 
complex (Donmez et al., 2004; Karijolich et al., 2010; Karijolich and Yu, 2010).  
AGCAAAGTGATGAGTAATACTGGCTGGAGCCCCAAAGAGGCACGTGTGTGTGTTTGTGTGT GTGTGTATATGCTTGTCAGTGCATGCACGTGTATGTCTGGGAGTACAAATGGGTGCGACTGG TTGTAGGGAACTAGCTATGTGCCTTCTATTAGGCCATGACAGTCAAACTGATAAGATCTGATTGCT 
C Box 
D Box Antisense 
 Human CD8 RNA (189 nt): 
Figure 25. The human CD8 RNA is predicted to direct U2 modification. A. The 
CD8 sequence exhibits all structural hallmarks of box C/D RNAs. A. Boxes C and D are shown in red, the antisense region in blue. Probes used for Northern blot and FISH experiments are indicated by a green arrow. Sequence alignment of predicted vertebrate CD8 sequences. The conserved box motifs and antisense regions are shown in red and blue, respectively. The host gene encoding human CD8 is indicated below. B. Putative function of CD8 RNA. Secondary structure of the 5’ end of human U2 snRNA. (m3G) N2,2,7-trimethylguanosine; (m) 2′O-methyl; (Ψ) pseudouridine; (m6) N6-methyl. The branchpoint recognition sequence is indicated. Stem loops are numbered with roman numbers (Donmez et al., 2004). The antisense region of CD8 is complementary to nucleotides 44 to 55 of the human U2 snRNA. The U47 base is known to be methylated.  
B 
HOST GENE: Transformation/transcription domain-associated protein 
Human U2 snRNA: 
A 
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So far, for the 23 documented 2’-O-methylation and pseudouridylation sites in the 
U2 snRNA, 15 guide RNAs have been identified (http://www-snorna.biotoul.fr). It 
has been demonstrated that modification of the U2 snRNA, together with other Pol 
II-specific spliceosomal snRNAs, occurs in the Cajal body and it is mediated by 
small Cajal body-specific box H/ACA and C/D RNPs (scaRNPs) (Jady et al., 2003). 
Therefore, we can predict that the CD8 RNP is a new member of the very small 
family of box C/D scaRNPs which interact with the “CAB box-associated protein”  
WDR79. 
 
 
Detection and structural characterization of CD8 RNA 
 To confirm the in vivo expression and to define the correct size of the human 
CD8 RNA, we performed Northern blot analysis (Figure 26A). RNAs isolated from 
human HeLa cells were fractionated on a sequencing gel, blotted onto a nylon 
membrane and probed with a terminally labelled oligodeoxynucleotide 
complementary to the conserved antisense region of CD8 (Figure 26A). After 
autoradiograhphy, we detected a single hybridizing RNA. Importantly, the 
electrophoretic mobility of the detected RNA perfectly corresponded to the predicted 
size (189 nts) of the human CD8 RNA.  
  To define the potential two-dimensional structure of the 189-nt-long human 
CD8 RNA, we performed computer-mediated RNA folding experiments. Using the 
RNAfold program, we attempted to define a CD8 secondary structure with the 
possible lowest calculated free energy at 37°C (Figure 26B). The predicted, 
energetically most stable structure of CD8 is composed of two highly structured 
distal hairpins (St1 and St2) and the proximal C/D core domain encompassing of the 
5’-3’-terminal Kink-turn motif and the antisense element. Since other alternative 
structures fail to provide a comparable energetic stability for CD8, we strongly 
believe that this conformation is adopted by the human CD8 RNA in vivo. 
All mammalian box H/ACA scaRNAs carry a short Cajal body-specific 
localization signal sequence (consensus UGAG) that is located in the terminal loop 
of their 5- and/or 3’-terminal hairpin structures (Richard et al., 2003).  This motif, 
called the CAB box, is believed to directly interact with the WDR79 protein that 
targets H/ACA scaRNPs into the Cajal body. Interestingly, most of the known 
mammalian box C/D guide RNAs directing 2’-O-methylation of spliceosomal 
snRNAs are fused to box H/ACA scaRNAs carrying canonical CAB boxes which 
target these composite H/ACA-C/D RNAs into the Cajal body. Their C/D RNA 
components, when expressed alone, fail to localize to the Cajal body, they 
accumulate in the nucleolus.  
Figure 26. Human CD8 RNA is a relatively short box C/D scaRNA with a well- 
defined secondary structure. A. CD8 RNA is detected in 25μg of nuclear RNAs extracted from HeLa cells by Northern blot. B. In silico predicted secondary structure of CD8 RNA. C/D boxes are shown in red. Non canonical G:A base pairs in the predicted kink-turn structure are shown. The antisense region is thought to be single-stranded.  
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Thus far, only very few independent box C/D scaRNAs have been identified. 
Similarly to the box H/ACA scaRNAs, the box C/D scaRNAs also associate with the 
WDR79 Cajal body localization protein (Tycowski et al., 2009). However, the known 
C/D scaRNAs carry no apparent UGAG CAB box motifs, leaving it mysterious how 
they are recognized by WDR79. Early attempts to define the WDR79-binding 
elements of C/D scaRNA all failed, because the previously known C/D scaRNAs 
were unusually lengthy and they were loosely structured. Thus, we believed that 
identification of the human CD8 box C/D scaRNA that is the shortest known C/D 
scaRNA with a well-defined secondary structure provides us an excellent 
opportunity to experimentally define the WDR79-binding and Cajal body localization 
signal of human box C/D scaRNAs.   
 
 
In vivo expression and mutation analysis of CD8 RNA 
The finding that the coding gene of the human CD8 scaRNA is located in the 
second intro of the TRRAP gene in the sense orientation indicated that CD8, instead 
of being transcribed from its independent promoter, is an intron-processed RNA. 
Therefore, to transiently overexpress CD8 RNA, the CD8 gene was PCR-amplified 
and inserted into the second intron of the human β-globin gene under the control of 
the CMV promoter (Figure 27A). The resulting pGL/CD8 expression construct was 
transfected into HeLa cells. After RNA extraction, Northern blot analysis 
demonstrated the in the transfected cells CD8 showed an about 50-fold 
overaccumulation compared to the non-transfected control cells (Figure 27B).  
Next, to determine the subcellular localization of CD8 and to define the 
element directing WDR79-binding, besides the wild-type CD8 RNA, we 
overexpressed truncated versions of CD8 lacking the St1 (CD8Del1), the St2 
(CD8Del2) or both (CD8Del1+2) stem-loop regions. Northern blot analysis 
demonstrated that similarly to the wild-type RNA, the truncated CD8 RNAs were 
faithfully expressed from the host globin introns and they accumulated efficiently 
(data not shown). This indicated that directed by their intact C/D core motifs, the 
internally truncated CD8 RNAs were efficiently packaged into C/D RNPs. 
  
Figure 27. Schematic structure of the pGL/CD8 expression vector. A. The CD8 gene and flanking regions (open arrow) were inserted into the second intron of the human β-globin gene that had been placed under the control of the cytomegalovirus promoter (CMV). The exons (E1, E2 and E3), the polyadenylation site (PA) and SP6 promoter are indicated. Relevant restriction sites are shown (H, 
HindIII; C, ClaI; X, XhoI) Nucleotide distance between ClaI XhoI sites is indicated by the upper arrow B. Schematic structure of CD8 deletion mutants. Grey areas underline stem-loop (St) sequences deleted in CD8Del1 and CD8Del2. Dashed lines indicate stem-loop sequences deleted in the CD8Del1+2 mutant. Upon transient transfection into HeLa cells, the constructs efficiently overexpressed CD8 (see Northern blot) and expressed CD8 mutant versions (data not shown).  Endogenous CD8 is not abundant and hardly detectable in non-transfected cells under the exposure conditions used in this experiment. 
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CD8 RNA is a small Cajal body-specific RNA 
To determine the in vivo localization of transiently overexpressed wild-type 
and internally truncated CD8 RNAs, we performed in situ fluorescent microscopy 
using the fluorescently labelled antisense oligonucleotide complementary to the U2-
recognition sequence of CD8 (see Figure 25A). Specificity of this probe had been 
earlier demonstrated by Northern blot analysis of HeLa CD8 (Figure 26A).  
Probing of HeLa cells transfected with the pGL/CD8 expression plasmid 
revealed that the transiently expressed CD8 RNA concentrated in several dot-like 
structures in the nucleoplasm. Importantly, no signal was detected in non-
transfected cells (circled) (Figure 28, upper panel). This demonstrated that the 
endogenous HeLa CD8 accumulated below the detection level under the applied 
conditions and further confirmed the sequence specificity of our fluorescent probe. 
When CD8 was co-expressed with the green fluorescent protein-tagged Cajal body 
marker protein coilin (coilin-GFP), it became apparent that CD8 co-accumulated 
with coilin-GFP within the nucleoplasmic Cajal bodies. These results clearly 
demonstrated that CD8 is a box C/D small Cajal body-specific RNA (scaRNA). 
It has been earlier demonstrated that all box H/ACA and composite box 
H/ACA-C/D scaRNAs possess localization elements, the CAB boxes, which are 
necessary to override the nucleolar localization function of the box C/D and H/ACA 
core motifs (Richard et al., 2003). Therefore, we assumed that destroying the 
putative Cajal body localization element of CD8 will result in nucleolar accumulation 
of the mutant CD8 RNAs. To define the position of the Cajal body localization 
element of CD8, the CD8Del1, CD8Del2 and CD8Del1+2 mutant RNAs were 
transiently overexpressed in HeLa cells and their localization was determined by 
fluorescent in situ hybridization (Figure 28, lower panels). Similarly to the wild-type 
CD8, the CD8Del2 RNA lacking stem-loop St2 accumulated in Cajal bodies together 
with coilin-GFP. In contrast, CD8Del1 and CD8Del1+2 RNAs were detected in large 
domains of the nucleus. Expression of the GFP-tagged nucleolar marker protein 
fibrillarin, a common protein component of box C/D snoRNPs, demonstrated that 
CD8Del1 and CD8Del1+2 accumulated predominantly in the nucleoli of transfected 
cells. These results demonstrated that stem-loop St1 contains sequence or 
structural elements responsible for the Cajal body-specific localization of CD8 
scaRNA.  
Further dissection of the Cajal body localization signal of CD8 RNA is 
currently in progress. Apparently, dissection of the molecular background of 
targeting box C/D scaRNPs into the Cajal body is an important step towards the 
understanding of the complex intranuclear trafficking of mammalian small nuclear 
RNPs. 
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Figure 28. CD8 and CD8 Del2 localizes to Cajal bodies, but CD8 Del1+2 and CD8 
Del1 localize to the nucleolus. CD8, CD8 Del1+2, CD8 Del2 or CD8 Del1 transfected HeLa cells were probed with �luorescent oligonucleotides complementary to the antisense region of CD8 RNA. Nucleoli and Cajal bodies were stained by transient expression of �ibrillarin-GFP and coilin-GFP, respectively. DNA was visualized by DAPI staining.   
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Characterization of CD5 RNA: 
Sequence analysis and predicted function of human CD5 RNA  
 
Vertebrate box C/D modification guide RNAs have been demonstrated to 
function in 2′-O-methylation of rRNAs and spliceosomal snRNAs. During the past 
decade, several mammalian box C/D RNAs lacking complementarities to rRNAs or 
snRNAs have been identified. This strongly suggested that box C/D RNAs, besides 
modifying rRNA and snRNA, may participate in 2’-O-methylation of other cellular 
RNAs. However, so far no experimental evidence supported this hypothesis. In the 
following section, I briefly discuss the preliminary characterization of a novel box 
C/D RNA, called CD5, which is predicted to direct 2’-O-methylation of the vertebrate 
tRNA-MET-CAT elongator.  
 
A perfect genomic copy of the 3’-terminal sequence of human CD5 identified 
by Illumina sequencing was detected in the tenth intron of the human La-related 
protein 4 (LARP4) gene. The CD5 region of the LARP4 gene showed a strong 
evolutionary conservation, indicating that it likely codes for an intronic RNA. Indeed, 
these conserved intronic sequences of the LARP4 gene carried perfect C 
(GUGAUGA) and D (CUGA) box motifs flanked by short complementary sequences 
which predicted the expression of a 215-nt-long human box C/D RNA (Figure 29A). 
Consistent with this, Northern blot analysis of HeLa RNAs with a CD5-specific 
antisense oligodeoxynucleotide probe confirmed the accumulation of a 215 nt-long 
RNA in human cells (Figure 30). Alignment of the predicted CD5 intronic RNA 
sequences retrieved from dog, mouse, chicken, Fugu, Tetraodon and zebrafish 
LARP4 genes showed that the 3’-terminal core C/D motif encompassing a potential 
kink-turn motif is perfectly conserved in vertebrate CD5 RNAs (Figure 29A). 
Moreover, the CD5 sequence alignment also revealed the presence of a 12-nt-long 
evolutionarily invariant potential antisense element immediately preceding the D 
box. This suggests that vertebrate CD5 RNAs possess a common function; they 
likely direct 2’-O-methylation of an evolutionarily conserved cellular RNA. To identify 
potential target sequences for CD5, we performed a computer-mediated analysis of 
the sequences of known human stable cellular RNAs including rRNAs, snRNAs, 
snoRNAs, miRNAs, scaRNAs and tRNAs. We noticed that the predicted antisense 
element of CD5 can form a perfect double helix with internal sequences of the 
human elongator tRNA-MET-CAT (Figure 29B). Intriguingly, its predicted interaction 
with CD5 positions the C34 wobble residue of the anticodon of tRNA-MET-CAT for 
2’-O-methylation. Nucleotides at the wooble position are frequently modified to 
facilitate the faithful recognition of the cognate mRNA codons (see Introduction). 
The wooble residue of elongator tRNAMet is known to be 2’-O-methylated in Archea, 
suggesting that it is likely modified in vertebrates too. Although vertebrate tRNA-
MET-CAT sequences show some nucleotide variations, the putative target 
sequences recognized by CD5 are perfectly conserved (Figure 29B). This further                               
  
A CD5 RNA (215 nt): 
Figure 29. The human CD5 RNA is predicted to direct 2’-O-methylation of 
cytidine 34 at the Wobble position of tRNA-Met elongator A. The CD5 
sequence exhibits structural hallmarks of box C/D RNAs. Boxes C and D are shown in red, the antisense region in blue. Probes used for Northern blot and FISH experiments are indicated by a green arrow. An unusual long internal polypyrimidine track is shown in green. Sequence alignment of identified vertebrate CD5 sequences show that the C/D and the antisense sequences are highly conserved. The internal long polypyrimidine track is conserved as well. The host gene encoding CD5 is indicated. B. Putative function of CD5 RNA. The antisense sequence of CD5 is complementary to the anticodon loop of tRNA-MET-CAT elongator. The C34 wooble base is predicted to be targeted by CD5. Sequence alignment of tRNA-MET-CAT elongator sequences reveals that the putative target region of CD5 is highly conserved.  
CAGCCCAGTGATGATCACTATTCCTACTTAGAGAGAATAGGACTAACTTTCAGAAATCCAGGCATTTTTCTACC  TTTCATACTATCTTTCTTTCACTTTACTTCTCTTTTCTGTCTTTTATCACTTCTTTCTTTCTTCATTCTTTCTCT  CTTTTGCCTGGATCGAGATTGTTAAGTCCCTCTCAGTGAAGGGTAAGATTATGAGATCTGAGGGCT 
B 
C Box 
D Box Antisense 
polypyrimidine track 
       Putative target of CD5 
human6          GCCTCCTTAGCGCAGTAGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAACCTCAGAGGGGGCA 73 
human7          GCCTCCTTAGCGCAGTAGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAACCTCAGAGGGGGCA 73 
MOUSE           GCCTTCTTAGCGCAGTAGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAACCTCAGAGAGGGCA 73 
human1          GCCCTCTTAGCGCAGCTGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCAAGCCTCAGAGAGGGCA 73 
Chicken         GCCCTCTTAGCGCAGCAGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAGCCTCAGAGAGGGCA 73 
human4          GCCCTCTTAGCGCAGCGGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAGCCTCAGAGAGGGCA 73 
human5          GCCCTCTTAGCGCAGCGGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAGCCTCAGAGAGGGCA 73 
human3          GCCCTCTTAGCGCAGCGGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAGCCTCAGAGAGGGCA 73 
human2          GCCCTCTTAGCGCAGCGGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAGCCTCAGAGAGGGCA 73 
human8          GCCCTCTTAGCGCAGTGGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAGCCTCAGAGAGGGCA 73 
DOG             GCCTTCTTAGCGCAGTGGGCAGCGCGTCAGTCTCATAATCTGAAGGTCCTGAGTTCGAGCCTCAGAGAGGGCA 73 
TETRAODON       GCCTCGTTGGCGCAGCAGGCAGCGCGTCAGTCTCATAATCTGAAGGTCGTGAGTTCGAGCCTCACACGGGGCA 73 
ZEBRAFISH       GCCTCGTTGGCGCAGTAGGCAGCGCGTCAGTCTCATAATCTGAAGGTCGTGAGTTCGAGCCTCACACGGGGCA 73 
human9          GCCTCGTTAGCGCAGTAGGTAGCGCGTCAGTCTCATAATCTGAAGGTCGTGAGTTCGATCCTCACACGGGGCA 73 
FUGU            GCCTTGTTGGCGCAGCAGGCAGCGCGTCAGTCTCATAATCTGAAGGTCGTGAGTTCGAGCCTCACACAGGGCA 73 
                ***   ** ******  ** **************************** ******* * ***** *  ***** 
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Figure 30. Characterization of CD5 RNA. A. Northern blot analysis. CD5 RNA was detected in 25μg of nuclear RNAs extracted from HeLa cells. B. In silico predicted secondary structure of CD5 RNA.  The structure was obtained using the RNAfold 
program. An unusually long internal polypyrimidine track is predicted to be unfolded.  
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supports the idea that CD5 may be the first vertebrate 2’-O-methylation guide RNA 
that functions in tRNA modification.  
 
A common structural feature of vertebrate CD5 RNAs is that they carry long 
internal polypyrimidine stretches. For example, the human CD5 features a 94-nt-
long pyrimidine-rich internal sequence that contains only 11 purines. RNA folding 
programs failed to establish any secondary structure for the internal polypyrimidine 
regions of vertebrate CD5 RNAs, although the 5’- and 3’-terminal portions of CD5 
were readily folded into an energetically stable structure (Figure 30). According to 
our knowledge, no similar unstructured polypyrimidine region has been detected in 
other stable cellular RNAs; it is unique feature of CD5 RNAs. 
 
Remarkably, the expression of the intronic CD5 RNA is coordinated by the 
expression of the LARP4 host gene. This is interesting since proteins belonging to 
the La family are known to have important functions in RNA metabolism. They have 
an essential function in the stabilization of nascent Pol III transcripts. For example 
La protein plays a critical role on promoting pre-tRNA processing. The human 
LARP4 protein is less characterized, but it has been shown that it can act as a 
positive factor to promote mRNA stability in the cytoplasm (Bayfield et al., 2010; 
Yang et al., 2011). 
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CD5 is a small Cajal body-specific RNA 
 We attempted to determine the subcellular localization of the human CD5 
RNA. To transiently overexpress CD5, its coding region was PCR-amplified and 
inserted into the pGL expression vector (Figure 31A). Given the evolutionary 
conservation of the unusual internal polypyrimidine stretch, we also wanted to 
understand the functional importance of this motif in CD5 RNAs. To this end, a 
truncated version of CD5 (CD5Del) lacking the internal polypyrimidine sequence 
was also expressed in HeLa cells by using the pGL expression system. RNAs 
extracted from the transfected HeLa cells were analyzed by Northern blotting with a 
CD5-specific oligonucleotide probe. Similarly to the wild-type CD5, the truncated 
CD5Del was efficiently processed from the globin intron. This demonstrates that the 
internal polypyrimidine domain is not essential for the expression and packaging of 
human CD5 into box C/D RNP. 
 Fluorescent in situ hybridization was used to determine the localization of 
overexpressed CD5 and CD5Del RNAs. Staining of pGL/CD5-transfected cells with 
a CD5-specific fluorescent oligonucleotide detected CD5 RNA accumulation in a few 
small nucleoplasmic dots highly reminiscent of Cajal bodies. Indeed, co-expression 
of coilin-GFP with CD5 clearly demonstrated that the transiently expressed CD5 
RNA specifically accumulated in Cajal bodies, demonstrating that human CD5 is a 
Cajal body-specific RNA. The internally truncated CD5Del RNA, however, 
concentrated in the nucleoli of transfected cells. This conclusion was corroborated 
with coexpression of the GFP-tagged nucleolar marker protein fibrillarin. We 
concluded that the internal polypyrimidine stretch of CD5 is crucial for targeting of 
CD5 into the nucleoplasmic Cajal bodies. 
 
 
  
Figure 31. Human CD5 RNA accumulates in Cajal bodies. A. Transient 
expression of human CD5 and CD5Del RNAs in HeLa cells. Schematic structure of the pGL/CD5 expression vector is shown. The computer-predicted structures of CD5 and CD5Del RNAs are shown. RNAs extracted from HeLa cells non-transfected or transfected with the pGL/CD5 and pGL/CD5Del expression plasmids were fractionated on a 6% sequencing gel, electroblotted onto a nylon membrane and probed with terminally labelled oligodeoxynucleotide complementary to the predicted antisense element of CD5 (see Figure 29A). Molecular size markers are indicated B. Localization of CD5 and CD5Del RNAs by fluorescent in situ 
hybridization. HeLa cells transiently expressing CD5 and CD5Del RNAs and GFP-tagged fibrillarin and coilin, as indicated, were probed with a fluorescent oligonucleotide complementary to the antisense region of CD5 RNA. DNA was visualized by DAPI staining.   
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 Association of CD8 and CD5 RNAs with WDR79 
 Although CD8 and CD5 RNAs have been identified as RNAs co-purified with 
WDR79, we wanted to confirm the in vivo interaction of these RNAs with WDR79 
and to confirm that this interaction is necessary for the localization into Cajal bodies.    
We performed co-immunoprecipitation experiments in which transiently 
expressed Flag-WDR79 was immunoprecipited with an anti-Flag antibody and 
association of endogenous RNAs was monitored by Northen blot analysis (Figure 
32). We detected a strong interaction of Flag-WDR79 with the U85 box H/ACA-C/D 
composite scaRNA that was used as a positive control (Figure 32A, and data not 
shown). The CD8 and CD5 RNAs were detected in the pellet of the 
immunoprecipitation reaction, albeit the CD5 signal was quite weak. When the CD8 
RNA was transiently overexpressed in HeLa cells and the endogenous WDR79 
protein was immunoprecipitated with a specific antibody, Northern blotting readily 
detected both U85 and CD8 in the pellet (Figure 32B).  However, as compared to 
the total cell extract, only a small fraction of CD8 was recovered by 
immunoprecipitation of WDR79. This might indicate that WDR79 either weakly 
associates with CD8 or it dissociates from CD8 after targeting it into the Cajal body.     
To confirm the interaction of WDR79 with CD8 and CD5 in living cells, we 
performed in vivo RNA-protein cross-linking experiments (Figure 32C). HeLa cells 
transiently expressing Flag-WDR79, CD5 and CD8 RNAs were treated with 
formaldehyde. Cell extract was prepared and anti-Flag immunoprecipitation reaction 
was performed under very harsh conditions which were predicted to interrupt non-
covalent RNA-protein interactions. Under these stringent conditions CD8, CD5 and 
U85 RNAs remained cross-liked to Flag-WDR79 demonstrating that they interact in 
living HeLa cells. These results confirmed the specificity of the WDR79 association 
with the CD8 and CD5 scaRNAs. 
 Since CD8Del1+2, CD8Del1 and CD5Del mutants do not localize to Cajal 
bodies, we would expect that they do not interact with WDR79. Therefore, it will be 
interesting to test the association of these mutants with WDR79 protein. 
  
Formaldehyde crosslinking
TOT TOT
TOT TOT
nontransfected transfectedFLAG-WDR79
transfectedCD8CD5
transfectedFLAG-WDR79CD8CD5
Pellet FLAG Pellet FLAG
Pellet FLAG Pellet FLAG U85
CD5CD8
U85
CD5CD8
368
313
267
234
213
192
184
368
313
267
234
213
192
184
313
267
234
213
192
184
U85
CD8
transfectedCD8
TOT Beads Pellet WDR79
A B
C
p. 90 
Figure 32. WDR79 associates with CD5 and CD8 in living cells. 
A. Co-immunoprecipitation of U85, CD5 and CD8 RNAs with transiently expressed FLAG-WDR79. Total cell extracts (TOT) prepared from HeLa cells transfected or not transfected with the pFLAG-WDR79 expression construct were subjected to immunoprecipitation with an anti-FLAG antibody. RNAs in the extracts and in the pellets of the immunoprecipitation reactions were analysed by Northern blotting with a mixture of terminally labeled oligodeoxynucleotide probes speci�ic for the U85, CD5 and CD8 RNAs. Size markers are indicated. 
B. A fraction of overexpressed CD8 associates with endogenous WDR79. WDR79 was immunoprecipitated from an extract (TOT) prepared from HeLa cells transfected with the pGL/CD8 expression vector. Co-precipitation of CD8 and U85 was detected by Nothern blotting. Lane beads, mock immunoprecipitation performed without antibody. 
C. In vivo cross-linking of WDR79 and U85, CD5 and CD8 scaRNAs. HeLa cells transfected with pFLAG-WDR79, pGL/CD5 and pGL/CD8 or only with pGL/CD5 and pGL/CD8 were treated with formaldehyde before extract preparation. Immunoprecipitation of Flag-WDR79 was performed under highly stringent conditions and co-puri�ication of covalently cross-linked U85, CD5 and CD8 RNAs were con�irmed by Northern blotting. 
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MATERIALS AND METHODS: 
 
General procedures 
Unless stated otherwise, all techniques used for manipulation of DNA, RNA 
oligonucleotides and proteins were performed according to standard laboratory 
procedures. The identity of all plasmid constructs was verified by sequence 
analysis. Human HeLa cells were grown in Dulbecco's modified Eagle medium 
supplemented with 10% fetal calf serum (Invitrogen). Expression plasmids were 
introduced into HeLa and G3H cells by using the FuGENE transfection reagent 
(Roche), or JetPRIME (Polyplus transfection SA). 
Plasmid constructions, immunoprecipitations, immunofluorescence and in 
situ hybridization where performed as in (Jobert et al., 2009) and in (Richard et al., 
2003).  
Structural analysis of U1 snRNAs  
Following immunoprecipitation, the RNA bound to the beads were partially 
digested by S1, T1, A RNases as described (Antal et al., 2002), except that 5 µg of 
carrier tRNA was added. RNAs partially digested 15 min at room temperature and 
removed from the beads by incubating the beads with proteinase K for 30 min at 37 
°C, phenol extracted, and analysed by reverse transcription as described in the 
reference. The oligonucleotide used as primer for reverse transcription is 5’ GAA 
AGC GCG AAC GCA GTC CCC CAC 3’. 
Purification and identification U1-TAF15 snRNP associated proteins 
 160.106 HeLa cells were incubated 10 min in hypotonic buffer (10 mM Hepes-
KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT). Cells were broken in a tight-
fitting Dounce homogenizer, and nuclei were collected by centrifugation 5 min 1000 
g at 4 °C. Nuclei were resuspended in Buffer II (50 mM Tris-HCl pH 7.5, 200 mM 
NaCl, 5% glycerol, 1 mM EDTA, 1mM DTT, 1 mM PMSF) and disrupted by 10 
passages through a 22 gauge needle, sonicated 5x30 sec (Diagenode Bioruptor, 
medium setting), and 3 freeze-thaw cycles in liquid nitrogen.  The obtained nuclear 
extract was centrifuged 13 000 rpm 10 min at 4 °C and further clarified by 
ultracentrifugation at 100 000 g 15 min at 4 °C. The extract was loaded in a 10-30% 
glycerol gradient and centrifuged 14 hours at 100 000 g. Fractions containing U1 
snRNA were collected and incubated 3 hours with 8TA antibodies immobilized on 
agarose beads for 1 h at 4 °C. Beads were washed 4 times in NET-2 buffer (40 mM 
Tris-HCl pH 7.5, 200 mM NaCl, 0.05% NP-40). 5% of bound RNAs were removed 
from the beads by incubating the beads with proteinase K (40 mM Tris-HCl pH 7.5, 
300 mM NaCl, 1.7% SDS, 0.5mg/ml proteinase K) for 30 min at 37 °C. RNA 3’ end 
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labeling with [5’-32P]pCp was performed as described (Jobert et al., 2009). The 
remaining fraction of the beads was incubated in 100 µl of NET-2 buffer with 5 µg of 
RNase A at room temperature for 30 min. Eluted proteins were precipitated using 
Trichloroacetic acid (TCA), migrated in a 8-15% SDS-PAGE gradient gel and 
subjected to silver staining. Visible specific bands were cut and analysed by MALDI-
TOF mass spectrometry by the Taplin Biological Mass Spectrometry Facility. 
Purification and identification of WDR79-associated RNAs 
108 HeLa cells expressing an N-terminal flag tagged version of human 
WDR79 (GeneCopoeia) were incubated 10 min in hypotonic buffer (10 mM Hepes-
KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT). Cells were broken in a tight-
fitting Dounce homogenizer, and nuclei were collected by centrifugation 5 min 1000 
g at 4 °C. Nuclei were resuspended in NET-2 buffer (40 mM Tris-HCl pH 7.5, 200 
mM NaCl, 0.05% NP-40) and sonicated for 5x30 sec (Diagenode Bioruptor, medium 
setting) The obtained nuclear extract was centrifuged 13 000 rpm 10 min at 4 °C 
and further clarified by ultracentrifugation at 100 000 g 1 hour at 4 °C. The clarified 
extract was incubated with anti-flag antibodies (Sigma-Aldrich) immobilized on 
agarose beads for 1 h at 4 °C. Beads were washed 4 times in NET-2 buffer and 
bound RNAs were removed from the beads by incubating the beads with proteinase 
K (40 mM Tris-HCl pH 7.5, 300 mM NaCl, 1.7% SDS, 0.5mg/ml proteinase K) for 30 
min at 37 °C. Purified RNAs were ethanol precipitated and resuspended in H2O. 
Identification of the purified RNAs by deep-sequencing was done by Fasteris SA 
Genome Analyzer Service (Switzerland) using an Illumina Genome Analyzer GAIIx. 
Endogenous WDR79 IP were performed using rabbit polyclonal antibodies to 
WDR79 suplied by Abcam (ab99376). 
In vivo RNA immunoprecipitation (RIP) of FLAG-WDR79 associated RNAs. 
We performed FLAG immunoprecipitations (IP) following standard 
procedures described before (Muniz et al., 2010). In brief, total sonicated extracts 
from 19.106 of HeLa cells transfected or not with FLAG-WDR79 were subjected to 
IP by incubation with 20µl of ANTI-FLAG M2 affinity gel (Sigma-Aldrich) for 1 hour at 
4 °C, or with anti-flag antibodies (Sigma-Aldrich) immobilized on agarose beads for 
1 h at 4 °C. Beads were washed 4 times in NET-2 buffer and bound RNAs were 
removed from the beads by incubating the beads with proteinase K for 30 min at 37 
°C. Purified RNAs were ethanol precipitated and analysed by Northern blot or 
RNase A/T1 protection as described (Egloff et al., 2006). 
In vivo formaldehyde crosslink and RIP assays 
Prior to extract preparation, formaldehyde crosslink was performed (10 
minutes in 10 mL of phosphate-buffered saline (PBS), 1% formaldehyde). After 
immunoprecipitation, the beads were washed extensively under highly stringent 
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conditions (50 mM Tris-HCl pH 7.4, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 
1% sodium deoxycholate, 0.1% SDS). Formaldehyde-induced RNA-protein 
crosslinks were reversed by mild heat treatment before RNA exctraction. The 
proceure is described in (Niranjanakumari et al., 2002).  
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DISCUSSION I: A NOVEL U1-TAF15 snRNP. 
Biogenesis of the U1-TAF15 particle 
A surprising observation of our study was that we failed to detect Sm core 
proteins in immonuporified U1-TAF15 particles, suggesting that the U1-TAF15 
snRNP does not contain Sm proteins. Nevertheless, we demonstrated that 
biogenesis of the U1-TAF15 snRNP depends on the Sm binding motif of U1 snRNA. 
This suggests that a fraction of the U1 Sm snRNP undergoes a remodeling to 
produce the Sm-free U1-TAF15 snRNP.  
 
 
Several lines of evidence indicate that biogenesis of the spliceosomal U1 Sm 
snRNP has some specific features compared to the assembly of other Sm snRNPs 
(U2, U4 and U5). Vertebrate U1 snRNAs possess a non-canonical Sm-binding site 
and the minimal regions of U1 recognized by SMN are structurally different from the 
SMN-docking elements of other Pol II-specific spliceosomal snRNAs (Battle et al., 
2006; Jarmolowski and Mattaj, 1993). It is therefore possible that the unique Sm-
binding properties of U1 might contribute to the biogenesis of the U1-TAF15 snRNP. 
One could imagine that the nuclear SMN recognizes specifically the U1 Sm snRNP, 
promotes the disassembly of the U1-Sm core complex and chaperones formation of 
the U1-TAF15 particle. During this procedure it is possible that structural and 
sequence specificities of the U1 snRNA may trigger its specific recognition by SMN 
and a selective Sm core disassembly (Pomeranz Krummel et al., 2009). 
Consistent with this idea the SMN-mediated assembly of the snRNA-Sm core 
complex is a reversible process. We can hypothesize that the U1-Sm core complex 
can be specifically disassembled by the nuclear SMN in the Cajal bodies after 
importation of the nascent U1 Sm snRNPs from the cytoplasm. Indeed, binding of 
Sm proteins is required for the nuclear reimportation of snRNPs. We demonstrated 
that U1 pre-snRNAs with altered Sm-binding motifs accumulate in the cytoplasm. 
Recently, a mass spectrometry investigation of the U1 Sm snRNP revealed its 
structural heterogeneity in solution (Hernandez et al., 2009). Furthermore, 
stimulating the dissociation of its components by treatment with 15% of butanol 
revealed a highly ordered disassembly of the U1 snRNP resulting in different 
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subcomplexes. As this dissociation in subcomplexes arise from different interface 
strength interactions, it is probable that they have a correspondence in vivo. 
Therefore, just as the assembly of the Sm core complex requires multiple steps and 
association of different preformed complexes (see Introduction), its dissociation may 
also be accomplished in several steps. This study also revealed that complexes 
containing U1-70K isoform 1 (about 70% of U1 snRNPs) presented a greater 
dissociation tendency of SmB/B’ compared to the complexes containing U1-70K 
isoform 2. The presence of different U1-70K isoforms may have a major effect on 
dynamics of the assembly and disassembly U1 snRNP subunits in vivo.   
The idea that the U1 snRNA can form structurally and most probably 
functionally distinct snRNP complexes in the cell is conceptually not new, since 
examples for  dynamic remodeling of small RNP complexes have been already 
reported. As discussed in the Introduction, several examples show that cellular 
RNAs can associate with distinct sets of RNP proteins under different physiological 
conditions. For example, the 7SK transcriptional regulatory snRNP changes its 
protein composition during transcriptional arrest to control the level of active positive 
transcriptional elongation factor b (P-TEFb). Interestingly the U1-TAF15 association 
is increased upon transcription inhibition, suggesting a regulation upon cellular 
stress. It will be interesting to examine whether other kind of stress signals can 
regulate the biogenesis of the U1-TAF15 particle. 
 
Protein composition of the U1-TAF15 particle 
Given that the major fractions of both known components of the U1-TAF15 
snRNP associate with other nuclear complexes, namely the U1 Sm snRNP and 
TFIID complexes, we expected that purification of the U1-TAF15 snRNP would be a 
challenging task. The fact that we detected the spliceosomal U1 snRNP 
components by the mass spectrometry technique corroborated this. Our results 
strongly suggest that the U1-TAF15 snRNP is structurally distinct from the U1 Sm 
snRNP. Supplemental evidence that TAF15 and U1 snRNA form a distinct complex 
is that after immunodepletion of U1-70K particles, TAF15 association with U1 
snRNA is still detected (L. Jobert, unpublished results). Unfortunately, the glycerol 
gradient fractionation did not allow us to size-separate the U1 spliceosomal 
complexes from the U1-TAF15 snRNP (data not shown). It is possible that a fraction 
of TAF15 associates with the U1-Sm spliceosomal particle or that binding of the 
abundant U1 spliceosomal proteins occurred in the extract during precipitation. This 
needs to be clarified in the future. In order to purify specifically the U1-TAF15 
snRNP, it will be important to separate the U1-Sm complexes from the U1-TAF15 
complexes prior to purification.  
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We detected hnRNP H1 in the TAF15 purification, but the specificity and 
functional significance of hnRNP H1 association with U1 needs further confirmation. 
In principle, this could be an interesting observation given the established role of 
hnRNP proteins in splicing regulation. It is possible that TAF15 binds directly to U1 
and other components binding indirectly to the U1-TAF15 particle were lost during 
the precipitation. To solve this problem, we could try to perform in vivo cross-linking 
before TAF15 precipitation. Cross-linking could prevent the dissociation of bona fide 
U1-TAF15 snRNP-specific proteins. It would also be interesting to treat the cells 
with α-amanitin prior to immunoprecipitation, as this treatment increases the amount 
of U1 associated with TAF15.  
What about the function?  
According to the emerging view, the U1 snRNA, although predominantly 
involved in pre-mRNA splicing, participates in several other aspects of eukaryotic 
gene expression. 
Considering the limited data currently available, we can only speculate about 
the possible function of the U1-TAF15 snRNP. The reader can address some 
important aspects of the discussion of (Jobert et al., 2009). Details on some ideas 
will be discussed in the following section. 
Targeting of U1 snRNA to nascent pre-mRNAs can have multiple 
consequences. So what could be the role of the U1-TAF15 particle on pre-mRNA 
biosynthesis? 
The U1-TAF15 snRNP could have a direct or indirect role on splicing. It is 
now becoming clear that the U1 capacity to recognize proper processing signals 
goes beyond simple U1-mRNA complementarity. This process involves a great 
number of RNA-protein “exploratory” interactions to identify correct 5’ ss. In fact, 
many interactions in the early spliceosome formation are weak, but the combination 
of multiple weak interactions enhances the overall stability. Therefore, it is easy to 
imagine that recruitment of U1 snRNA by TAF15 to nascent transcripts can have an 
effect on splicing.  
A simple possibility would be that the pool of U1 bound by TAF15 would 
base-pair with 5’ splice sites and interfere with the recruitment of the spliceosomal 
U1 snRNP. In this case, it would act as a splicing inhibitor. The U1-TAF15 snRNP 
could also recruit cofactors regulating splicing events. Interestingly, extended U1-5’ 
splice site base-pairing diminishes splicing efficiency in yeast, but not in humans, 
where 5’ splice site recognition is enhanced (Freund et al., 2005). TAF15 could 
modulate the strength of the interaction between its U1 partner and the 5’ splice 
sites. 
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EWS protein, which shares extensive sequence homology with TAF15, binds 
directly to alternatively regulated exons. Upon DNA damage, it is transiently 
relocated into the nucleolus; affecting alternative splicing events with functional 
important consequences (Paronetto et al., 2011). We also observed a partial 
relocalization of the U1-TAF15 snRNP inside the nucleolus in an early stage of 
transcription inhibition, and an increasing amount of U1 snRNA associated to 
TAF15. Therefore, it is possible that upon cellular stress, TAF15 binding to U1 
results in alternative splicing changes relevant for cellular response. It will be 
interesting to test the effect of TAF15 depletion on alternative splicing with splicing-
sensitive microarrays assays. It is also possible that the effect of TAF15 on splicing 
depends on cellular conditions, as it was found in the case of EWS.  
The U1-TAF15 snRNP and transcription initiation. The fact that TAF15 
associates with TFIID, together with the observation that U1 interacts with the 
general transcription initiation factor TFIIH and directly with Pol II might suggest that 
the U1-TAF15 snRNP functions in some aspect of Pol II transcription initiation 
(Kwek et al., 2002; Spiluttini et al., 2010). In addition, this RNP is tightly associated 
to chromatin and is regulated upon transcription inhibition, which would strongly 
agree with a transcription regulatory function of this RNP.  
In addition, this RNP is tightly associated to chromatin and is regulated upon 
transcription inhibition, which would strongly agree with a transcriptional regulatory 
function of this RNP.  
The U1-TAF15 snRNP could also be involved in the processing of pre-
mRNAs. The U1 snRNA can inhibit the two major steps of pre-mRNA 3’ end 
processing: the cleavage and the polyadenylation reactions. In the case of the 
polyadenylation reaction, the main mechanism responsible for U1 inhibition is 
believed to be the interaction between U1-70K and the Poly (A) polymerase. 
Inhibition of the cleavage reaction by U1 snRNP is less understood. Nevertheless, in 
vitro studies suggest that neither U1-70K nor U1A proteins are involved (Vagner et 
al., 2000). The U1 inhibition seems to be general and it seems to occur all over the 
transcript (Kaida et al., 2010), even if its effect on the 3’end was the most studied. 
Interestingly, early U1 crosslinking-map experiments showed interactions with 
regions that exhibit low complementarity to the 5’ end of U1 snRNA (Wassarman 
and Steitz, 1993). This “promiscuous” binding of U1 is specific and functional, and 
may account for its general role on protecting transcripts from premature cleavage 
and polyadenylation. Somehow, the U1 snRNA, through its capacity to recognize 
proper processing signals, seems to play an important role on the “quality control” of 
pre-mRNAs, and its presence is important for full expression of transcripts.  
In this context, it is possible to imagine that the recruitment of U1 snRNA 
molecules to nascent pre-mRNA transcripts by TAF15 would provide novel 
interactions ensuring the correct biosynthesis of some pre-mRNAs.  
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Moreover, U1-independent splicing can occur in humans (Buratti and Baralle, 
2010; Fukumura and Inoue, 2009; Fukumura et al., 2009; Raponi and Baralle, 
2008). Given the essential function of U1 snRNA in protection of pre-mRNAs, we 
could imagine that U1 recruitment by TAF15 into nascent transcripts could be 
important for the biogenesis of transcripts containing U1-independent introns. 
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DISCUSSION II: THE EXPANDING WORLD OF BOX C/D RNPs: NEW 
INSIGTHS INTO THE INTRANUCLEAR TRAFFICKING AND FUNCTION 
OF BOX C/D RNPs 
Deep-sequencing is a powerful technique to characterize eukaryotic 
transcriptomes and to identify novel cellular RNAs. High-throughput sequence 
analysis of human WDR79-associated RNAs provided a substantial amount of 
information on the RNA composition of human Cajal bodies. We have confirmed the 
expression of some of the newly detected WDR79-associated box C/D RNAs by 
Northern blot analysis and concentrated on the characterization of two particularly 
attractive RNAs, termed CD5 and CD8. The in vivo association of CD5 and CD8 
with WDR79 has been confirmed by co-immunoprecipitation and in vivo RNA-
protein cross-linking experiments. 
The newly identified CD8 RNA is predicted to direct 2’-O-methylation of the 
U2 spliceosomal snRNA. Consistent with its association with WDR79 and its 
predicted cellular function, fluorescent in situ hybridization experiments 
demonstrated that the human CD8 RNA concentrates in Cajal bodies. The RNA 
sequence and structural elements directing WDR79-binding and Cajal body-specific 
accumulation of box C/D scaRNAs are fully unknown. 
CD8 is the shortest known scaRNA and, as predicted by computer folding, it 
has a well-defined, thermodynamically highly stable two-dimensional structure. The 
structural properties of CD8 provide the possibility to define the CB-specific 
localization signal of box C/D scaRNAs by using a systematic deletion and mutation 
analysis followed by in situ hybridization. In our preliminary experiments, we have 
identified a stem-loop element (St1) of CD8 that is indispensable for Cajal body 
localization. Further detailed mutational analysis will be conducted in the future. 
First, we will try to identify the minimal elements in St1 which direct the localization 
of CD8 to Cajal bodies. We are also testing whether fusion of the St1 stem-loop of 
CD8 to a nucleolar box C/D snoRNA can target that composite snoRNA-St1 RNA 
into the Cajal body. To this end, we have built a pGL expression construct that upon 
transfection into HeLa cells, efficiently expressed an artificial hybrid snoRNA 
composed of the MBII52 canonical box C/D snoRNA and the St1 stem-loop 
structure of CD8 (our unpublished data). In situ localization of the transiently 
expressed MBII52-St1 RNA is in progress. In conclusion, we strongly believe that 
this strategy will allow us to determine and functionally characterize in great details 
the Cajal body localization signal of box C/D scaRNAs. 
The human CD5 RNA has attracted our attention since it possesses unique 
structural features. The CD5 RNA seems to be the first example of an eukaryotic 
box C/D RNA which directs 2’-O-methylation of a tRNA. Many important functions 
have been reported for tRNA modifications in the cell, as detailed in the Introduction. 
Notably, modifications of the wooble nucleotide of tRNAs decoding methionine 
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amino acids (tRNA-MET-CAT initiator and tRNA-MET-CAT elongator) are current. In 
fact, the initiator and elongator tRNA-MET are special since they read exclusively 
the Met-AUG codon, and modifications of the wooble base support the specificity of 
this recognition. Until now, it was supposed that the capacity of Archeal box C/D 
sRNPs to target tRNAs could be specific to this kingdom, but this may not be the 
case.  
It will be important to further confirm the target of CD5 by demonstrating that 
the C34 wobble residue in human tRNA-MET elongator is 2’-O-methylated. We are 
currently mapping the methylation pattern of tRNA-MET by using reverse 
transcripton assays. We will perform antisense oligonucleotide-mediated CD5 
knock-down experiments to demonstrate that CD5 is required for tRNA-MET 
methylation. Of course, efficient interruption of tRNA-MET methylation at C34 would 
also allow us to understand the functional importance of this wooble modification 
event.  
The internal part of the human CD5 RNA contains a long evolutionarily 
conserved polypyrimidine stretch that cannot be folded into a secondary structure. 
This unusual structural element of CD5, thus far unique to CD5, has been 
demonstrated to be essential for Cajal body-specific accumulation of CD5. It remain 
unclear whether this sequence motifs can direct WDR79 binding or it represents a 
novel Cajal body localization signal that interacts with some, thus far unknown Cajal 
body protein. This hypothesis might be supported by the observation that CD5 
shows very weak association with WDR79.   
 In addition, it would be of great interest to analyze the in vivo trafficking of 
the pre-tRNA-MET elongator before its accumulation in the cytoplasm. Since CD5 is 
a scaRNA, it is possible that the CD5-guided pre-tRNA-MET modification occurs in 
the Cajal body. This would provide us with new insights into the function of the Cajal 
body, and implicate these structures in the biogenesis of tRNAs. 
These days, we are witnessing a rapid expansion of the noncoding RNA 
world. It is becoming evident that eukaryotic cells express a tremendous number of 
uncovered noncoding RNAs which are still waiting for discovery and for functional 
characterization. We can predict with great certainty that further exploration the 
complex universe of noncoding cellular RNAs will provide us with new, significant 
and surprising insights into the function of eukaryotic cells. 
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SUMMARY 
 
Noncoding regulatory RNAs (ncRNAs) are in the focus of current research, since 
they participate in nearly all cellular processes. To get further insights into the 
functional and structural complexity of ncRNAs, we studied human ncRNAs belonging to 
two classes of ncRNAs, the nucleoplasmic spliceosomal snRNAs and the nucleolar and 
Cajal body-specific box C/D 2’-O-methylation guide RNAs. 
The U1 snRNP is an evolutionarily conserved, abundant nucleoplasmic snRNP 
that plays a central role in pre-mRNA splicing. According to a recently emerging view, 
besides its constitutive role in splicing, the U1 snRNP has important regulatory functions 
in different steps of pre-mRNA production. We demonstrated that a fraction of the 
human U1 snRNA specifically associates with the nuclear RNA-binding protein TAF15 
that is known to interact with a subpopulation of TFIID and RNA polymerase II 
complexes. The U1-TAF15 snRNP is structurally and functionally distinct from the well-
characterized U1 spliceosomal snRNP and it tightly associates with chromatin. The 
function of U1-TAF15 snRNP remains unknown; it might contribute to the coupling of 
transcription and splicing. 
WDR79 (also called WRAP53) has been recently identified as an essential factor 
for targeting a subclass of box C/D and H/ACA modification guide RNAs, as well as 
telomerase H/ACA RNA, into the Cajal bodies. Accumulation of box C/D and H/ACA 
RNPs in Cajal bodies is essential for the biogenesis of functional spliceosomal snRNPs 
and telomere synthesis. Co-immunopurification of WDR79-associated human RNAs, 
followed by cDNA synthesis and deep sequencing identified a large number of novel 
Cajal body-specific RNAs. We are currently dissecting the cis-acting RNA element 
responsible for WDR79-binding and for targeting box C/D 2’-O-methylation guide RNPs 
into Cajal bodies. We have also identified a novel Cajal body-specific 2’-O-methylation 
guide RNA that is predicted to direct methylation of cytidine 34 at the Wobble position 
of tRNA-Met-CAT elongator. Interestingly, tRNA modification is a novel function for 
vertebrate box C/D scaRNPs. 
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